Structure And Activities Of The Saccharomyces Cerevisiae Nuclear Rna Exosome by Zinder, John
  
STRUCTURE AND ACTIVITIES OF THE SACCHAROMYCES CEREVISIAE 
NUCLEAR RNA EXOSOME 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of Weill Cornell Graduate School 
Of Medical Sciences 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
by 
John Charles Zinder 
March 2018  
  
 
 
 
 
 
 
 
 
 
 
©2018 John Zinder   
 STRUCTURE AND ACTIVITIES OF THE SACCHAROMYCES CEREVISIAE 
NUCLEAR RNA EXOSOME 
John Charles Zinder, Ph.D 
Cornell University, 2018 
 
 The eukaryotic RNA exosome is an essential and conserved protein complex 
that can degrade or process RNA substrates in the 3’ to 5’ direction. The nuclear RNA 
exosome includes a non-catalytic donut-shaped core (Exo9) that binds Dis3 (aka 
Rrp44) and the Rrp6/Rrp47 heterodimer to modulate their processive and distributive 
exoribonuclease activities, respectively. Additionally, cofactor proteins such as Mpp6 
and the TRAMP and Ski complexes assist the exosome in RNA decay in different 
subcellular compartments. 
 Decades of study have revealed that the exosome acts on all classes of RNA in 
diverse model organisms and that the catalytic subunits primarily engage these 
substrates by first threading them through a prominent central channel in Exo9. 
Structural and biochemical studies have demonstrated that this channel is wide enough 
to permit single-stranded but not double-stranded RNA to enter, presenting an obstacle 
for degradation of structured substrates. This can be overcome by extension of the 
RNA 3’ end, which can be accomplished by the polyadenylation and RNA helicase 
activities of the nuclear TRAMP complex. Recruitment of TRAMP to the exosome 
and the interplay between the various activities contained within these complexes 
remain unclear due to lack of rigorous biochemical characterization. 
 Contained within this dissertation are our efforts to investigate this important 
process, starting with structural characterization of the cofactor-less nuclear exosome 
(Exo9 plus Rrp6 and Dis3) in Chapter 1. Use of an engineered substrate enabled 
crystallization and X-ray structure determination of this complex, which uncovered 
 features in the non-catalytic core that modulate Dis3’s activity in vitro. We also show 
that a 3’ phosphate containing RNA cannot be trimmed by Rrp6 and instead is fully 
degraded by Dis3. Chapters 2 and 3 concern recruitment of Mtr4, the TRAMP 
complex RNA helicase, to the exosome. In Chapter 2, we solve the crystal structure of 
the nuclear exosome bound to the cofactor Mpp6. Biochemical characterization of the 
Mpp6-exosome revealed that Mpp6, along with Rrp6/Rrp47, physically tethers Mtr4 
to the complex and enables ATP-dependent degradation of structured substrates. 
Chapter 3 details preliminary work on structurally characterizing a substrate-loaded 
Mtr4-exosome complex using cryo-electron microscopy. 
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	 1 
 INTRODUCTION 
 
RNA decay in eukaryotes  
 
 RNA decay is an essential cellular process that regulates gene expression, 
generates mature RNAs from precursors, and monitors RNA quality in all organisms. 
RNAs can be degraded in either of three ways: from 5’ end towards the 3’ end by 5’-
3’ exoribonucleases, from 3’ end towards the 5’ end by 3’-5’ exoribonucleases, or by 
cleavage in the middle by endoribonucleases. Every organism has evolved an 
ensemble of RNA degrading enzymes (RNases) possessing unique enzymatic 
characteristics (e.g. decay rate, decay processivity, nucleotide specificity etc.), protein-
protein interaction networks, and subcellular localizations that are tailored to the 
particular needs of that organism. In spite of this tremendous diversity, several themes 
of RNA decay have emerged that seem to be generally applicable. Most notably, 
decay rates by many RNases are affected by the proteins bound to that particular 
RNA, and activities of many exoribonucleases are regulated based on specific 
chemical or structural features of the ends from which they are degrading (Belair et 
al., 2017; Kilchert et al., 2016). These types of restrictions ensure that RNA decay can 
be regulated, often enabling for targeting of aberrant transcripts over healthy ones 
(quality control) or unneeded regulatory genes over housekeeping ones (gene 
regulation). Furthermore, functional RNAs are rarely transcribed in their fully mature 
form, often requiring many steps of endo- and exonucleolytic degradation to ensure 
they achieve their proper mature form. While this generation of excess RNA may 
seem wasteful at first glance, it can provide an effective check of the fidelity of 
transcription, RNA folding, protein association, and post-transcriptional modifications 
of diverse RNAs. A prototypical example of this is tRNA splicing, where the pre-
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tRNA contains an intron that is excised by the essential Sen2 and Sen34 
endonucleases in yeast (Ho et al., 1990). These nucleases associate with the essential 
Sen54 protein, which binds the acceptor stem and functions as a ‘ruler’ to position the 
endonuclease active sites precisely at the boundaries of the intron. This ensures that 
only properly folded tRNAs will have their introns removed, and misfolded tRNAs 
will be retain them and be targeted for degradation (Trotta et al., 1997). 
 Pervasive transcription of eukaryotic genomes generates a great diversity of 
RNAs (ENCODE Project Consortium, 2012), some of which go on to carry out 
specific functions but many of which are targeted by adaptor proteins for rapid 
degradation by the RNA decay machinery (Belair et al., 2017; Kilchert et al., 2016). 
Examples of the latter category include cryptic unstable transcripts (CUTs), promoter 
upstream transcripts (PROMPTs), and enhancer RNAs (eRNAs) (Pefanis et al., 2015; 
Preker et al., 2008; Wyers et al., 2005). Whether these RNAs result from 
transcriptional noise or can be stabilized under certain conditions to carry out discrete 
functions is still a subject of ongoing research. Stable transcripts, by contrast, are 
thought to escape degradation via co-transcriptional recruitment of stabilizing factors 
(e.g. capping enzymes, the spliceosome). Some healthy, functional RNAs can also be 
degraded at faster rates than others, with housekeeping genes tending to have slower 
decay rates than regulatory genes (Hanson and Coller, 2018; Lima et al., 2017; 
Presnyak et al., 2015; Yang et al., 2003). This both limits the steady-state expression 
levels of regulatory proteins and enables cells to rapidly alter their transcriptional 
program in response to changes in the extracellular environment. 
 In this introduction, we will first give a brief survey of conserved exonucleases 
other than the exosome and their RNA targets, structures, and roles within the cell. 
Then we will move on to discuss the exosome and its cofactors, including structures, 
biological functions, and means of selective RNA targeting. 
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XRN1 and XRN2: the major eukaryotic 5’-3’ exonucleases 
 In eukaryotes, 5’-3’ exonucleolytic degradation of RNAs is primarily carried out 
by the structurally related Xrn1 and Xrn2 (aka Rat1) nucleases in the cytoplasm and 
nucleus, respectively. These enzymes are highly processive RNA degradation 
machines, but they cannot act on capped or recessed 5’ ends, thus restricting their 
activities on properly processed and structured RNAs (Akiyama et al., 2016). 
 Xrn1 is the primary source of mRNA turnover in the cytoplasm of S. cerevisiae 
(Anderson and Parker, 1998), and it participates in the translation-dependent RNA 
decay pathways non-stop-, no-go-, and nonsense-mediated decay (NSD, NGD, NMD) 
(Łabno et al., 2016a). Additionally, S. cerevisiae Xrn1 targets a subset of unstable 
non-coding RNAs (ncRNAs) known as Xrn1-sensitive unstable transcripts (XUTs) for 
rapid degradation, thus preventing their accumulation (van Dijk et al., 2011). The 
structure of Drosophila melonogaster Xrn1 bound to a small fragment of 5’ phosphate 
containing DNA (to prevent turnover during crystallization) revealed that the 5’ 
terminus of the substrate resided in a conserved basic patch at the end of a narrow cleft 
which could accommodate approximately 4 nucleotides (nt) of single-stranded nucleic 
acid (Jinek et al., 2011). This situates the penultimate nt perfectly within the 
hydrolytic active site and explains why a 5’ OH at the 5’ end but not modifications 
significantly bulkier than a phosphate, such as a triphosphate or m7GpppG cap, can be 
degraded by the enzyme. 
 During transcription, Xrn2 recognizes the 5’ end of downstream RNAs that have 
been cleaved after polyadenylation or co-transcriptional cleavage site and rapidly 
degrades them, which in turn stimulates dissociation of RNA polymerase from the 
template in a so-called ‘torpedo’ mechanism (Proudfoot, 1989; West et al., 2004). 
Additionally Xrn2 functions in 5’ end processing of rRNA and snoRNAs in the 
nucleolus (Gasse et al., 2015; Nagarajan et al., 2013; Łabno et al., 2016a). The 
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structure of Rat1 bound to its partner Rai1 from Schizosaccharomyces pombe 
resembles the active site architecture of Drosophila Xrn1 but highlighted a 
pyrophosphohydrolase activity of Rai1 (Xiang et al., 2009). This activity can remove 
the beta and gamma phosphate from 5’ triphosphate RNAs in vitro, leaving behind 
Xrn2’s preferred substrate. While the interaction between Rai1 and Xrn2 is poorly 
conserved in other organisms, this suggests a strategy by which Xrn2 can degrade 
aberrantly uncapped or viral RNAs (Nagarajan et al., 2013; Xiang et al., 2009). In 
vertebrates, three proteins contain Xrn2-binding domains (XTBD) that bind and 
stabilize Xrn2 via the same conserved interface, suggesting the existence of multiple 
heterodimeric Xrn2 complexes in these organisms (Miki et al., 2014; Richter et al., 
2016). 
 
Other major eukaryotic 3’ to 5’ exonucleases 
 Eukaryotic genomes encode a variety of distributive 3’-5’ exoribonucleases with 
specificity towards poly(A) RNA collectively known as deadenylases. In many cases 
mRNA deadenylation is thought to precede decapping and full degradation, 
underscoring the importance of these enzymes in RNA metabolism. The two most 
prominent among the deadenylases are the Pan2/3 and Ccr4-Not complexes (Collart 
and Panasenko, 2012; Wolf and Passmore, 2014; Łabno et al., 2016a). Pan2/3 is a 
predominantly cytoplasmic complex that consists of an asymmetric dimer of Pan3 
proteins bound to a single molecule of Pan2 exonuclease (Jonas et al., 2014; Schäfer et 
al., 2014; Wolf et al., 2014). Because Pan2/3 can trim but not totally remove poly(A) 
tails and is stimulated by the presence of poly(A)-binding protein (PABP), it is 
thought that this complex initiates poly(A) tail removal (Lowell et al., 1992; Uchida et 
al., 2004; Łabno et al., 2016a). Ccr4-Not is a large multiprotein complex found in both 
the nucleus and cytoplasm of cells that contains two separate exonuclease subunits: 
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Ccr4 and Caf1/Pop2 (Collart and Panasenko, 2012; Stowell et al., 2016). Because 
Ccr4-Not can completely remove poly(A) tails and is inhibited by poly(A) binding 
protein (PABP) (Stowell et al., 2016; Tucker et al., 2002), fewer of which would be 
bound to shorter tails, it is thought to finish the deadenylation that was initiated by 
Pan2/3. Recently, it was shown that the most abundant Caenorhabditis elegans 
mRNAs contained approximately 30 or 60 nt poly(A) tails, which roughly corresponds 
to only one or two PABPs bound (Lima et al., 2017). Because initial poly(A) tail 
length is thought to be the same for all mRNAs, the authors suggest a role of 
deadenylases in pruning of these RNAs to achieve this apparently optimal poly(A) tail 
length on abundant RNAs. They also note that these abundant, short-tailed RNAs are 
very efficiently translated, have highly optimized codon content, and relatively long 
half-lives, suggesting crosstalk between the translation, deadenylation, and RNA 
decay pathways (Lima et al., 2017; Presnyak et al., 2015). 
 In addition to polyadenylation by poly(A) polymerases, RNA 3’ ends of certain 
transcripts can be uridylated by terminal uridyl transfereases (TUTases) and targeted 
for degradation without the need for deadenylation. Dis3l2, a paralog of human Dis3 
that does not associate with the exosome, is a processive 3’-5’ exoribonuclease that 
targets 3’ poly(U) containing RNAs for full degradation (Malecki et al., 2013; Viegas 
et al., 2015). Notably, both Dis3l2 and TUTases are present in diverse eukaryotes but 
absent in S. cerevisiae (Viegas et al., 2015; Łabno et al., 2016a). In higher eukaryotes, 
TUTases also add poly(U) tracts to mRNAs after deadenylation, after which point they 
are acted upon by both 5’-3’ and 3’-5’ decay pathways (Lim et al., 2014). 
 Genetic analysis of individuals with Perlman’s overgrowth syndrome revealed 
that Dis3l2 was lacking exons critical for activity, and subsequent analysis of Dis3l2 
knockdown cells in culture revealed a dysregulation of mitotic control (Astuti et al., 
2012). Soon after this discovery, Dis3l2’s activity was shown to play an important role 
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in the surveillance of let-7 family micro RNAs. The pluripotency factor LIN28 
recognizes let-7 precursors (pre-let7) and recruits the TUTases Zcchc11 or Zcchc6 
(aka TUT4 and TUT7, respectively), which add a ~14 nt poly(U) tract to allow 
degradation by Dis3l2 (Chang et al., 2013; Heo et al., 2009; Thornton et al., 2012; 
Ustianenko et al., 2013). Transcriptome-wide studies have connected Dis3l2’s activity 
to surveillance of a wide variety of cytoplasmic ncRNAs in a uridylation-dependent 
manner (Pirouz et al., 2016; Łabno et al., 2016b). In Drosophila, the connection 
between 3’ uridylation and Dis3l2-dependent decay is taken a step further: DmDis3l2 
physically interacts with the TUTase Tailor to form the so-called TRUMP complex, 
which can degrade a wide variety of structured substrates in vitro and in vivo (Reimão 
Pinto et al., 2016). Structural and biochemical studies of mammalian Dis3l2 revealed 
base-specific contacts that underlie poly(U) recognition and an RNA path that explains 
the preference of the enzyme for RNAs containing 3’ poly(U) tracts of ~14 nt or 
longer (Faehnle et al., 2014). 
 
The eukaryotic RNA exosome 
 The eukaryotic RNA exosome is a conserved multi-subunit protein complex that 
catalyzes 3’-5’ processing or degradation of a vast array of different RNA substrates 
(Januszyk and Lima, 2014; Kilchert et al., 2016). Since its discovery as a key factor 
involved in 3’ processing of rRNAs during ribosome biogenesis in budding yeast 
(Mitchell et al., 1997), transcriptome-wide analyses in diverse eukaryotic model 
systems revealed that the RNA exosome contributes to the processing and/or 
degradation of every known class of RNA (Chekanova et al., 2007; Pefanis et al., 
2014; Schneider et al., 2012). 
 Nuclear and cytoplasmic forms of the RNA exosome are defined by unique 
subunit compositions that interact with distinct cofactors in these subcellular 
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compartments (Table 1 and Figure 1). In the cytoplasm of S. cerevisiae, the exosome 
includes a nine-subunit core (Exo9) that interacts with Dis3 (aka Rrp44) to form a ten-
subunit complex (Exo10Dis3). The Exo9 core lacks catalytic activity while Dis3 
catalyzes endoribonuclease (endo) and processive 3’-5’ exoribonuclease (exo) 
activities (Dziembowski et al., 2007; Lebreton et al., 2008; Liu et al., 2006). Although 
redundant with cytoplasmic 5’-3’ decay pathways (Anderson and Parker, 1998), 
Exo10Dis3 contributes to translation-dependent mRNA surveillance pathways NSD, 
NMD, and NGD (Łabno et al., 2016a). All ten genes encoding subunits of Exo10Dis3 
are essential for viability in yeast (Brouwer et al., 2001; Mitchell et al., 1997). While 
dis3 alleles that disrupt its endo activity bear few phenotypic defects, mutations that 
disrupt its exo activity result in slow-growth, and mutations that disrupt both activities 
result in a synthetic growth defects or inviability (Lebreton et al., 2008; Schaeffer et 
al., 2009; Schneider et al., 2008). In the nucleus, Exo10Dis3 associates with a 
distributive 3’ to 5’ exoribonuclease Rrp6 (aka EXOSC10 and PM/Scl-100) and its 
obligate binding partner C1D (aka Rrp47) to form a 12-component complex 
(Exo12Dis3/Rrp6/C1D) (Briggs et al., 1998; Feigenbutz et al., 2013a). While Rrp6 is not 
essential, Δrrp6 strains display a slow-growth phenotype, temperature sensitivity, and 
RNA processing defects (Allmang et al., 1999a; 1999b; Briggs et al., 1998). 
 Subunit compositions of nuclear and cytoplasmic RNA exosomes from human 
resemble yeast, with some notable differences. For instance, humans encode two 
exosome associated Dis3 enzymes that associate with the core, Dis3 and Dis3l, that 
localize to the nucleus and cytoplasm, respectively (Staals et al., 2010; Tomecki et al., 
2010) (Figure 1). Similar to yeast, human Dis3 and Dis3l possesses exo activity, 
though only Dis3 has an intact endo catalytic site. Dis3 is excluded from the nucleolus 
in human cells while Rrp6, C1D, and Mpp6 are localized to the nucleus and enriched 
in the nucleolus (Schilders et al., 2007; Staals et al., 2010; Tomecki et al., 2010),  
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Table 1: RNA exosome and cofactors 
 
 
 
 Human Gene Protein Name(s) Localization 
S1/KH cap 
EXOSC1 Csl4, Ski4 Nucleus/cytoplasm 
EXOSC2 Rrp4 Nucleus/cytoplasm 
EXOSC3 Rrp40 Nucleus/cytoplasm 
PH-like ring 
EXOSC4 Rrp41, Ski6 Nucleus/cytoplasm 
EXOSC5 Rrp46 Nucleus/cytoplasm 
EXOSC6 Mtr3 Nucleus/cytoplasm 
EXOSC7 Rrp42 Nucleus/cytoplasm 
EXOSC8 Rrp43 Nucleus/cytoplasm 
EXOSC9 Rrp45, PM/Scl-75 Nucleus/cytoplasm 
Distributive 3’-5’ 
exoribonuclease EXOSC10 Rrp6, PM/Scl-100 Nucleus 
Processive 3’-5’ 
exoribonuclease, 
endonuclease 
DIS3 Dis3, Rrp44 Nucleus (yeast), Nucleoplasm (human) 
Processive 3’-5’ 
exoribonuclease DIS3L1 Dis3l1 Cytoplasm (human) 
Exosome cofactor C1D C1D, Rrp47, Lrp1 Nucleus 
Exosome cofactor MPP6 Mpp6 Nucleus 
Exosome cofactor HBS1L HBS1L (isoform 3, human), Ski7 (yeast) Cytoplasm 
Ski complex 
SKIV2L Ski2 helicase Cytoplasm 
TTC37 Ski3 Cytoplasm 
WDR61 Ski8 Cytoplasm 
TRAMP complex 
MTR4 Mtr4 helicase Nucleus  
ZCCHC7 Air1/2 (yeast), Air1 (human) 
Nucleus (yeast), 
Nucleolus (human) 
PAPD5 Trf4/5 (yeast), PAPD5/Trf4-2 (human) 
Nucleus (yeast), 
Nucleolus (human) 
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Figure 1. Localization and subunit composition of the exosome and related 
complexes. Schematic representations of the exosome composition and major 
exosome-related cofactors in the different compartments of S. cerevisiae (A) and 
human (B) cells. Cartoons were designed to reflect available structural, biochemical, 
and genetic data.  
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suggesting that the nuclear RNA exosome in humans includes Exo9, Dis3, Mpp6, and 
Rrp6/C1D (Exo13Dis3/Mpp6/Rrp6/C1D) and that a nucleolar exosome may include Exo9, 
Mpp6, and Rrp6 as the only nuclease, presumably associated with C1D 
(Exo12Mpp6/Rrp6/C1D). Mammalian cells lacking Dis3 cannot grow, and mutations that 
disrupt both its exo and endo activities are synthetic lethal in HeLa cells, indicating 
that Dis3 activities are not fully redundant with other RNA decay pathways (Tomecki 
et al., 2014). 
 
RNA exosome structure, activities, and RNA paths to enzymatic subunits 
 
 While the structure of the human Exo9 core was obtained more than a decade 
ago, more recent crystal and cryo-electron microscopy (cryo-EM) structures have 
revealed architectures for intact yeast cytoplasmic and nuclear RNA exosomes in 
complex with RNA substrates and co-factors. Combined with biochemical and genetic 
studies, these structures illuminate roles for the non-catalytic core in modulating the 
activities of the associated ribonucleases and the impact of RNA path selection with 
respect to the fate of RNA substrates. 
 
RNA exosome core and catalytic subunits 
 The Exo9 core includes a ring of six proteins (Rrp41, Rrp42, Rrp43, Rrp45, 
Rrp46 and Mtr3; collectively known as the PH-like ring) that are structurally 
homologous to the bacterial phosphorolytic exoribonuclease RNase PH, which 
consumes phosphate to degrade RNAs and releases NDPs as products. This ring is 
capped by a ring of three proteins with S1 and K-homology (KH) domains (Rrp4, 
Rrp40, and Csl4, which lacks a KH domain; the S1/KH cap). Together, Exo9 forms a 
non-catalytic donut shaped complex with a prominent central channel that is wide 
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enough to accommodate single-stranded RNA (ssRNA) (Liu et el., 2006; 
Dziembowski et al., 2007) (Figure 2 and Table 1). While the architecture of Exo9 
closely resembles those of bacterial PNPase and the archaeal exosome, an important 
difference is that the bacterial and archaeal complexes contain phosphorolytic activity 
and Exo9 is devoid of catalytic activity (Dziembowski et al., 2007; Januszyk and 
Lima, 2014; Liu et al., 2006) (Figure 2A). A notable exception is the exosome core of 
Arabidopsis thaliana, which has recently been shown to contain phosphorolytic 
exonuclease activity in the Rrp41 subunit of its Exo9 (Sikorska et al., 2017). 
Inactivation of this activity resulted in specific rRNA processing defects, suggesting 
that it collaborates with the hydrolytic exonucleases within the nuclear complex. 
Phylogenetic analysis of the Rrp41 protein supported that this activity operates 
throughout the green lineage and suggests an ancestral eukaryotic RNA exosome that 
retained its phosphorolytic activity. 
 Catalytic subunits of the RNA exosome include Rrp6 and at least one isoform 
of Dis3. Dis3 and Dis3l (in the cytoplasm of higher eukaryotes) include an active site 
that catalyzes processive Mg2+-dependent hydrolytic (meaning the enzymes consume 
water to degrade RNAs, releasing NMPs as products)  3’ to 5’ exoribonuclease 
activity (Dziembowski et al., 2007; Makino et al., 2013b; Staals et al., 2010; Tomecki 
et al., 2010). The exoribonuclease module of Dis3 encompasses a two cold-shock (CS) 
domain, a central catalytic RNB domain, and a C-terminal S1 domain (Figure 3A). 
Dis3’s domain architecture and structure resemble those of bacterial RNAse II and 
RNAse R, as well as mammalian Dis3l2 (Chu et al., 2017; Faehnle et al., 2014; Frazão 
et al., 2006; Lorentzen et al., 2008) (Figure 3). The RNA path to the active site of 
ScDis3 is nearly identical to that of Mus musculus Dis3l2 and E. coli RNase II until 
the 6th nt. After this point, it turns to enter a channel between CSD1 and the S1 domain 
in ScDis3 while it turns the opposite way to go between CSD2 and the S1 domain of  
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Figure 2. Conservation of architecture among 3’ to 5’ RNA degradation 
complexes. (A) Schematic (left) and surface representations (right) of top views of 
bacterial RNase PH (PDB 1UDN), bacterial PNPase (PDB 1E3P), the Rrp4 containing 
archaeal exosome (PDB 2JE6), and human Exo9 (PDB 2NN6). Phosphorolytic RNase 
active sites are depicted as red dots on the schematics. Modified from Figure 2 of 
Januszyk and Lima, 2014. (B) Simplified schematic representation of the side and top 
views of the eukaryotic Exo9 core. The central channel is represented by dotted lines 
in the side view.  
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Figure 3. Comparison of domain architecture and RNA paths among Dis3 
homologs. (A) Domain schematic for S. cerevisiae Dis3 (ScDis3). Active sites are 
highlighted with stars, and domains are colored to correspond with those in panels B 
through E. Amino acid length is shown. The PIN domain, which binds the exosome 
core and is not encompassed in the structure in panel B, is indicated with a white box. 
(B-D) RNA paths to the RNB active site of ScDis3 (B), mouse Dis3l2 (C) and the 
bacterial Dis3 homolog RNAse II (D). Structures were aligned to the RNB domain of 
ScDis3. E) Overlay of RNA paths to the RNB exonuclease site. Surfaces were 
generated in Pymol (Schrödinger) using domains from the ScDis3 structure (PDB 
2VNU). RNA from all three structures is represented as a ribbon with 5’ and 3’ ends 
indicated.  
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the other two enzymes (Figure 3E). Dis3 from yeast and human include a second 
active site in the PilT N-terminal (PIN) domain that catalyzes distributive Zn2+/Mn2+-
dependent endoribonuclease activity (Lebreton et al., 2008; Schaeffer et al., 2009; 
Schneider et al., 2008). The PIN domain also binds the PH-like ring subunits opposite 
to their surfaces that interact with the S1/KH cap (Bonneau et al., 2009), tethering 
Dis3 to the exosome. The nuclear subunit Rrp6, a homolog of bacterial RNAse D, 
includes a single active site that catalyzes Mg2+-dependent distributive 3’ to 5’ 
hydrolytic exoribonuclease activity (Burkard and Butler, 2000; Targoff and Reichlin, 
1985) (Figure 4). While Rrp6’s C-terminal exosome interacting region (EAR) wraps 
around Exo9 making extensive contacts to Csl4, Mtr3, and Rrp43, the catalytic 
module, which includes the Exo domain, an N-terminal region and a helicase and 
RNase D C-terminal (HRDC) domain (Figure 4), rests atop the Exo9 on a conserved 
surface of cap proteins Rrp4 and Rrp40 (Makino et al., 2013b; Wasmuth et al., 2014) 
(Figures 1 and 5).  
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Figure 4. Structures of Rrp6 and RNase D. (A) Domain schematic for S. cerevisiae 
Rrp6 (ScRrp6). The active site is highlighted with a star, and domains are colored to 
correspond with those in panels B through D. Amino acid length is indicated. The 
PMC2NT, EAR, and lasso domains, which are not encompassed in the structure in 
panel B, are indicated with white boxes. (B-D) Crystal structures of the catalytic 
module of ScRrp6 (B), human Rrp6 (E) and the bacterial Rrp6 homolog RNAse D 
from E. coli (D). Structures were aligned based to the Exo domain of ScRrp6. AMP 
and/or metal ions proximal to the active site of each enzyme are highlighted. 
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Figure 5. RNA paths and Dis3 conformations in the yeast nuclear exosome. (A) 
Domain schematics for S. cerevisiae Exo9 components. Amino acid lengths are 
indicated. (B) Direct-access conformation of Dis3. Dis3 and Rrp6 EAR domain are 
from PDB 5K36. The central channel is indicated by black dashed lines and RNA is 
represented as a red line with 5’ end indicated. (C) Through-channel conformation of 
Dis3. Dis3 is from PDB 4IFD and Rrp6 EAR domain is from PDB 5K36. RNA and 
the central channel are indicated as previously, with the dashed red line representing a 
speculative RNA path to the Dis3 endo active site. (D) Rrp6 catalytic module (from 
PDB 5K36) bound to the core with RNA in its active site. RNA path to Rrp6 is based 
on biochemical data and PDB 5K36. Modified from Figure 1 of Zinder and Lima, 
2017.  
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 An early hypothesis posited that RNA degradation by the exosome was 
conceptually similar to protein degradation by the proteasome (van Hoof and Parker, 
1999). In this model, the ribonuclease active sites of the complex are sequestered from 
the cellular milieu to prevent spurious degradation, and purposeful degradation 
requires that substrates be licensed to gain access to the active sites through a 
restricted channel. Subsequent studies largely confirmed this hypothesis (Makino et 
al., 2013a), including the observation that Rrp6 and Dis3 activities were modulated or 
inhibited when associated with the Exo9 core (Bonneau et al., 2009; Dziembowski et 
al., 2007; Wasmuth and Lima, 2012a), and that various surfaces within the Exo9 
central channel were important for guiding RNA to the respective active sites in both 
yeast and human models (Drazkowska et al., 2013; Wasmuth and Lima, 2012a; 2017; 
Wasmuth et al., 2014; Zinder et al., 2016). Additionally, results from genetic studies in  
yeast showed that sterically occluding or mutating conserved basic residues lining the 
central channel led to substantial RNA processing and decay defects (Drazkowska et 
al., 2013; Wasmuth and Lima, 2012a). Subsequent structures also support these 
models: RNA can thread through the Exo9 central channel to reach Dis3 for 
processive degradation (Kowalinski et al., 2016; Liu et al., 2016; Makino et al., 
2013b) or it can be deflected back to the Rrp6 active site for distributive processing or 
degradation (see below; Figure 5) (Wasmuth et al., 2014; Zinder et al., 2016). 
 
Yeast Dis3 conformations and RNA paths 
 Structures of S. cerevisiae RNA exosome complexes with Dis3 revealed two 
prominent conformations for the enzyme (Bonneau et al., 2009; Liu et al., 2016; 2014; 
Makino et al., 2013b; 2015). While the PIN domain remains relatively static, the 
catalytic module rotates nearly 120 degrees between the two conformations (Figures 
5B and 5C). One conformation can bind short ssRNAs (<14 nt), bypassing the Exo9 
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central channel (termed the direct-access or channel-independent Dis3 conformation, 
Figure 5B). This conformation features an extensive interaction surface with Exo9 and 
is also observed in the absence of RNA, suggesting that it is the resting state of the 
yeast RNA exosome (Bonneau et al., 2009; Liu et al., 2014; 2016). The other 
conformation is observed when Dis3 binds longer RNAs (>24 nt) that can pass 
through the Exo9 central channel (termed the through-channel or channel-dependent 
conformation, Figure 5C) (Liu et al., 2014; Makino et al., 2013b). This conformation 
features fewer interactions with Exo9, and is thought to be stabilized by the presence 
of long RNAs (Liu et al., 2016). 
 
Rrp6 conformations and RNA paths 
 As previously mentioned, Rrp6 is tethered to the Exo9 core through a C-
terminal EAR that wraps around the S1/KH cap and PH-like ring (Figures 4A and 5). 
In several structures, its catalytic domain is positioned atop the Exo9 core via 
interactions between the Rrp6 HRDC and Exo domains and a conserved surface on the 
S1/KH ring near the entrance to the central channel (Wasmuth et al., 2014; Makino et 
al., 2015; Zinder et al., 2016) (Figure 5). However, the catalytic module of Rrp6 can 
be displaced at equilibrium if a structured RNA with 3’ overhang long enough to reach 
a catalytically inactivated Dis3 is present (Makino et al., 2015). 
 The model in which RNA accesses the Rrp6 catalytic site via interactions with 
the S1/KH ring proteins is supported by UV-crosslinking, biochemical analysis of 
complexes with mutant S1/KH or Rrp6 subunits (Wasmuth and Lima, 2012a; 2017), 
and two recent structures. These structures show the 3’ end of RNA anchored to the 
Rrp6 active site, with the RNA path directed towards the S1/KH region of the central 
channel. While the remaining RNA was disordered in an earlier structure (Wasmuth et 
al., 2014), a more recent model showed that RNA can be deflected by the S1/KH ring 
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to position its 5’ end near a channel formed between the HRDC and Exo domains of 
Rrp6 (Zinder et al., 2016) (Figure 5D and Chapter 1 of this dissertation). 
 While some models suggest that Rrp6 plays a passive role during Dis3-
mediated RNA decay (Makino et al., 2015), other data suggest that Rrp6 can enhance 
Dis3 activities in the nuclear RNA exosome. One line of evidence supporting this is 
that degradation of poly(A)+ transcripts that accumulate in yeast strains lacking Rrp6 
can be partially rescued by expressing catalytically inert Rrp6 (Assenholt et al., 2008; 
Mukherjee et al., 2016). Furthermore, in vitro studies showed that Rrp6 can activate 
the RNA decay activities of Dis3, especially evident for substrates with poly(A) tails 
(Wasmuth and Lima, 2012a; 2017; Wasmuth et al., 2014). Interestingly, Dis3 
activation requires two portions of Rrp6, its catalytic module and its C-terminal tail, 
termed the RNA lasso (Wasmuth and Lima, 2017) (Figures 4A and 5B through 5D). 
While the catalytic module binds the S1/KH ring to presumably widen the central 
channel, the C-terminal domain binds RNA to enhance Rrp6 and Dis3 activities on a 
variety of RNA substrates. Although disordered in all available structures, it is perhaps 
noteworthy that the RNA lasso is positioned near the top of the Exo9 core where it 
could assist binding RNA adjacent to the central channel (Figure 5). 
 
TRAMP and Ski complexes 
 
 The previous section focused on structure/activity relationships for the RNA 
exosome as a standalone machine, however it is likely that exosome cofactors mediate 
most encounters between RNA substrates and the RNA exosome. Recent studies 
focused on mechanisms that recruit these cofactors to the exosome and how their 
various activities influence RNA decay. We will restrict discussion in this section to 
the Trf/Air/Mtr4 polyadenylation (TRAMP) and Ski complexes, as their RNA helicase 
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components are important and conserved modulators of RNA exosome activities in the 
nucleus and cytoplasm, respectively. Intact structures of TRAMP or Ski complexes 
with the RNA exosome are not available, but structures of individual components or 
sub-complexes combined with genetic and biochemical studies support models as 
presented in Figures 6 and 7. 
 
The TRAMP complex 
 The TRAMP complex was initially uncovered by analysis of a temperature 
sensitive mutant of S. cerevisiae that expressed hypomodified tRNAiMet whose 
phenotype was suppressed by mutations in a non-canonical nuclear poly(A) 
polymerase (Kadaba et al., 2004). This polymerase (Trf4) and its paralog (Trf5) were 
found to exist in complexes with zinc knuckle proteins Air1 or Air2, and the DExH 
helicase Mtr4 (LaCava et al., 2005; Vanacova et al., 2005; Wyers et al., 2005) (Figure 
6). TRAMP is thought to assist nuclear degradation in yeast, including decay of 
cryptic unstable transcripts (CUTs) and processing of rRNAs (LaCava et al., 2005; 
Vanacova et al., 2005; Wyers et al., 2005). The TRAMP complex genetically interacts 
with the RNA exosome to promote RNA degradation via its 3’ non-templated poly(A) 
polymerase and RNA helicase activities, presumably via physical interactions between 
the helicase and exosome (Chen et al., 2001; Falk et al., 2017; Schuch et al., 2014; 
Wasmuth et al., 2017). While Mtr4 is essential and likely integrated into other 
complexes, an mtr4 allele that lacks ATP binding activity fails to rescue lethality of a 
Δmtr4 strain (Taylor et al., 2014). With respect to TRAMP, Air1/Air2 are dispensable 
for viability (LaCava et al., 2005), however simultaneous deletion of trf4 and trf5 
results in lethality (Castaño et al., 1996). These observations underscore the 
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Figure 6. The TRAMP complex and the nuclear exosome. (A) Domain schematics 
for S. cerevisiae C1D, Mpp6, and TRAMP components. Catalytic sites are indicated 
as stars and amino acid lengths are shown. (B) Structural models for the nuclear 
exosome and associated cofactors with RNA omitted for clarity. Black dotted lines 
represent connecting regions for which no structural information is available. Mtr4 
and Trf4/Air2 peptides are from PDB 4U4C; Trf4/Air2 zinc-knuckles are from PDB 
3NYB; PH-like ring, Rrp40, Rrp4, Csl4, Dis3, Rrp6 catalytic module, and Rrp6 EAR 
are from PDB 5K36; minimal Mpp6 (Mpp6min) is from 5VZJ; Rrp6 PMC2NT domain, 
C1D, and Mtr4 N-terminal peptide are from PDB 4WFD and were positioned based 
on PDB 5C0W. (C) Model for Mtr4 threading of RNA to the nuclear exosome after 
polyadenylation by Trf4/5. The central channel is indicated by black dashed lines and 
RNA is represented as a red line with 5’ end indicated. Dashed red arrows represent 
RNA paths to the catalytic subunits. Helicase direction is indicated by a gear and 
arrow. Modified from Figure 2 of Zinder and Lima, 2017  
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importance of a functioning TRAMP complex for nuclear RNA exosome function and 
for viability. 
 Crystal structures of Mtr4 revealed a multi-domain helicase core that 
resembles the bacterial DNA repair helicase Hel308, with a flexible insertion termed 
the arch domain that is specific to Mtr4 and Ski2 helicases (Jackson et al., 2010; Weir 
et al., 2010) (Figure 6). Biochemical and structural studies showed that Trf and Air 
proteins form a stable heterodimer that can be isolated from tagged Mtr4 using a high-
salt wash, and its interactions with the helicase core of Mtr4 occur via short peptide 
motifs (Falk et al., 2014; Hamill et al., 2010; LaCava et al., 2005; Losh et al., 2015) 
(Figure 6B). It is presumed that the polyadenylation activities of TRAMP are 
important for generating 3’ single stranded tails that are long enough to be captured by 
Mtr4 for unwinding (Figure 6C) or by Rrp6 or Dis3 for deadenylation or degradation, 
respectively. 
 
Nuclear cofactors that bridge Mtr4 and the exosome 
C1D is a small protein with functions in RNA metabolism (Mitchell, 2010) 
and the DNA damage response (Jackson et al., 2016). While often referred to as a 
nuclear exosome cofactor, the observations that C1D is critical for stable Rrp6 
expression and it is present in approximately stoichiometric amounts in endogenous 
nuclear complexes support its inclusion as a primary subunit of the nuclear exosome 
(Feigenbutz et al., 2013a; Shi et al., 2015). GST-C1D from humans can pulldown in 
vitro translated Rrp6 and knockdown of Rrp6 shifts eGFP-C1D from being 
concentrated in nucleoli to being evenly distributed throughout the nucleus, supporting 
a similar role for C1D in higher eukaryotes (Schilders et al., 2007). A structure of the 
nuclear exosome bound to C1D revealed interactions with the N-terminal PMC2NT 
domain of Rrp6 and its position above the Rrp6 catalytic module, forming a ‘lid’ 
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above the exosome (Makino et al., 2015). The composite interface between Rrp6 and 
C1D binds a small peptide motif near the N-terminus of Mtr4, providing a physical 
tether to the exosome (Schuch et al., 2014) (Figure 6), while C-terminal region of C1D 
binds nucleic acid in vitro and interacts with protein components of Box C/D 
snoRNPs (Costello et al., 2011). With that said, the N-terminal domain of C1D fully 
rescues growth in synthetic lethal Δrex1Δrrp47 and Δmpp6Δrrp47 S. cerevisiae 
strains, suggesting that the most critical functions for C1D may pertain to 
Mtr4/TRAMP recruitment and stabilization of Rrp6 (Costello et al., 2011; Feigenbutz 
et al., 2013a; Garland et al., 2013). 
Mpp6 is another small, nucleic acid binding protein that associates with the 
Exo9 core (Falk et al., 2017; Schilders, 2005; Schuch et al., 2014; Wasmuth et al., 
2017). Cross-linking experiments coupled to mass spectrometry showed that it 
contacts the S1/KH protein Rrp40 in the yeast complex (Shi et al., 2015), and 
competition binding experiments at high concentrations reported low affinity 
interactions between its C-terminal region and the Rrp6 Exo domain (Kim et al., 
2016). Subsequent structural and biochemical studies of yeast proteins corroborated 
the mass spectrometry data (Figure 6B) and further showed that a small conserved 
region in Mpp6’s N-terminus can recruit Mtr4 to the exosome (Falk et al., 2017; 
Wasmuth et al., 2017) (see Chapter 2). This recruitment enables the exosome to 
degrade a dsRNA with a short 3’ overhang and to cover a longer (~50 nt vs ~30 nt) 
fragment of RNA in RNase protection assays (Falk et al., 2017; Wasmuth et al., 2017). 
Human Mpp6 also interacts with Mtr4 (Chen et al., 2001; Schilders et al., 2007) and 
the exosome core (Falk et al., 2017), supporting a role for Mpp6 in recruitment of 
Mtr4 or Mtr4 complexes in higher eukaryotes. 
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The Ski complex 
The cytoplasmic Ski complex consists of a DExH box helicase Ski2, a 
tetratricopeptide repeat scaffold protein Ski3, and two copies of the beta propeller 
protein Ski8 (Fig. 7) (Brown et al., 2000; Halbach et al., 2013; van Hoof et al., 2000). 
The Ski complex contributes to mRNA turnover, degradation of aberrant mRNAs, 
viral defense (Molleston and Cherry, 2017), and RNAi pathways in some eukaryotes 
(Łabno et al., 2016a). Deletion of any subunit of the Ski complex in S. cerevisiae 
results in synthetic lethality when combined mutations of decapping enzymes or 
deletion of the 5’-3’ exoribonuclease Xrn1 (Anderson and Parker, 1998; Araki et al., 
2001; Johnson and Kolodner, 1995; van Hoof et al., 2000). Ski2 contains an N-
terminal region that is necessary for Ski complex interactions followed by a helicase 
core and a flexible insertion domain, similar to features observed in Mtr4 (Halbach et 
al., 2013; 2012; Wang et al., 2005) (Fig. 7). Ski2 is the only member of the Ski 
complex with a clear homolog in humans (SKIV2L), however it plays important roles 
in viral defense and elimination of Rig-I-like receptor ligands generated by Ire1 during 
the unfolded protein response, presumably through association with the human 
exosome (Aly et al., 2016; Eckard et al., 2014). 
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Figure 7. The Ski complex and the cytoplasmic exosome. (A) Domain schematics 
for S. cerevisiae Ski complex components. Catalytic sites are represented as stars and 
amino acid lengths are shown. (B) Structural models for the cytoplasmic exosome and 
associated cofactors with RNA omitted for clarity. Black dotted lines represent 
connecting regions for which no structural information is available. Ski3, Ski8 and 
Ski2 N-terminus are from PDB 4BUJ; Ski2 globular region and insertion are from 
PDB 4A4Z and were aligned to PDB 4BUJ; Ski7 C-terminal domains are from PDB 
4ZKE; PH-like ring, Rrp40, Rrp4, Csl4, Dis3, and Ski7 EAR are from PDB 5JEA. (C) 
Model for Ski complex channeling of RNA to the cytoplasmic exosome. The central 
channel is indicated by black dashed lines and RNA is represented as a red line with 3’ 
end shown bound to the Dis3 exonuclease active site. Helicase direction is indicated 
by a gear and arrow. Figure 3 of Zinder and Lima, 2017.  
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RNase protection assays further suggest that association of the Ski complex 
with the exosome extends the through-channel RNA path to Dis3 by ~10 nt, leading to 
a model for channeling (Halbach et al., 2013) (Figure 7C). Channeling through the 
helicase of the Ski complex was directly observed in a recent cryo-EM structure of the 
Ski complex bound to a ribosome containing an mRNA plus a 3’ overhang (Schmidt 
et al., 2016). In this structure, the small subunit (SSU) of the ribosome contacts the 
Ski2 helicase, the N-terminal TPR region of Ski3, and one of the Ski8 proteins, and 
the mRNA overhang is seen channeled through Ski2’s pore. Notably, Ski2’s arch 
insertion inhibits RNA binding in the context of the Ski complex bound to the 
exosome (Halbach et al., 2013), but binding of the arch to the ribosome stabilizes it in 
a conformation that enables easy accessibility of the RNA 3’ end to the helicase core 
(Schmidt et al., 2016). 
 
Ski7/HBS1Lv3 bridges the Ski complex and RNA exosome 
Yeast Ski7 contains a globular C-terminal GTPase domain and N-terminal 
domains that bridge the RNA exosome and Ski complexes (Araki et al., 2001; van 
Hoof et al., 2000; Wang et al., 2005). A crystal structure of the C-terminal domain of 
S. cerevisiae Ski7 revealed its structural similarity to active translational GTPases, 
though GTPase activity could not be confirmed in vitro (Kowalinski et al., 2015). 
Aligned 2D class averages from negative stain EM of endogenous S. cerevisiae Ski7 
containing cytoplasmic exosome complexes suggests that the C-terminal globular 
domains of Ski7 adopts multiple conformations when bound to the exosome, and 3D 
reconstructions from cryo-EM revealed that the Ski7 N-terminal domain interacts with 
the Exo9 core via surfaces that overlap with those used by the Rrp6 C-terminal 
domain (Liu et al., 2016) (Figures 6 and 7). This latter result was confirmed with 
binding assays and observed in a contemporaneous crystal structure (Kowalinski et al., 
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2016). Additionally, two groups independently identified a short splicing isoform of 
human HBS1L (HBS1Lv3) as the long sought-after Ski7 homolog and confirmed its 
ability to interact with the human exosome and Ski complex (Kalisiak et al., 2016; 
Kowalinski et al., 2016). The canonical HBS1L isoform in humans contains a C-
terminal GTPase fold that isoform 3 lacks, but it does not interact with the exosome, 
suggesting that multiple and unique sub-complexes of the Ski complex may exist in 
higher eukaryotes. 
 
Targeting RNAs to the exosome and associated complexes 
 
 The RNA exosome can cooperate with its cofactors to specifically target 
transcripts for degradation. Selective targeting has purported roles in diverse processes 
such as rRNA processing, transcription-coupled decay, suppression of untimely 
meiosis in S. pombe, as well as viral defense (Aly et al., 2016; Harigaya et al., 2006; 
Kilchert et al., 2016; Lee et al., 2013; Molleston and Cherry, 2017; Molleston et al., 
2016). RNAs can be targeted for decay based on recognition of specific sequences or 
structural elements by adaptor proteins and subsequent recruitment of the exosome or 
associated cofactor complexes. Additionally, the integrity of the RNA, which can be 
compromised via misfolding, RNA polymerase errors, or lack of proper post-
transcriptional modifications, may be sensed by the exosome or associated cofactors 
and specifically target that RNA for decay over its correctly generated counterparts. 
 
Suppression of untimely meiosis in S. pombe 
Perhaps the most extensively studied system for selective targeting of RNAs 
based on sequence elements by the exosome is that of meiotic transcript degradation in 
S. pombe. Under normal growth conditions, meiotic RNAs such as mei4 are 
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transcribed but rapidly targeted for degradation, thus preventing cells from 
unintentionally entering meiosis (Harigaya et al., 2006). The regions responsible for 
degradation of these transcripts were found to contain multiple repeats of a 
U(U/C)AAAC sequence that acted as determinants of selective removal (DSR) 
(Harigaya et al., 2006; Yamashita et al., 2012). When these sequences were appended 
to reporter genes that would normally be expressed at high levels, they were strongly 
repressed except during meiosis (Harigaya et al., 2006). It was found that DSR 
sequences in S. pombe are specifically recognized by the YTH domain of a protein 
called Mmi1, which in turn recruits the RNA exosome via an interaction with the 
MTREC complex (discussed below) (Egan et al., 2014; Harigaya et al., 2006; Lee et 
al., 2013; Wang et al., 2016). During nitrogen starvation, Mei2, a master regulator of 
meiosis in S. pombe, sequesters Mmi1 into a single nuclear focus, allowing its RNA 
targets to accumulate and meiosis to proceed (Harigaya et al., 2006). Recently, DSRs 
were found in introns of non-meiotic S. pombe genes and were shown to regulate 
expression of those RNAs in an intron-retention dependent manner (Kilchert et al., 
2015). In cases where co-transcriptional splicing fails to remove these introns, the 
resulting transcript is recognized by Mmi1 and degraded by the exosome. 
 
Cofactor mediated bridging to the cap-binding complex 
 In addition to TRAMP, human Mtr4 is present in at least two other complexes, 
the nuclear exosome targeting (NEXT) and poly(A) tail exosome targeting (PAXT) 
complexes (Lubas et al., 2011; Meola et al., 2016; Ogami et al., 2017). These 
complexes include mutually exclusive interactions between Mtr4, a zinc finger protein 
(Zcchc8 in NEXT and ZFC3H1 in PAXT), and an RNA binding protein (Rbm7 in 
NEXT and Pabpn1 in PAXT) (Figure 1B). The NEXT complex promotes degradation 
of PROMPTs and 3’ extended RNAs in the nucleoplasm (Lubas et al., 2011; Preker et 
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al., 2008). PAXT promotes degradation of longer and more mature (with respect to 
poly(A) tail length) substrates compared to NEXT substrates (Meola et al., 2016; 
Ogami et al., 2017). Both NEXT and PAXT interact with the cap-binding complex 
containing Ars2 (CBCA complex) via an adaptor protein ZC3H18, physically 
tethering the exosome to nascent capped transcripts to promote degradation following 
termination (Andersen et al., 2013; Meola et al., 2016). In S. pombe, a nuclear Mtr4-
like helicase Mtl1 associates with a zinc finger protein Red1 and as many as four other 
proteins to form the MTREC complex, which is involved in maintenance of facultative 
heterochromatin and degradation of meiotic RNAs, CUTs, and unspliced transcripts 
(Egan et al., 2014; Kilchert et al., 2015; Lee et al., 2013; Zhou et al., 2015). Because it 
also interacts with the CBCA complex and the exosome and Red1 is homologous to 
ZFC3H1, MTREC is possibly a fission yeast counterpart to the human PAXT 
complex. Importantly, NEXT, PAXT, and MTREC complexes lack 3’ polyadenylation 
activity, suggesting that their RNA binding and helicase activities are sufficient to 
generate 3’ ssRNA that is long enough to engage the exosome. 
 
Mtr4/AIM interactions for selective RNA decay 
 Ribosomal RNAs are derived from two transcripts in S. cerevisiae, one that 
codes for the 18S, 5.8S, and 25S rRNAs and the other codes for the 5S rRNA (Figures 
8A and 8B) (Henras et al., 2014). A set of proteins known as the processome 
dynamically associates with the pre-rRNA co-transcriptionally to direct endo- and 
exonucleolytic RNA processing in addition to chaperoning ribosomal proteins within 
the RNP (Woolford and Baserga, 2013). 
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Figure 8. AIM-arch interactions recruit the exosome for rRNA processing (A) 
Schematic for the S. cerevisiae 7 kb pre-rRNA molecule. Regions of the RNA 
contained within the mature ribosome are shown as boxes and spacers are shown as 
lines. Direction of transcription is shown with an arrow and A0 and C2 endonucleolytic 
cleavage sites are indicated. (B) Schematic for a mature ribosome. (C) A Utp18AIM - 
Mtr4Arch interaction recruits the exosome for 5’ ETS removal after endonucleolytic 
cleavage at the A0 site. (D) A Nop53AIM - Mtr4Arch interaction recruits the exosome for 
5.8S rRNA processing after LasI cleavage at the C2 site. Modified from figure 4 of 
Zinder and Lima, 2017.  
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 A recent study examining rRNA processing uncovered a conserved motif (arch 
interacting motif or AIM) in processome proteins Utp18 and Nop53 that interacts with 
the arch of Mtr4 to recruit the exosome (Thoms et al., 2015). They found that 
interaction of the Mtr4 arch with this motif in Utp18, a subunit of the early-associating 
SSU processome subcomplex UtpB, enables removal of the 5’ externally transcribed 
spacer (5’ ETS) while interaction with Nop53, an LSU processome factor, enables 3’ 
processing of the 7S precursor RNA (Figures 8C and 8D). Mutation of the AIM motif 
on either Nop53 or Utp18 results in accumulation of unprocessed precursors for their 
respective substrates (Thoms et al., 2015). Interestingly, other proteins such as Air2 
and Sqs1 can interact with the Mtr4 arch in a similar region as Nop53/Utp18, 
suggesting that hierarchical competition for the arch may contribute to RNA decay in 
the nucleus (Losh and van Hoof, 2015). 
 A recent high-resolution cryo-EM structure of the S. cerevisiae SSU 
processome positions the N-terminus of Utp18 proximal to the 3’-most nucleotide that 
could be modeled from the 5’ ETS (Barandun et al., 2017). Neither the Utp18 AIM, 
which resides near the its N-terminus, nor the 3’ end of the 5’ ETS that would be 
expected from A0 cleavage could be modeled, though their approximate locations are 
close enough to be compatible with recruitment of the Mtr4-exosome to this site for 
degradation (Barandun et al., 2017). 
 
3’ end chemistry and RNA fate 
 Dis3 or Rrp6 mediated degradation of model substrates by exosomes 
containing Dis3 and Rrp6 appears stochastic in vitro, however this seems an unlikely 
strategy for RNA decay in vivo. While nuclear cofactor complexes can influence RNA 
fate as discussed, recent studies suggested that the chemical structure of the 3’ end 
might influence the fate of a particular RNA. For example, Rrp6 from humans and S. 
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cerevisiae lacks activity on synthetic RNAs containing a 3’ phosphate, while Dis3 
family enzymes readily degrade these RNAs (Burkard and Butler, 2000; Domanski et 
al., 2016; Lubas et al., 2013; Tomecki et al., 2010; Zinder et al., 2016). While RNAs 
with 3’ phosphate may not be abundant in vivo, cleavage by exo- and 
endoribonucleases generates 2’,3’-cyclic phosphate ends for tRNA introns, U6 
snRNA, and some ribosomal RNA precursors (Gasse et al., 2015; Knapp et al., 1979; 
Lund and Dahlberg, 1992). Structural models suggest that Dis3 but not Rrp6 could 
degrade RNAs with 2’,3’-cyclic phosphate (Lorentzen et al., 2008; Zinder et al., 
2016). 
. For U6 snRNA, a component of the spliceosome, Mpn1/Usb1 generates a 
2’,3’-cyclic phosphate at the 3’ end as a product of its exonuclease activity, and U6 
RNA is polyadenylated and rapidly degraded in Δmpn1 S. pombe strain (Shchepachev 
et al., 2012; 2015). This suggests that a 2’,3’-cyclic phosphate at the 3’ end stabilizes 
the U6 RNA by preventing decay by Rrp6 or polyadenylation by TRAMP. Indeed, a 
transcriptome-wide survey of 2’,3’-cyclic phosphate RNAs revealed U6 is by far the 
most abundant RNA with this chemical signature in HeLa cells, though this approach 
may have missed other RNAs that are targeted for rapid degradation (Schutz et al., 
2010). Interestingly, Usb1 from S. cerevisiae was recently demonstrated to possess 
cyclic phosphodiesterase activity that cleaves the terminal 2’,3’-cyclic phosphate to 
generate a 3’ phosphate, which it is unable to further trim into shorter products 
(Didychuk et al., 2017). This additional activity, which the human enzyme lacks, may 
prevent ScUsb1 from over-shortening the U6 3’ poly(U) tail, which the authors of the 
study note would not be a concern for organisms that could extend over-shortened tails 
via TUTases (Didychuk et al., 2017). 
To generate the 7S rRNA (5.8S rRNA with a 3’ extension), the Las1 
endonuclease component of the tetrameric Las1 complex cleaves the rRNA precursor 
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molecule at the C2 site of internally transcribed spacer 2 (ITS2) (Gasse et al., 2015) 
(Figures 8A and 8D), resulting in a 2’,3’-cyclic phosphate at the 3’ end of the 7S 
rRNA and a 5’OH on the other fragment. While the latter RNA is 5’ phosphorylated 
by the Grc3 kinase subunit of the complex to enable processing by Rat1/Rai1 (the two 
other components of the Las1 complex), the 2’,3’-cyclic phosphate end is an 
intermediate prior to processive 3’ to 5’ processing by Dis3 in the exosome (Figure 
8D). The produces the 5.8S rRNA plus ~30 nt at the 3’ end, the approximate length 
required to span the Exo9 central channel. This overhang is subsequently removed by 
Rrp6 (Allmang et al., 1999a; Briggs et al., 1998) leading to the handoff model 
presented in Figure 7D. Interestingly, the length of 5.8S overhang produced in siRNA 
knockdowns of human Rrp6 is 40 nt, suggesting a longer through-channel RNA path 
for the human exosome (Tafforeau et al., 2013). While this and other 2’,3’-cyclic 
phosphate 3’ ends may be resolved by phosphodiesterases prior to processing or 
degradation, it is likely that 3’ modified RNAs could be substrates of Dis3 and the 
nuclear RNA exosome. Supporting this, a recent study reconstituted 5.8S processing 
using purified components from S. cerevisiae (Fromm et al., 2017). By placing a tag 
on Nop53, the investigators were able to purify a population of LSU processomes 
containing a significant amount of 7S precursor RNA. They incubated these particles 
with WT or mutant exosome complexes, Mtr4, and ATP in different combinations and 
observed rRNA processing via northern blotting and negative stain EM. Their 
experiments showed that Dis3’s endo and exo activities, Mtr4’s helicase activity, and 
ATP were all required for efficient removal of the 7S product. Consistent with in vivo 
data, inactivation of Rrp6 minimally affected the disappearance of the 7S species, 
which presumably contains a 2’,3’-cyclic phosphate at its 3’ end, but resulted in the 
accumulation of a 5.8S + 30 nt species (Fromm et al., 2017). 
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The RNA exosome and its roles in cellular homeostasis 
 
 Because the Exo9 components and Dis3 are essential for viability in single-
celled organisms, it is perhaps unsurprising that the exosome contributes to important 
and diverse biological processes in higher eukaryotes and is mutated in several 
diseases (Fabre and Badens, 2014; Robinson et al., 2015; Staals and Pruijn, 2010). 
Here we present several recent advances in our understanding of how the exosome and 
its cofactors contribute to proliferation, differentiation, innate immunity against RNA 
viruses, and telomerase RNA surveillance. 
 
Proliferation and differentiation 
 Dis3 has gained notoriety for its role in cellular proliferation, and was 
identified as one of the most frequently mutated genes in genome-wide association 
studies of multiple myeloma (MM) (Chapman et al., 2011; Lohr et al., 2014; Walker 
et al., 2012). Most mutations observed in these studies cluster within its 
exoribonuclease domain and are predicted to disrupt its 3’ to 5’ decay activity. As 
Dis3 activities are generally associated with promoting cell division (Ohkura et al., 
1988; Tomecki et al., 2014), inactivation of Dis3 in MM was somewhat perplexing. A 
recent study addressed this by characterizing inactivating mutations in Dis3 in 
Drosophila, C. elegans, and mouse models (Snee et al., 2016). While mutating Dis3 
alone resulted in mitotic defects, increased RAS activities acted synergistically with 
this mutant to stimulate growth, a phenotype that was not evident using activated RAS 
alone. This perhaps explains the observation that KRAS activities were often 
increased in MM clones that contained inactivating DIS3 mutations (Lohr et al., 
2014). Furthermore, another study depleted Dis3 in human MM and other cell-lines 
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and observed accumulation of Let28b, a protein that sequesters the let-7 family of 
micro RNAs to prevent their maturation (Segalla et al., 2015). Because let-7 RNAs 
can silence MYC, RAS, and other mRNAs, Dis3 depletion ultimately results in 
accumulation of these gene products, potentially explaining correlations observed for 
DIS3 inactivation and RAS activation in model systems (Snee et al., 2016) and MM 
(Lohr et al., 2014). Perhaps consistent with this model, decreased Dis3 expression has 
been observed in high risk genotypes associated with pancreatic cancer (Hoskins et al., 
2016), where activating RAS mutants are common (Eser et al., 2014). 
 Recent work has also illuminated a role for the exosome during erythropoiesis, 
the process through which hematopoietic stem cells differentiate into erythrocytes 
(McIver et al., 2014; 2016). In this process, the balance between hematopoietic stem 
cell differentiation and proliferation is critical: too much proliferation can lead to 
tumor formation while excessive differentiation can exhaust the supply of stem cells. 
For erythropoiesis, proliferation and terminal differentiation are enforced by stem cell 
factor (SCF) and erythropoietin, respectively. GATA-1 and Foxo-3 are master 
transcription factors that control differentiation during erythropoiesis, and both down-
regulate expression of EXOSC8, an Exo9 subunit (Table 1). Interestingly, shRNA 
knockdown of exosome core subunits in hematopoietic stem cells resulted in an 
accumulation of GATA-1 and Foxo-3 regulated transcripts, suggesting that the 
exosome may counter differentiation by degrading these transcripts in the absence of 
erythropoietin (McIver et al., 2014), similar to a role proposed for the exosome in 
maintaining a proliferative state in human skin stem cells via selective targeting of the 
GRLH mRNA (Mistry et al., 2012). Furthermore, hematopoietic stem cells depleted of 
exosome components were non-responsive to SCF due to decreased levels of its 
cognate receptor tyrosine kinase, Kit, though they remained responsive to 
erythropoietin (McIver et al., 2016). 
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Viral defense 
A role for the exosome and its cofactors in viral defense was described nearly 
two decades before its discovery through a genetic screen that identified the ‘SKI’ 
genes in S. cerevisiae. The SKI genes were so named because of the “superkiller” 
phenotype observed: mutations in SKI genes increased levels of a killer toxin that was 
produced by the M viral dsRNA (Ridley et al., 1984; Toh-E et al., 1978). It was later 
discovered that three of these proteins (Ski2, Ski3, and Ski8) form the Ski complex 
(Brown et al., 2000) that interacts with the RNA exosome via Ski7 (Araki et al., 2001; 
van Hoof et al., 2000) (Figures 1A and 7). Other SKI genes were later identified as 
subunits of the exosome itself (Table 1). 
 A more recent study using cultured human cells revealed a role for the Ski 
complex in antiviral defense against Hepatitus B virus (HBV) (Aly et al., 2016). A 
screen for helicases that could suppress HBV replication identified the human Ski 
complex RNA helicase SKIV2L (Table 1). It was further demonstrated that 
interactions between the HBV X-RNA, SKIV2L, HBS1L (HsSki7) and the exosome 
resulted in selective degradation of the HBV X-RNA via the NSD pathway. 
 The metazoan TRAMP complex was recently shown to participate in viral 
defense in the cytoplasm (Molleston et al., 2016). Infection of human and Drosophila 
cells with the disparate RNA viruses vesicular stomatitis virus, Sindbis virus, or Rift 
Valley fever virus (RVFV) was potentiated by knockdown of exosome and TRAMP 
components. While normally restricted to the nucleus and concentrated in the 
nucleolus (Lubas et al., 2011), TRAMP subunits are exported to the cytoplasm during 
infection where they participate in the degradation of viral RNAs (Molleston et al., 
2016). Furthermore, appending a 3’ UTR from RVFV to a GFP reporter was sufficient 
to stimulate its degradation upon RVFV infection in human cells, suggesting that viral 
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RNA sequences are targeted for selective degradation under these conditions. 
Mechanisms underlying TRAMP export to the cytoplasm and targeting of viral 3’ 
UTRs await further investigation. 
 
Telomerase RNA quality control 
Several recent studies implicated the exosome and its cofactors in degradation 
and quality control of telomerase RNA (hTR) in HeLa cells (Nguyen et al., 2015a; 
Shukla et al., 2016; Tseng et al., 2015). Degradation of hTR is stimulated by the 3’ 
polyadenylation activity of the human TRAMP complex and antagonized by the 
poly(A) binding protein Pabpn1 and the deadenylase PARN, which is mutated in some 
cases of the premature aging disease dyskeratosis congenita (DKC). One study further 
showed that knockdown of nuclear RNA decay machinery could rescue telomerase 
RNA levels and defects in telomerase activity in cells depleted of dyskerin, a protein 
subunit of the telomerase RNP that is also mutated in DKC, prompting the authors to 
suggest that the exosome could be a therapeutic target for certain telomere pathologies 
(Shukla et al., 2016). 
DGCR8, a dsRNA binding protein involved in miRNA biogenesis, has been 
recently implicated as an adaptor protein for exosome targeting to structured substrates 
such as hTR (Macias et al., 2015). DGCR8 contains dsRNA binding and heme 
domains, which interact with the stem and apical regions of the pri-miRNA, 
respectively, as a dimer (Nguyen et al., 2015b). In the nucleoplasm, this dimer 
interacts with DROSHA, an RNA endonuclease involved in miRNA maturation, to 
ensure its fidelity in producing miRNAs (Macias et al., 2013). Investigators found that 
DGCR8 also interacts in a distinct complex with the nucleolar exosome, and this 
interaction is necessary for the turnover of snoRNAs and hTR in that compartment 
(Macias et al., 2015). 
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Outstanding questions 
 
Contained in this dissertation are our attempts to answer several outstanding 
questions regarding the structure and functions of the exosome. It had long been 
appreciated that RNA exosome complexes are recalcitrant towards crystallization 
except in the presence of specific RNA substrates that presumably stabilize the 
enzymatic subunits in discrete conformations. One persistent challenge had been to 
structurally characterize RNA exosome complexes containing both Rrp6 and Dis3, as 
each enzyme requires an RNA 3’ end and both engage RNA via channeling through 
the Exo9 pore. Chapter 1 describes a strategy we successfully employed to overcome 
this difficulty, namely synthesizing an RNA with two 3’ ends (3’-3’ RNA), and co-
crystalizing the complex with it. Subsequent characterization of mutants designed 
based on the structure are described as well as a biochemical investigation of the 
degradation of a 3’ phosphate RNA by the nuclear exosome. 
Other questions remained that related to the biochemical functions of protein 
cofactors of the nuclear RNA exosome. In Chapter 2, we report a crystal structure of 
the same complex bound to a similar 3’-3’ RNA and a minimal exosome-associating 
region of the nuclear cofactor Mpp6. Biochemical investigation that followed showed 
that Mpp6 and Rrp47 cofactors both contribute to recruitment of Mtr4 for helicase-
dependent RNA degradation using purified S. cerevisiae proteins. Finally, Chapter 3 
outlines our unpublished efforts towards determination of high-resolution structural 
models for Mtr4-dependent RNA degradation using cryo-EM 
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Author’s note 
 
All experiments contained in this dissertation were performed by the author 
except where explicitly noted in the figure legend. Experiments performed by 
individuals other than the author were included because they were essential to provide 
context for the author’s work and for discussion in the text. Much of the content has 
been previously published in either Zinder and Lima, 2017 (Introduction), Zinder et 
al., 2016 (Chapter 1), and Wasmuth et al., 2017 (Chapter 2). 
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CHAPTER 1: Crystal Structure of the Nuclear Exosome 
 
Introduction 
 
The RNA exosome, a conserved multi-protein complex, processes and 
degrades RNA in the 3’ to 5’ direction in eukaryotes (Houseley and Tollervey, 2009; 
Januszyk and Lima, 2014). Substrates of the nuclear RNA exosome include Cryptic 
Unstable Transcripts (CUTs) (Wyers et al., 2005), PROMoter uPstream Transcripts 
(PROMPTs) in humans (Preker et al., 2008), hypomodified tRNAs (Kadaba et al., 
2004), sn(o)RNAs (Allmang et al., 1999a), and ribosomal RNAs (Mitchell et al., 
1997). Mutations that result in loss of function of the RNA exosome have been 
identified in hematopoietic malignancies (Chapman et al., 2011) and 
neurodegenerative disorders (Fabre and Badens, 2014), underscoring its physiological 
importance. 
The RNA exosome core (Exo9) includes nine subunits, a six-membered ring 
formed by the RNase PH-like proteins Rrp45, Rrp41, Rrp43, Rrp46, Rrp42, and Mtr3 
(the PH-like ring), that is capped by a three-membered ring of S1 and KH domain 
containing proteins Rrp4, Rrp40, and Csl4 (the S1/KH ring). The structure of Exo9 
from human revealed a donut-shaped architecture with a prominent central channel 
large enough to accommodate single-stranded RNA (Liu et al., 2006) (Figure 2). Both 
yeast and human Exo9 cores are devoid of catalytic activity (Dziembowski et al., 
2007; Liu et al., 2006). 
In the budding yeast S cerevisiae, the cytoplasmic RNA exosome includes the 
Exo9 core and the processive exoribonuclease Rrp44 (aka Dis3) to form a ten-
component complex (Exo1044). In the nucleus, Exo1044 associates with the distributive 
exoribonuclease Rrp6 (Figure 1A) to form an eleven-component complex (Exo1144/6). 
	 42 
Protein cofactors such as Rrp47, Mpp6, and the TRAMP complex associate with the 
nuclear exosome to target particular RNA substrates or to alter its activities (Houseley 
and Tollervey, 2009; Januszyk and Lima, 2014; LaCava et al., 2005; Lubas et al., 
2012; Wasmuth and Lima, 2012b; Wyers et al., 2005). All protein subunits of Exo1044 
are essential for cell viability in yeast (Brouwer et al., 2001; Dziembowski et al., 2007; 
Mitchell et al., 1997), while deletion of Rrp6 results in temperature sensitivity, slow-
growth, and RNA processing defects (Allmang et al., 1999a; 1999b; Briggs et al., 
1998). 
Previous efforts to understand how Exo9 contributes to the RNA decay 
activities of the exosome revealed that the central channel was essential, that Rrp6 and 
Rrp44 activities are attenuated or altered when bound to the RNA exosome core, that 
RNA passes through the PH-like and S1/KH rings to access the Rrp44 active site, that 
RNA engages the S1/KH proteins to access the Rrp6 active site, and that RNA path(s) 
to the catalytic subunits are partially overlapping (Bonneau et al., 2009; Drazkowska 
et al., 2013; Makino et al., 2013b; Malet et al., 2010; Wasmuth and Lima, 2012a; 
Wasmuth et al., 2014). 
A crystal structure of Exo1044 bound to a fragment of Rrp6 and a stem-loop 
RNA with a 3’ polyU30 single-stranded extension at 2.8 Å (PDB 4IFD) showed RNA 
passing through the Exo9 central channel and a conformation for Rrp44 that differed 
from that observed in the absence of RNA (Bonneau et al., 2009; Makino et al., 
2013b). A similar conformation of Rrp44 was observed in a recent 2.7 Å structure of 
Exo1044 bound to an N-terminal fragment of the cytoplasmic RNA Exosome cofactor 
Ski7 and RNA (Kowalinski et al., 2016). Negative stain EM studies on Exo1044 at 20-
25 Å resolution (Liu et al., 2014) revealed two conformations for Rrp44, one in the 
absence of RNA or in the presence of short RNAs or structured RNAs with short 3’ 
overhangs (termed the direct-access or channel-independent Rrp44 conformation) and 
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the other conformer observed in the presence of RNAs with single-stranded 3’ ends 
long enough to span the Exo9 central channel (termed the through-channel or channel-
dependent Rrp44 conformation). When Exo1044 was degrading a structured RNA that 
included a long single-stranded 3’ extension, sub-classification of EM data suggested 
that both conformations co-exist. More recent cryo-EM structures captured these same 
two conformations for Exo1044 in complex with Ski7, now at 4.2 Å for the channel-
independent Rrp44 conformation and 5.8 Å for the channel-dependent Rrp44 
conformation (Liu et al., 2016). 
A structure of Exo9 bound to Rrp6 (Exo106exo-ΔNΔC) and 24 nt poly(A) RNA at 
3.35 Å resolution (PDB 4OO1) revealed an RNA path to Rrp6 that partially 
overlapped with the channel-dependent RNA Exo1044 path (Wasmuth et al., 2014), 
confirming predictions based on biochemical and genetic methods (Wasmuth and 
Lima, 2012a). Based on mutational analysis, a similar path was posited for the human 
Exo106 complex (Wasmuth et al., 2014). A twinned crystal structure reported at 4.6 Å 
resolution (69.5% overall completeness) of the nuclear exosome bound to the cofactor 
Rrp47 and 18 nt AU-rich RNA (PDB 5C0W) revealed its overall architecture, a 
speculative path for RNA bypassing Rrp6, and RNA bound to the channel-
independent conformation of Rrp44 (Makino et al., 2015). Atomic resolution features 
of the nuclear exosome containing both Rrp6 and Rrp44, including the RNA path to 
Rrp6 and elements that stabilize the channel-independent conformation of Rrp44, 
remain unclear due to the nominal resolution of structures to date. 
 Here we report a crystal structure at 3.1 Å resolution of a nuclear 
Exo1144/6ΔNΔC complex with RNA bound to both Rrp6 and Rrp44 active sites. The 
structure reveals extensive RNA contacts to Rrp6 and the S1/KH subunits, Rrp44 in a 
channel-independent conformation bound to RNA, elements of the Exo9 core that 
interact with Rrp44 in the channel-independent conformation and inhibit its activities, 
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and details within the Rrp44-RNA active site that provide a structural basis for its 
ability to degrade 3’ phosphorylated RNA substrates. 
 
Results 
 
3’-3’ RNA and the nuclear RNA exosome structure 
High-resolution structures of the nuclear exosome have not been achieved thus 
far, possibly because the Rrp44 and Rrp6 catalytic subunits are dynamic when not 
bound to RNA substrates. As both catalytic subunits require a 3’ end to bind RNA in 
their respective active sites, we employed CuI-catalyzed alkyne-azide cycloaddition, or 
‘copper click chemistry,’ to synthesize an RNA with two 3’ ends that we hypothesized 
would enable simultaneous capture of both catalytic subunits (Figures 9A and 10A 
through 10D). After surveying different RNA lengths, we obtained crystals that 
diffracted to 3.1 Å resolution of the S. cerevisiae nuclear exosome  
(Exo1144exo-endo-/6exo-ΔNΔC) in complex with an RNA composed of two 17 nt segments 
linked by 19 carbon to carbon, nitrogen, or oxygen bonds (Figure 9). This complex 
contains all full-length, catalytically inactive proteins except Rrp6, which lacks its C-
terminal RNA-binding ‘lasso’ portion (Wasmuth and Lima, 2017) and N-terminal 
Rrp47 interaction domain (Figure 4A) (Stead et al., 2007). A molecular replacement 
solution was obtained using S. cerevisiae Exo106exo-ΔNΔC (PDB 4OO1) and Rrp44 from 
the Rrp44-Rrp41-Rrp45 complex (PDB 2WP8) as search models (Bonneau et al., 
2009; Wasmuth et al., 2014), and iterative rounds of building and refinement resulted 
in an Rwork/Rfree of 0.201/0.249 with good stereochemistry for a structure that 
includes 3731 amino acids and 24 nucleotides of RNA (Table 2). 
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Figure 9. Architecture of Exo1144/6 bound to 3’-3’ RNA. (A) Domain schematics of 
Rrp6 and Rrp44. The shaded area indicates the amino acid boundaries used for 
crystallization. Active site aspartates that were mutated to asparagine for binding 
assays and crystallization are indicated. (B) Schematic for synthesis of a 34 nt RNA 
molecule with two 3’ ends. RNA is represented as an arrow pointing from 5’ to 3’. Gel 
is 15% acrylamide TBE-urea and RNA is visualized using SYBR gold stain. The lane 
for the reaction containing 2:1 [RNA]:[diazide] is indicated with an asterisk. (C) 
Surface representation of Exo1144/6 bound to 3’-3’ 34 nt RNA. RNA is shown as a 
cartoon with 3’ and 5’ ends of the model indicated. (D) RNA path in Exo1144/6/3’-3’ 
RNA crystals. Mesh is a simulated annealing 2Fo-Fc omit map contoured at 1.0 σ. The 
dashed lines indicate the most likely path connecting 5’ ends of the RNA fragments. 
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Figure 10. Purification and characterization of 3’-3’ RNA and Exo1144/6/3’-3’ 
RNA crystals. (A) Chromatograms from DEAE separation of an RNA click reaction 
using an NaCl gradient. Buffers A and B are as described in the Materials and 
Methods section. For this experiment, 135 µg of total RNA was loaded in a volume of 
500 µL. B) 15% polyacrylamide TBE-urea gel of fractions, which were taken every 
minute from the HPLC run in (A). RNA is visualized using SYBR gold stain. C and 
D) Rrp44 decay time courses on 5’-3’(C) or 3’-3’ (D) 36 nt AU-rich RNA substrates. 
Rrp44 is at a concentration of 5 nM and substrate RNA is at a concentration of 50 nM. 
Decay intermediates apparent between the alkynyl 25 and alkynyl 18 marker in panel 
C indicate that Rrp44 cannot degrade through the di-triazole linker. RNA is visualized 
using SYBR gold staining. E and F) ~10 crystals were transferred from the mother 
liquor into three separate 2 µl drops of well solution (washes) and then dissolved in 20 
µL of 20 mM Tris-Cl pH 8.0, 100 mM NaCl 1 mM TCEP-HCl. Volumes in the 
‘Crystal’ lane indicate how much of this solution was loaded in that lane. For the 
protein gel (E), 10µL of dissolved crystal solution was added to 5 µl of 4x loading dye 
and 5 µL of ultrapure water and 10 µL of that solution was run on a 4-12% acrylamide 
BIS-TRIS run in MOPS-SDS buffer and stained with SYPRO Ruby. Standards are 
1.3, 0.65 and 0.32 pmol of purified complex. For the RNA gel (F), 5 µL crystal 
solution was added to 5 µL 10 mM Tris-Cl pH 8.0, 0.2 % w/v SDS, 10 mM EDTA, 
0.1 U/µL proteinase K and incubated at 50°C for 10 minutes. Following this 
incubation, 10 µL of 2x urea-PAGE loading buffer was added and 10 µL of that was 
run on a 15% acrylamide TBE-urea gel. Standards are 1.2, 0.59, and 0.29 pmol of 
RNA. Quantification of Rrp44 and RNA bands yields an approximate protein to RNA 
molar ratio of 1:1.3. 
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Table 2. Crystallographic data and refinement statistics 
 
 Exo11Rrp44/Rrp6/RNA  
Data collection   
X-ray Source APS NE-CAT 
24IDC 
 
Space group P212121  
Cell dimensions     
    a, b, c (Å) 140.7, 212.3, 218.2  
  α, β, γ (°)  90.0, 90.0, 90.0  
Wavelength (Å) 0.9795  
Resolution (Å) 106-3.1 (3.21-3.1) *  
Rmerge 0.111 (0.534)  
I/σI 14.3 (2.8)  
CC1/2 0.994 (0.495)  
Completeness (%) 98.8 (97.0)  
Redundancy 3.6 (3.0)  
Wilson B factor (Å2) 66.2  
   
Refinement   
Resolution (Å) 106-3.1  
No. reflections observed 423414  
No. unique reflections 106037  
Rwork/ Rfree 0.201/0.249  
No. atoms 30252  
    Protein 29377  
    RNA 502  
    Ligands 92  
    Water 280  
Average B-factors   
    Protein 80  
    RNA 107  
    Ligands 96  
    Water 52  
R.m.s deviations   
    Bond lengths (Å)  0.002  
    Bond angles (º) 0.43  
Ramachandran plot   
    % favored  94.6  
    % allowed 5.2  
    % outliers 0.16  
Molprobity   
    Clashscore/Percentile  5.7/100th   
    MolProbity Score/Percentile 1.68/100th   
One crystal was used. Highest resolution shell is shown in parenthesis.  
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The overall architecture of the complex (Figure 9C) reveals Rrp6 and Rrp44 at 
opposite ends of the Exo9 central channel with Rrp6 bound to RNA above the S1/KH 
ring and Rrp44 below the PH-like ring bound to RNA in the channel-independent 
Rrp44 conformation. This conformation of Rrp44 resembles that observed in previous 
structures (Bonneau et al., 2009; Liu et al., 2014; 2016; Makino et al., 2015), while the 
Rrp6 conformation resembles that observed for Exo106exo-ΔNΔC bound to poly(A) 
(Wasmuth et al., 2014), a position that is rotated away from the S1/KH ring in a model 
of the nuclear exosome structure with Rrp6 bound to the cofactor Rrp47 and not 
bound to RNA (Makino et al., 2015). Distance constraints and electron densities 
suggest that the 3’-3’ RNA traverses between Rrp6 in one Exo11 complex to Rrp44 in 
an adjacent complex (symmetry mate) rather than traveling through the central 
channel of a single complex (Figure 9D). 
 
Contacts between the Exo9 core and Rrp44 contribute to Rrp44 activities 
Previous structural studies observed a channel-independent conformation of 
Rrp44 in association with the Exo9 core (Bonneau et al., 2009; Liu et al., 2014; 2016; 
Makino et al., 2015), but none were determined at sufficient resolution to reveal all of 
the features of the Exo9 core proteins that stabilize this conformation. We now 
observe that Rrp43 residues 100-120 (Rrp43L1) form a loop followed by a pair of 
helices that contact Rrp44 near the point of RNA ingress (Figures 11A, 11B, and 12). 
Inspection of electron density in a previous structure revealed the presence of 
Rrp43L1 however it was not modeled (Makino et al., 2015) (Figure 13). In addition, 
the C-terminus of Rrp45 (Rrp45Cterm) forms an extended strand that contacts Rrp44 
near the 3’ end of its bound RNA in our structure as previously observed (Bonneau et 
al., 2009; Liu et al., 2016; Makino et al., 2015). 
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Figure 11. Features in the non-catalytic Exo9 core contact the RNA channel-
independent and channel-dependent conformations of Rrp44. (A) Illustration of 
the channel-independent and channel-dependent conformations of Rrp44 along with 
associated features in the Exo9 core from the side and top views. The center panel 
depicts a theoretical transition between the two states in which the Rrp43L1, Rrp43L2 
and Rrp45Cterm are disordered. Surface representations of Rrp44 were generated using 
the model from this work and PDB 4IFD for the channel-independent and channel-
dependent conformations, respectively. (B and C) Rrp43L1, Rrp43L2 and Rrp45Cterm 
features associated with the channel-independent (B) and channel-dependent (C) 
conformations of Rrp44 from this work and PDB 4IFD, respectively. Order/disorder 
boundaries of Rrp43L1 and Rrp43L2 are indicated by colored spheres. 
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Figure 12. Order-disorder transitions in Rrp43 features and Rrp45Cterm . (A 
through F) Structures were aligned based on the Rrp43 and Rrp45 chains or, in panel 
C, only Rrp45. RNase PH-like subunits Rrp41, Rrp46, Rrp42, and Mtr3 subunits are 
shown as a transparent gray surface for clarity. Terminal residues modeled for 
Rrp43L1 and Rrp43L2 features are shown as spheres and highlighted with arrows in 
the channel-dependent (D and E) and channel-independent (A, B and C) 
conformations, respectively. The dashed line in panel E indicates the presumed RNA 
path in that structure. (G) Rrp43L1 in the Exo1144/6 structure. Mesh is a simulated 
annealing 2Fo – Fc map contoured at 1.5 σ and carved to within 3 Ångstroms of 
Rrp43. H) Rrp43L2 termini in the Exo11 structure. Mesh is a simulated annealing 2Fo 
– Fc map contoured at 1.0 σ. I) Panel H with Rrp43 from the Exo1044 structure (PDB 
4IFD) aligned to the Rrp43 chain of Exo1144/6 with electron densities shown as in 
panel H.  
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Figure 13. Rrp43L1 clashes with the 5’ end of Rrp44 bound RNA from the 
Exo1244/6/47 (A) Orientation of Exo1244/6/47 used in analysis. (B) Close-up of RNA 5’ 
end with Fo – Fc map shown as green mesh contoured at 2.0 σ and 2Fo – Fc map 
shown as blue mesh contoured to 1.0 σ. Rrp43 residues Thr99 and Asn126, the 
boundaries of Rrp43L1 in that model, are shown as spheres. Maps were generated in 
Phenix using the twin operator -h,-k, l. (C) The same view as in (B) but with Rrp43 
replaced with Rrp43 from the Exo1144/6 structure presented in this work. Alignment 
was performed based on the Rrp43 chain.  
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 Comparison to the Exo1044-RNA channel-dependent structure (PDB 4IFD) 
reveals that contacts between Rrp44 and the Rrp45Cterm and Rrp43L1 element are lost. 
While the Rrp43L1 element becomes disordered, the Rrp45Cterm forms a helix and 
does not contact Rrp44 in the channel-dependent Exo1044 (Liu et al., 2016; Makino et 
al., 2013b) or in the absence of Rrp44 in the Exo106 structure (Wasmuth et al., 2014) 
(Figures 11A, 11C, and 12). Instead, different contacts are established between the 
Exo9 core and Rrp44 including Rrp43 residues 251-270 (Rrp43L2), which form a beta 
hairpin that bridges the Rrp44 CSD1, catalytic domain, and RNA (Liu et al., 2016; 
Makino et al., 2013b) (Figures 11A, 11C, and 12). By contrast, this feature of Rrp43 is 
disordered in our structure (Figures 11A, 11B, and 12). A recent structure of 
Exo1144/Ski7N-term with Rrp44 bound in the through-channel conformation (PDB 5JEA) 
observed that Rrp43L2 was disordered (Kowalinski et al., 2016), but the authors noted 
that Rrp44 CSD1 is rotated relative to other RNA-through-channel structures due to 
crystal lattice contacts in that region, suggesting that ordering of Rrp43L2 may be 
dependent on rotation of Rrp44 CSD1 to that observed in the channel-dependent 
Rrp44 conformation. The unique contacts between Rrp44 and the Exo9 core in 
channel-dependent and channel-independent Rrp44 conformations suggested they 
might contribute differentially to the ability of Rrp44 to bind and degrade RNA. 
We reconstituted exosome complexes containing deletions of Rrp43L1, 
Rrp43L2, and/or deletion of Rrp45Cterm (Figures 14, 15, 16A, and 16) to test the 
importance of these elements in RNA binding and degradation assays. Mutant Rrp43 
and Rrp45 behaved as wild-type with respect to formation of Exo9 complexes and 
stable association with Rrp44. Consistent with Rrp43L1 and Rrp43L2 contacts to 
Rrp44 and not Rrp6, no differences in activity were observed for Rrp6 when 
associated with Exo9 containing the Rrp43 mutants (Figures 16C, and 16D). 
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Figure 14. Exo1044 activity on AU-rich RNAs is enhanced by deletion of 
Rrp43L1. (A) SDS-PAGE analysis of reconstituted Exo1044 complexes containing 
Rrp43 mutants. ‘41ChOcc’ refers to a loop insertion mutant in Rrp41 that occludes the 
central channel. (B and C) WT and mutant Exo1044 activity on 14 nt (B) and 36 nt (C) 
5’ FAM AU-rich RNA substrates. The experiment was performed in triplicate and 
quantification of mean values is shown with error bars at ±1 standard deviation. 
Representative polyacrylamide TBE-urea gels are shown below. (D) Quantification of 
initial rates of decay of Exo1044 complexes on 14 nt and 36 nt 5’ FAM AU-rich RNA 
substrates from the experiments in panels (B) and (C). Mean values of the triplicate 
experiments are plotted with error bars at ±1 standard deviation.  
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Figure 15. Deletion of features associated with the channel-independent 
conformation of Rrp44 enhance its activity in Exo1144/6 complexes. (A) SDS-
PAGE analysis of reconstituted Exo1144/6 complexes containing mutant Rrp43 and/or 
Rrp45 proteins. (B and C) WT and mutant Exo1144/6 activity on 14 nt (B) and 37 nt 
(C) 5’ FAM poly(A) RNA substrates. The experiment was performed in triplicate and 
quantification of mean values is shown with error bars at ±1 standard deviation. 
Representative polyacrylamide TBE-urea gels are shown below. (D) Initial rates of 
decay of Rrp44 in Exo1144/6 complexes and free Rrp44 on short (14 nt) and long (37 
nt) 5’ FAM poly(A) RNA substrates from the experiments in panels (B) and (C). 
Mean values are shown with error bars at ±1 standard deviation. (E and F) WT and 
mutant Exo1144/6 activity on 14 nt (E) and 36 nt (F) AU-rich RNA substrates. The 
experiment was performed in triplicate and quantification of mean values is shown 
with error bars at ±1 standard deviation. Representative polyacrylamide TBE-urea gels 
are shown below. 
 
 
 
 
 
	 59 
 
 
  
	 60 
 
 
 
 
 
Figure 16. Activities of Exo106 and Exo1044 complexes containing wild-type and 
mutant Rrp43 and Rrp45 proteins. (A) Exo1044 decay activity on 5’ FAM 14 nt and 
49 nt AU-rich and poly(A) substrates. Where indicated, a 3-fold molar excess (3 nM 
final concentration) of a catalytically inactive Rrp6 protein (residues 129-733, D238N 
mutant) was added to the reaction. The full-length RNA substrate is indicated with 14 
nt or 49 nt marker and the Rrp44 decay product is indicated with the 4-5 nt marker. 
N.D. indicates panels that were not done. B) Binding affinities of Exo1044 complexes 
and free Rrp44 for AU-rich RNA as measured by fluorescence anisotropy. ‘41ChOcc’ 
refers to a mutant in Rrp41 that occludes the central channel. Error bars indicate ±1 
standard deviation obtained from three independent experiments. C) SDS-PAGE 
analysis of reconstituted Exo106 complexes containing deletions in Rrp43. Gel is 4-
12% acrylamide BIS-TRIS run in MOPS-SDS running buffer and stained with 
SYPRO ruby. D) Decay time courses of reconstituted Exo106 complexes on 5’ FAM 
poly(A) and AU-rich 49 nt RNA.   
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We first assessed the impact of deleting Rrp43L1 and Rrp43L2 in the context 
of Exo1044 complexes in degradation of long (36/37 nt) and short (14 nt) AU-rich and 
poly(A) RNA substrates (Figures 14 and 16A). Deleting Rrp43L1 increased Rrp44 
activity on short and long AU-rich RNA substrates. In contrast, deletion of Rrp43L2 
had no detectable impact on degradation of short AU-rich RNA although a measurable 
defect was observed in degrading the long AU-rich substrate (Figures 14B and 14C). 
Interestingly, deletion of Rrp43L2 suppressed the stimulation observed for Rrp43L1 
deletion in degradation assays with short and long RNA when Rrp43L1 and Rrp43L2 
deletions were combined. A similar pattern was observed for degradation of short 
poly(A) RNA for the respective Exo1044 complexes, however none of these 
complexes exhibited activity on 37 nt poly(A) RNA in comparison to Rrp44 (Figure 
16A). The latter observation is consistent with previous results showing that the Rrp6 
protein was required for Rrp44 to bind and degrade poly(A) RNA in nuclear exosome 
complexes (Wasmuth and Lima, 2012a). 
Binding and decay assays with the AU-rich RNA substrates were also 
performed using Exo1044 complexes that contained a loop-insertion mutant of Rrp41 
(41ChOcc) that partially occludes the central channel (Wasmuth and Lima, 2012a). We 
observed that binding and initial rate of decay were inhibited when the channel was 
occluded, supporting the conclusion that Rrp44 remains dependent on RNA passing 
through the central channel when bound to Exo9 cores containing the mutated Rrp43 
subunit (Figure 16B). Notably, the dependence on the central channel was more 
pronounced for the 36 nt AU-rich RNA than the 14 nt RNA (Figure 16B), consistent 
with previous observations that Rrp44 conformational changes from channel-
independent to the channel-dependent are promoted by incubation with long (>24 nt) 
single-stranded RNAs under non-degrading conditions (Liu et al., 2014).  
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We next assessed reconstituted wild-type and mutant nuclear Exo1144/6ΔN 
complexes in degradation assays using short (14 nt) or long (37/36 nt) poly(A) and 
AU-rich RNAs (Figure 15). For Exo1144/6ΔN complexes, deletion of Rrp43L1 
increased Rrp44 activity for each RNA substrate tested, especially evident for the 
short RNA substrates. In contrast to that observed for Exo1044 complexes, deletion of 
Rrp43L2 resulted in a measurable loss of Rrp44 activity for the 14 nt AU-rich while 
deletion of Rrp43L2 had little impact on degradation of the 14 nt poly(A) RNA. 
Deletion of Rrp43L2 reduced Rrp44 activity on both 36 nt AU-rich and 37 nt poly(A) 
substrates. Consistent with results obtained using Exo1044 complexes, deletion of 
Rrp43L2 suppressed the stimulatory effect of removing Rrp43L1 while removal of 
Rrp43L1 largely suppressed the defects observed for Rrp43L2 deletion. Deletion of 
Rrp45Cterm tail resulted in a measurable increase in Rrp44 activity, albeit less than that 
observed for deletion of Rrp43L1. Deletion of both the Rrp45Cterm tail and Rrp43L1 
appeared additive. The presence of Rrp6 activities in these assays could lead to 
artifacts in analysis of Rrp44 decay products, so we also added catalytically inactive 
Rrp6 (Rrp6exo-) to Exo1044 complexes in degradation assays with the poly(A) RNA 
substrates (Figure 16A). Results from these assays are qualitatively similar to those 
obtained for catalytically active Exo1144/6ΔN complexes. Deletion of Rrp43L1 and 
Rrp45Cterm stimulated degradation, deletion of Rrp43L2 inhibited degradation, and 
deleting both Rrp43L1 and Rrp43L2 suppressed the effects observed for the individual 
deletions. 
Taken together, these results suggest that Exo9 subunit contacts between the 
Rrp43L1, Rrp45Cterm and channel-independent Rrp44 conformation inhibit Rrp44 
activity in Exo1044 and Exo1144/66ΔN, while Rrp43L2 contacts to the channel-
dependent Rrp44 conformation promote activity in Exo1144/6. Longer RNA substrates 
presumably enter the 11-component exosome via its central channel, and the greater 
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dependence on Rrp43L2 for degrading longer RNA is consistent with Rrp43L2 
contacting RNA as it exits the central channel to Rrp44 (Liu et al., 2016; Makino et 
al., 2013b). Rrp43L2 appears dispensable for degradation of shorter RNA substrates, 
but enhanced degradation of 14 nt RNA by deletion of Rrp43L1 and Rrp45Cterm was 
suppressed by deletion of Rrp43L2. Although other models are possible (see 
Discussion), we believe the simplest explanation is that Rrp44 is stabilized in the 
channel-independent conformation by contacts to Rrp43L1 and Rrp45Cterm, and that 
Rrp44 is stabilized in the channel-dependent conformation by contacts to Rrp43L2. 
Because deletion of Rrp43L1 and Rrp45Cterm enhances activity in a manner dependent 
on Rrp43L2, we posit that Rrp44 conformational changes are important for degrading 
both long and short substrates independent of whether RNA enters the exosome 
through the central channel (long RNA) or via direct binding to Rrp44 (short RNA). It 
remains unclear if this could be a regulated feature of the RNA exosome, or if it serves 
to inhibit Rrp44 activities when RNA is not presented through the Exo9 central 
channel, the presumed route for most cellular RNAs (Delan-Forino et al., 2017; 
Drazkowska et al., 2013; Wasmuth and Lima, 2012a). 
 
In vitro analysis of a Dis3 direct-access mutant 
In a recent study, investigators analyzed the in vivo effects in a strain 
expressing a rrp44 allele that harbored five alanine substitutions predicted to 
destabilize the channel-independent Rrp44 conformation but not affect the channel-
dependent conformation (Han and van Hoof, 2016) (Figure 17). Among many 
observations, they showed that cells expressing this rrp44 allele were viable, albeit 
with a slow-growth phenotype (Figure 18A) and defects in degradation of structured 
substrates. The mutant, which they termed Rrp44da, also showed synthetic defects 
when combined with mutations that rendered the endo- and exoribonuclease sites of 
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Rrp44 inactive (Figure 18A). Perhaps most intriguing was the observation the rrp44da 
allele suppressed growth defects/lethality of mutations designed to occlude the Exo9 
central channel (Wasmuth and Lima, 2012a), suggesting strong genetic interactions 
between mutations in the Exo9 core and Rrp44 (Figures 18B and 18C). 
 Because their study lacked in vitro characterization of the mutant, we cloned 
(original clone obtained from A. van Hoof), expressed, purified, and reconstituted 
Rrp44da into nuclear exosome complexes, and assayed its decay activities (Figure 19). 
Rrp44da expressed, purified, and reconstituted into an Exo1244/6/47 complex as WT, 
indicating that the mutations did not result in severe protein folding defects (Figures 
19A and 19B). We assayed the mutant enzyme in and out of the complex for decay 
activity compared to the WT (Figure 19C). For both the free enzyme and the complex 
we observed markedly decreased intensity of Rrp44 products on 14 and 49 nt 
substrates relative to WT for both poly(A) and AU-rich RNAs. Because the mutations 
were designed to specifically inhibit conformational changes in the context of the 
exosome complex, the decrease in activity of the free enzyme was unexpected. 
However, the synthetic lethality of combining Rrp44exo- inactivation with these 
mutations and the rescuing of the channel block phenotype suggests that this mutant is 
not simply decreasing Rrp44 activity in vivo (Figure 18). That being said, mutation of 
D602, which forms a salt bridge to R600 near the 3’ end of the bound RNA, could be 
responsible for diminishing the activity of this enzyme (see next section). 
Additionally, the mutation of two consecutive arginines to alanines results in a 
considerable loss of steric bulk at that location, which could affect local folding or 
conformational dynamics important for substrate binding. 
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Figure 17. Structural modeling of Rrp44da mutations. Side-chains of the residues 
mutated to alanine in the Rrp44da mutant are highlighted as spheres in the RNA 
channel-independent (A) and RNA channel-dependent (B) conformations of S. 
cerevisiae. Structures were aligned based on all six PH-like proteins and RNA 3’ and 
5’ ends are indicated. ‘Rrp44 (Exo)’ refers to the exonuclease module of Rrp44, which 
encompasses its two cold shock domains, its RNB catalytic domain and its S1 domain.  
	 67 
 
 
 
 
Figure 18 The Rrp44da-exosome uses both the exo- and endonuclease activities 
and suppresses growth defects of channel occlusions. (A) rrp44-da is synthetic 
lethal with rrp44-exo− and rrp44-endo−. An rrp44Δ strain carrying a wild-
type RRP44 allele in a URA3 plasmid was transformed with LEU2 plasmids 
carrying RRP44 variants. The transformants were serially diluted and spotted on 
5FOA and SC-LEU-URA (control) media. (B and C) rrp44-da suppresses the growth 
defect of rrp41-L and rrp45-L. rrp44Δ rrp41Δ or rrp44Δ rrp45Δ strains 
carrying RRP44 variants in a LEU2 plasmid and a wild-type RRP41 or RRP45 in 
a URA3 plasmid were transformed with a TRP1 plasmid carrying the rrp41-
L or rrp45-L allele. The transformants were serially diluted and spotted on 5FOA 
media. Figure and caption adapted from Figures 3 and 5 of Han and van Hoof, 2016. 
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Figure 19: Rrp44da mutant has decreased activity on a variety of RNA substrates 
under standard assay conditions. (A) SDS-PAGE analysis of parallel preparations 
of WT and da mutant Rrp44 enzymes. Lanes 1 and 6 are whole cell extracts 16 hrs 
after induction with IPTG, lanes 2 and 7 are eluates from the Ni-NTA column, lanes 3 
and 8 are eluates from the heparin column, lanes 4 and 9 are heparin eluates post Ulp 
treatment, and lanes 5 and 10 are eluates from gel filtration. Gel was stained with 
Coomassie brilliant blue for visualization. (B) Protein gel showing purified free 
enzymes (first two lanes after marker) and gel-filtration purified Exo12Rrp6/Rrp47/Rrp44 
complexes (3rd and 4th lanes after marker). Gels were stained with SYPRO Ruby for 
visualization. (C) RNA decay activities of Rrp44 free enzymes and nuclear exosome 
complexes. Substrates are as indicated and contain a 5’ fluorescein label. Gels are 15% 
polyacrylamide TBE-urea and were imaged for fluorescein signal.  
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In spite of these issues, buffer pH, [Mg2+], and reaction temperature were 
screened in an effort to find conditions that mitigated the activity discrepancy (Figure 
20). From these efforts, we found that a reaction buffer that contains a lower [Mg2+] 
and is at a lower pH than our standard buffer retains activity of the wild-type enzyme 
but has substantially higher activity for the da mutant (Figures 20C and 20D). 
 Rrp44 da mutant and WT were reconstituted into complexes containing a loop 
insertion in Rrp41 (41ChOcc, see above) and were assayed for degradation activity on 
poly(A) RNA in the original buffer (Figure 21). We determined that Rrp44 activity 
was highly compromised in the Rrp44da/Rrp41ChOcc complex under these conditions 
(Figure 21). Though this experiment bears repeating using the newly formulated 
buffer conditions, these results are still at odds with the genetic findings (Figure 19B), 
and suggest that a different approach will be required in future studies to de-convolute 
the in vivo effects of Rrp44 activity loss and perturbation of conformational state (see 
Discussion). 
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Figure 20: Rrp44da favors low pH and low magnesium. All gels are 15% 
acrylamide TBE-urea and were imaged for fluorescein signal. (A) Decay of 5’ 
fluorescein poly(A) 49 nt RNA by Rrp44 using different buffer pH and incubation 
temperature. The reaction solution contained 50 mM KCl, 0.5 mM MgCl2, 1 mM 
TCEP HCl, 0.05 % v/v IGEPAL and the indicated buffer was included at 20 mM. 
Final pHs of the solutions were also measured empirically and were as follows: 8.3, 
7.8, 7.1, 5.9. (B) Decay of poly(A) 49 nt RNA by Rrp44 under varying MgCl2. Base 
buffer was 20 mM HEPES-KOH pH 7.5, 50 mM KCl, 1 mM TCEP pH 7.0, 0.05 % 
v/v IGEPAL and was at a final pH of 7.3. (C) Decay of 5’ fluorescein poly(A) 49 nt 
RNA by Rrp44. Buffer 1 contained 20 mM Tris-Cl pH 8.0, 50 mM KCl, 0.5 mM 
MgCl2, 1 mM TCEP-HCl, 0.05 % v/v IGEPAL and was at a final pH of 7.8. Buffer 2 
contained 20 mM HEPES-NaOH pH 7.0, 50 mM NaCl, 0.1 mM MgCl2, 1 mM TCEP 
pH 7.0, 0.05 % v/v IGEPAL and was at a final pH of 6.8. (D) Superficial 
quantification of product for the experiment in panel B. Conversion to nM was 
achieved by subtracting the fraction of substrate remaining at the given incubation 
time from 1 and multiplying that number by 10. Because only a single replicate was 
performed, no error bars are shown.  
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Figure 21: Rrp44da fails to rescue activity of a channel occluded nuclear exosome 
in vitro. Decay of 5’ fluorescein poly(A) 49 nt RNA by Rrp44 and nuclear exosome 
complexes using the original RNA decay buffer (20 mM Tris-Cl pH 8.0, 50 mM KCl, 
0.5 mM MgCl2, 1 mM TCEP-HCl, 0.05 % v/v IGEPAL). ‘41ChOcc’ indicates that the 
complex contains a loop insertion in Rrp41 designed to occlude the central channel. 
Gels are 15% acrylamide TBE-urea and were imaged for fluorescein signal.  
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3’ phosphorylated RNA is a Rrp44 substrate 
The RNA path for the last 7 nt of RNA in the Rrp44 active site in our structure 
resembles that previously observed in the structure of Rrp44 bound to poly(A) RNA 
(Lorentzen et al., 2008). A similar RNA path was modeled in the nuclear RNA 
exosome structure bound to an 18 nt AU-rich RNA (Makino et al., 2015), but its path 
diverges after the 7th nt and its 5’ end is modeled into densities that we assign to the 
Rrp43L1 loop near residue Asp105 (Figure 13). Inspection of electron densities 
proximal to the Rrp44 active site and 3’ end of RNA in our structure revealed a sulfate 
ion that was present in the crystallization medium (Figure 22A). The sulfate ion is 
positioned 2.6 Å or 3.4 Å from the 2’ and 3’ OH groups of the terminal base, 
respectively, and is situated in a positively charged pocket formed by Rrp44 Arg600 
(2.8 Å) and Rrp45 Arg303 (2.7 Å). 
The location of the sulfate ion in the Rrp44-RNA complex suggested that 
Rrp44 could accommodate a 3’ phosphorylated RNA in its active site. In contrast, 
inspection of the Rrp6 active site in this and previous structures of Rrp6 bound to 
AMP (PDB 2HBL) or Exo106exo-ΔNΔC bound to poly(A) (PDB  4OO1) suggested that 
the Rrp6 active site could not accommodate a 3’ phosphorylated RNA because the 
RNA 2’ OH is 2.5 Å from the backbone carbonyl of His 241 while the 3’ OH is 
coordinated by side chains of Asp240 and backbone amide of His241 (Midtgaard et 
al., 2006; Wasmuth et al., 2014) (Figures 22B and 23). The RNA and last nucleotide 
adopts a different configuration in the twinned structure of Rrp6 catalytic domain 
bound to polyU RNA modeled with partial occupancy (PDB 5C0Y) (Figure 23), 
however contacts to the RNA 3’ end in this structure would still appear to preclude 
accommodation of a 3’ phosphorylated RNA substrate (Makino et al., 2015). 
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Figure 22. 3’ Phosphate RNA is a substrate of Rrp44 but not Rrp6. (A and B) 3’ 
end of the RNA bound to Rrp44 (A) and Rrp6 (B). Mesh represents electron density 
from a simulated annealing 2Fo-Fc omit map contoured at 1.2 σ. Distances are shown 
in Ångstroms. (C) Binding affinities of Rrp44 and Rrp6 for a 5’ FAM 3’ phosphate or 
3’ OH 36 nt AU-rich RNA as measured by fluorescence anisotropy. Mean values are 
plotted with error bars at ±1 standard deviation of a triplicate experiment. (D) 
Polyacrylamide TBE-urea gel analysis of RNA decay time-courses using a 5’ FAM 3’ 
phosphate AU-rich 49 nt RNA performed in the presence or absence of calf intestinal 
phosphatase (CIP) as indicated. (E) Ion-pair reverse-phase HPLC analysis of Rrp44 
decay products. Reactions contained Rrp44 and either 5’ FAM 3’ phosphate 49 nt AU-
rich RNA, 5’ FAM 3’ OH 49 nt AU-rich RNA, 3’5’ pAp, or no substrate. Absorbance 
was monitored at 260 nm for detection of nucleotides and 4-5 nt RNA decay products. 
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Figure 23. RNA in proximity to the Rrp6 active site. (A) RNA in or near the active 
site of Rrp6 in several structures in the PDB. Distances to the backbone carbonyl and 
amide of His241 and side chain of Asp240 are shown in Ångstroms. (B) The three 
terminal nucleotides of RNA or AMP in the Rrp6 active site from four different 
structures. Rrp6 residues 150-300, which span the catalytic residues, were aligned and 
the protein is removed for clarity. 
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Consistent with the aforementioned predictions, Rrp44 can bind and degrade a 
3’ phosphorylated RNA (Figures 22C, 22D, 24F and 24G). By contrast, Rrp6 cannot 
degrade 3’ phosphate RNA, consistent with previous findings (Burkard and Butler, 
2000), despite its ability to bind it (Figures 22C, 22D, and 24G). These respective 
activities persist when Rrp6 and Rrp44 are reconstituted in complexes as Exo1044, 
Exo106ΔN or Exo1144/6ΔN (Figure 22D). A question remained as to whether Rrp44 
initiates degradation of the 3’ phosphate RNA substrate by first removing the 3’ 
phosphate of the terminal ribonucleotide, followed by subsequent hydrolysis and 
release of NMP products, or if it accommodates the 3’ phosphorylated terminal 
ribonucleotide in the active site, releasing 3’-5’ pNp and NMPs as products. To 
address this, Rrp44 decay products were analyzed by ion-pair reverse-phase HPLC. To 
validate our HPLC protocol, we first analyzed products of 3’ phosphate RNA decay 
by the Rrp44 homolog RNase R from E. coli and observed quantitative 3’-5’ pAp 
release, as previously observed using radiolabeled substrates and thin-layer 
chromatography (Cheng and Deutscher, 2002; Vincent and Deutscher, 2006) (Figures 
24C through 24D). Quantitative release of 3’-5’ pAp was also observed as a product of 
Rrp44 degradation for 3’ phosphorylated but not 3’ OH RNA substrates (Figures 22E, 
24A and 24B), indicating that cleavage by Rrp44 occurs at the 5’ phosphate of the 
terminal ribonucleotide, consistent with our structural model. 
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Figure 24. Analysis of Rrp44 activity on 3’ phosphate RNA. (A through D) Ion-
pair reverse phase HPLC analysis of RNA decay products. Reactions contained either 
Rrp44 (A and B) or E. coli RNAse R (C and D) and the indicated substrates. UV 
absorbance was monitored at 260 nm for detection of nucleotides (A and C) or 490 nm 
for detection of the 5’ fluorescein label (B and D). (E) Multiple sequence alignment 
using Clustal Omega (Sievers et al., 2011) of Rrp44 (Dis3) from six organisms as well 
as the related enzymes Dis3l and Dis3l2 from human and RNase II and RNase R from 
E. coli. (F) Binding affinities of wild type and mutant Rrp44 for AU-rich RNA as 
measured by fluorescence anisotropy. Error bars indicate ±1 standard deviation 
obtained from three independent experiments. (G) RNA decay of 3’ phosphate 5’ 
FAM 49 nt AU-rich RNA by the indicated enzymes. 
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An attempt to disrupt recognition of 3’ phosphate RNA identified Rrp44 
Arg600 and Asp602, as they are conserved in eukaryotic homologs (Figure 24E) and 
located near the sulfate ion and 3’ end of the RNA (Figure 22A). Differential binding 
defects were observed for the R600D/D602R mutant with 3’ OH RNA preferred over 
3’ phosphate RNA (Figure 24F), however mutation of Arg600, alone or in 
combination with mutation of Asp602, resulted in diminished decay activities on both 
3’ phosphate and 3’ OH RNA substrates (Figure 24G). This is perhaps consistent with 
amino acid substitutions at these positions in RNaseR and RNaseII as both enzymes 
are able to degrade 3’ phosphorylated RNA substrates (Cheng and Deutscher, 2002) 
(Figure 24E). It is notable that Rrp44 homologs from human, including Dis3, Dis3l 
and Disl2, can also degrade 3’ phosphate RNA by releasing pNp, suggesting that this 
activity may be evolutionarily conserved (Lubas et al., 2013; Tomecki et al., 2010). 
Although we were unsuccessful identifying separation of function mutations to 
selectively diminish Rrp44 activities on 3’ OH or 3’ modified RNA substrates, future 
efforts along this line will be critical to determine if Rrp44 participates in the 
degradation of 3’ modified RNA substrates in vivo. 
 
RNA path to Rrp6 
The structure of Exo106exo-ΔNΔC bound to poly(A) RNA (PDB 4OO1) revealed 
6-8 nt of the 24 nt substrate with the RNA 3’ end anchored in the Rrp6 active site, the 
5’ end extending toward the S1/KH ring, and the remaining RNA disordered 
(Wasmuth et al., 2014). An alternative model was proposed based on a twinned crystal 
structure of the isolated Rrp6 catalytic domain bound to 15 nt polyU RNA modeled 
with partial occupancy (PDB 5C0Y) suggesting that RNA would not contact the 
S1/KH ring, and that an 18 nt AU-rich RNA bypassed the Rrp6 active site altogether 
in a nuclear exosome complex (Makino et al., 2015) (Figure 23). 
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Electron densities are evident for 17 nt of RNA in our structure up to the 
position where the di-triazole linker connects the two segments in our symmetric 34 nt 
RNA substrate (Figures 25A and 9D). As observed in the Exo106exo-ΔNΔC structure 
bound to poly(A) RNA (Wasmuth et al., 2014), the RNA 3’ end is anchored in the 
Rrp6 active site, extending toward and contacting the S1/KH ring (Figures 9C and 
25A). After reaching the bottom of the S1/KH ring, the RNA is deflected and makes a 
U-turn back toward the Rrp6 HRDC domain. Although not modeled, additional 
electron densities ~20 Å from the 5’ end are observed between the HRDC and Exo 
domains of Rrp6 (Figures 9D, 25A and 25B), consistent with, but not identical to, a 
path proposed based on the twinned crystal structure of the Rrp6 catalytic domain 
bound to a 15 nt polyU RNA (Makino et al., 2015). Electron densities were not 
evident for the linker atoms, and RNA was not modeled in the HRDC/Exo domain 
channel due to poor definition of electron densities in this region. 
As anticipated for a non-specific exoribonuclease, protein-RNA interactions 
are dominated by contacts to the polyribonucleotide backbone and non-specific 
stacking with the nucleobases of the RNA chain. Contacts between the last 3 nt of 
RNA (A17-15) and Rrp6 are similar to those described for Exo106exo-ΔNΔC bound to 
poly(A) RNA (Wasmuth et al., 2014), however the paths diverge at the fourth nt 
(Figure 23). Instead, the nucleobase of A14 stacks on Rrp40 Arg110 while the A14 
phosphate is coordinated by Rrp6 Tyr315 and His326 (Figure 25C). The U13 
nucleobase is stacked on Rrp4 Phe177 and directed toward Rrp4 Ser175 (Figure 25D). 
The U12 and U11 nucleobases form base edge interactions with A2 and U4, 
respectively, with the U12 phosphate proximal to the Rrp41 Arg119 side chain and the 
U11 phosphate contacting Rrp4 Arg123. Density for the U10 nucleobase is not 
evident, but it points toward Rrp41 Lys62 (Figure 25D). The A9 nucleobase is 
sandwiched between Rrp40 Phe80 and the nucleobase of U7 while the A9 phosphate 
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contacts Rrp40 Lys85 (Figure 25E). The U8 nucleobase contacts Rrp40 Ser94 above 
Glu131 before turning to enable contacts between the U8 phosphate and Csl4 Arg150, 
a side chain that is also in proximity to the U7 phosphate (Figure 25E). The U6 
nucleobase is stacked between A9 and A5 and makes contacts to the Rrp40 Ser81 side 
chain and backbone amide (Figure 25E). The A5 nucleobase stacks between U6 and 
U11 with its base edge directed toward A14 and the U4 nucleobase stacks between A5 
and the A2 ribose with it base edge directed toward U12. The path twists to point the 
U3 nucleobase toward that of A16, with the A2 nucleobase contacting Rrp4 Met137 
with its edge directed toward U12. The final U1 nucleobase is sandwiched between 
Rrp4 Leu138 and Rrp6 Tyr430. 
Previous mutational analysis reported that Rrp6 Phe294 and Tyr315 did not 
play a role in Rrp6 mediated decay (Makino et al., 2015), although these residues 
contact RNA in both the Exo106exo-ΔNΔC and present structure (Wasmuth et al., 2014). 
Indeed, F294A/Y315A diminished Rrp6 activities when associated with Exo9 
(Exo106ΔN) or in the nuclear exosome (Figures 25F, 26A and 26C). Consistent with a 
path that guides RNA between the HRDC and Exo domains of Rrp6, Y244A and 
R245A substitution in Rrp6 reduced degradation activity in the exosome and as a free 
enzyme as noted previously (Makino et al., 2015) (Figures 25F, 26A and 26C). Rrp6 
Arg461 and Asn466 are just below Tyr244 and Arg245, and R461V and N466D 
substitutions resulted in altered degradation patterns for poly(A) RNA when 
associated with Exo9 or when combined with Rrp40 K85E (see below; Figures 26B 
and 26D). 
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Figure 25. RNA path to Rrp6 in Exo1144/6/3’-3’RNA structure. (A to E) RNA 
contacts to Rrp6, the S1/KH proteins, and Rrp41. Mesh represents electron density 
from a simulated annealing 2Fo-Fc omit map contoured at 1.2 σ. Unmodeled density 
between the Exo and HRDC domains of Rrp6 is shown (B). Residues mutated in this 
and/or previous studies that contribute to the activities of the RNA exosome are 
highlighted with colored asterisks. (F) Polyacrylamide TBE-urea gel analysis of decay 
of 5’ FAM 37 nt poly(A) RNA by mutants in Rrp6. (G) Polyacrylamide TBE-urea gel 
analysis of decay of 5’ FAM 37 nt poly(A) RNA by WT Exo1144/6 and a mutant in the 
S1/KH protein Rrp40.   
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Figure 26. Rrp6 activity is diminished by mutating non-catalytic residues in its 
Exo domain and both Rrp6 and Rrp44 activities are diminished by a mutation in 
the S1/KH protein Rrp40. (A and B) SDS-PAGE analysis of Rrp6 wild type and 
mutant enzymes and reconstituted complexes. Gel is 4-12% acrylamide BIS-TRIS run 
in MES-SDS running buffer and stained with SYPRO ruby. (C and D) Polyacrylamide 
TBE-urea analysis of decay time courses of free Rrp6 and reconstituted complexes on 
5’ FAM poly(A) 14 nt and 37 nt RNA. 
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RNA contacts occur deep in the S1/KH ring with Csl4 Arg145 and Arg150 
side chains contacting the phosphate backbone at U7 and U8, while Rrp40 Arg110 
buttresses the A14 nucleobase (Figures 25C). Consistent with these contacts, prior 
analysis revealed that mutation of these conserved residues diminishes both Rrp6 and 
Rrp44 activities (Wasmuth et al., 2014). In addition, insertions between residues 63 
and 64 of Rrp41 also disrupt Rrp6 and Rrp44 activity (Wasmuth and Lima, 2012a), 
consistent with occluding the RNA path to Rrp6 near U10 (Figure 25D). Among 
several unique contacts observed in our structure are those at the deepest point of 
RNA ingress to the S1/KH ring between the conserved Lys85 of Rrp40 (Liu et al., 
2006) and the RNA backbone phosphate of A9 (Figures 25A and 25E). Of note, Lys85 
lies just below that last nucleotide modeled in the channel-dependent RNA bound 
exosome structure (Makino et al., 2013b). Consistent with contacts observed in our 
structure and predicted contacts in the channel-dependent structure, Rrp40 K85E 
decreased both Rrp6 and Rrp44 activities, supporting a role in coordinating RNA via 
overlapping but distinct paths as RNA is guided to Rrp6 or Rrp44 (Wasmuth and 
Lima, 2012a; Wasmuth et al., 2014) (Figures 25G, 26B and 26D). 
 
Discussion 
 
The strategy employed here to satisfy both Rrp6 and Rrp44 exoribonuclease 
sites with a single RNA containing two 3’ ends enabled determination of a high-
resolution structure of the nuclear RNA exosome, and it may prove useful in 
characterizing other RNA exosome complexes in association with additional nuclear 
cofactors. 
Association of Rrp6 and Rrp44 with the essential non-catalytic Exo9 core 
attenuates or alters their activities (Dziembowski et al., 2007; Wasmuth and Lima, 
	 85 
2012a). Previous studies suggested that attenuation is due in part to sequestration of 
their active sites relative to the apo enzymes by imposing a requirement that RNA 
must pass into the S1/KH ring to be degraded by Rrp6 or through the entire central 
channel to be degraded by Rrp44 (Drazkowska et al., 2013; Makino et al., 2013a; 
2013b; Malet et al., 2010; Wasmuth and Lima, 2012a; Wasmuth et al., 2014). Using 
the high-resolution structure presented here, extensive interactions were revealed 
between the RNA and S1/KH ring of central channel on its way to the Rrp6 active site. 
Mutational analysis presented here and elsewhere suggests that amino acid sidechains 
along this path can contribute to both Rrp6 and Rrp44 activities, supporting the 
existence of overlapping yet distinct RNA paths that guide substrates to the respective 
catalytic subunits (Makino et al., 2015; Wasmuth and Lima, 2012a; Wasmuth et al., 
2014) (Figure 11A). We also resolved a feature of the Exo9 core, namely Rrp43L1, 
which together with Rrp45Cterm interact with the channel-independent Rrp44 
conformation (Figures 11A, 11C, and 12A through 12C) and inhibit Rrp44 activity. 
We found that deleting these features enhanced Rrp44 activity on long and short 
RNAs, and that activities remained dependent on the Exo9 central channel, especially 
for longer RNA substrates (Figures 14 through 16). 
One alternative explanation for enhanced activity in the absence of Rrp43L1 is 
that Rrp43L1 is highly acidic and contacts Rrp44 near the RNA point of ingress. As 
such, it might create an electrostatic barrier that inhibits binding to the direct-access or 
channel-independent Rrp44 conformation. However, this model predicts that binding 
and decay of RNA by the Rrp43L1 deletion mutant should not be affected by a 
channel occlusion nor should its activities be suppressed by deletion of Rrp43L2, 
which is not the case (Figures 14 through 16). We propose a model in which Exo9 
elements that bind and stabilize the channel-independent Rrp44 conformation 
(Rrp43L1 and Rrp45Cterm) compete with Exo9 elements that bind and stabilize the 
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channel-dependent Rrp44 conformation (Rrp43L2). Since deletion of Rrp43L2 
suppresses the activities gained by deleting Rrp43L1 and Rrp45Cterm on both long and 
short RNA substrates, we propose that conformational changes to the channel-
dependent Rrp44 conformation are required for the most efficient degradation of these 
substrates. 
A recent genetics study in S. cerevisiae showed that a strain expressing only 
Rrp44da (Figure 17) accumulated certain RNA species such as tRNAiMet and the 
rRNA 5’ externally transcribed spacer (5’ ETS) (Han and van Hoof, 2016). 
Intriguingly, the authors showed that expressing this mutant Rrp44 rescued growth 
defects but not 3’ processing defects in strains containing channel occlusions in the 
Rrp45 and Rrp41 proteins (Figures 18B and 18C). However, these results are 
complicated by our finding that this mutant contains an intrinsic loss of activity of the 
enzyme (Figure 19C), which could contribute to the accumulation of these substrates. 
Furthermore, a loss of exo activity could explain the synthetic effect with combining 
the da mutant with the endo-. Another genetics study purporting to selectively disrupt 
the channel-independent Rrp44 conformation employed a mutant in the S1 domain 
that we would predict to disrupt the free enzyme activity as well (Delan-Forino et al., 
2017). While the Rrp45 and Rrp43 loop deletion mutants we employ do alter Rrp44 
activity in the RNA exosome complex (its presumed physiological state), their use 
offers the advantage that they are not alterations in Rrp44 itself, and thus cannot affect 
its intrinsic activity. Use of these mutants in future genetics studies may allow for 
unambiguous determination of the effects of perturbing Rrp44 conformational 
switching in vivo. 
The models presented here and elsewhere provide a structural basis for the 
ability of Rrp44, but not Rrp6, to degrade 3’ phosphorylated RNA substrates. The in 
vivo significance of these findings are discussed extensively in the Introduction 
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section of this dissertation. Previous studies implicated Xrn1 in degradation of 2’,3’-
cyclic phosphate tRNA introns (Wu and Hopper, 2014), but the observation that 
Rrp44 and related human enzymes can degrade 3’ phosphorylated RNA begs the 
question as to whether the RNA exosome also participates in the degradation of 
aberrant 3’ modified forms of RNA, or if this activity contributes to generating clean 
3’OH RNA ends to promote post-transcriptional polyadenylation by TRAMP (LaCava 
et al., 2005; Wyers et al., 2005) or 3’ trimming by Rrp6.  
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Materials and Methods 
 
Cloning, expression, and purification of proteins 
 S. cerevisiae Exo9 components were cloned as N-terminal His6Smt3 fusions, 
expressed in E. coli,  and reconstituted into complexes as previously described 
(Greimann and Lima, 2008; Wasmuth and Lima, 2012a). Briefly, Smt3 was amplified 
from S. cerevisiae genomic DNA using PCR primers that added six histidines and a 
short linker to its N-terminus and cloned into the NcoI and BamHI sites of pRSF-duet 
(Novagen) to create pRSFduet-Smt3. PH-like subunits were cloned into this vector as 
heterodimers as follows: His6Smt3-Rrp42 paired with Mtr3, His6Smt3-Rrp46 paired 
with Rrp43, and His6Smt3-Rrp41 paired with Rrp45. Cap subunits Csl4, Rrp4 and 
Rrp40 were cloned into the first multiple cloning site of pRSFduet-Smt3 and 
expressed alone. Plasmids were transformed into BL21 (DE3) RIL cells (Agilent) and 
single transformants were inoculated into antibiotic containing Superbroth (Teknova) 
and incubated with shaking at 37°C. Cultures were induced at OD600 = 1.0 – 2.0 with 
cold shocking on slushy ice and 400 µM IPTG, grown at 18°C with shaking overnight 
and harvested by centrifugation. Cell pellets were resuspended in an equal volume of 
50 mM Tris-Cl pH 8.0, 20% w/v sucrose and stored at -80°C. Prior to lysis, the 
suspension was thawed and adjusted to 350 mM NaCl, 20 mM imidazole, 1 mM beta-
mercapto ethanol (BME), 0.1 % v/v IGEPAL co-630, 10 µg/mL lysozyme and 10 
µg/mL DNAse I. Cells were lysed by sonication with stirring on ice. The lysate was 
separated from unlysed cells and insoluble matter by centrifugation at 40,000 x g 
(4°C) for 45 min, added to Ni-NTA resin (Qiagen), and rotated for 1 hr at 4°C. Then, 
the resin and lysate were transferred to a disposable column, the flowthrough 
discarded, and the resin washed with 10 volumes of wash buffer (20 mM Tris-Cl pH 
8.0, 250 mM NaCl, 20 mM imidazole, 1 mM BME) using gravity flow. The resin was 
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then washed with 10 volumes of chaperone buffer (wash buffer plus 50 mM KCl, 10 
mM MgSO4, and 2 mM ATP) followed by another 5 volumes of wash buffer. Bound 
protein was eluted with 3 column volumes of wash buffer plus 250 mM imidazole pH 
8.0 and injected onto a 320 mL Superdex200 (for the PH-like protein heterodimers 
and Rrp4) or Superdex75 columns (for Csl4 and Rrp40) that had been equilibrated in 
20 mM Tris-Cl pH 8.0, 350 mM NaCl, 1 mM NaCl. Peak fractions were pooled, 
concentrated to >5 mg/mL, and a 1:1000 molar ratio of Ulp was added and incubated 
at 4°C with the protein or heterodimer overnight to cleave the tag. The next morning 
the preparation was flash frozen and stored at -80°C for later use. For the Rrp46/43 
heterodimer, the Ulp cleavage step was omitted and the preparation was simply 
concentrated and flash frozen after Superdex elution. For Exo9 reconstitution, purified 
protein stocks were thawed, centrifuged, and the concentrations of the supernatants 
measured using a Bradford assay. Then, they were mixed in a molar ratio of 
Rrp41/Rrp45 : Rrp42/Mtr3 : Rrp46/Rrp43 : Csl4 : Rrp40 : Rrp4 = 1 : 1 : 3 : 1.75 : 1.75 
: 1 and dialyzed into 20 mM Tris-Cl pH 8.0, 100 mM NaCl, 0.1 mM MgCl2, 10 mM 
DTT at 4°C overnight. The next day the dialysate was injected over a Superdex200 
column that had been equilibrated in the dialysis buffer, peak fractions were pooled 
and concentrated to >5mg/mL, flash frozen in liquid nitrogen and stored at -80oC for 
later use. 
 Genes for the Rrp43 deletion mutants were synthesized by Life Technologies 
and were as follows: Rrp43ΔL1 has residues 101-119 of Rrp43 replaced with Gly-Ser-
Gly-Ser-Gly-Ser, Rrp43ΔL2 has residues 254-270 deleted, and Rrp43ΔΔ contains 
both of these modifications. Rrp45ΔCterm (residues 1-290) has the C-terminal 14 nt 
deleted and was generated using standard PCR/restriction enzyme based cloning. Point 
mutants in Rrp6, Rrp40, and Rrp44 were introduced by PCR based site-directed 
mutagenesis. All mutants were verified by Sanger sequencing of the entire gene. For 
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cloning of the Rrp6/Rrp47 heterodimer used in the complexes in Figures 19 to 21, 
Rrp47 was cloned into the first multiple cloning site of pRSFduet-Smt3 and full length 
Rrp6 was cloned into the second. 
 For reconstitution of complexes containing catalytic subunits, Exo9 cores were 
mixed with an equivalent of Csl4, a 3-fold molar excess of Rrp6 (or Rrp6/47 for 
Figures 19 through 21) and/or 1.5-fold molar excess of Rrp44, incubated at 4°C for 2-
4 hrs, and separated from free enzymes using a Superdex200 increase 10/300 GL 
column (GE) in 20 mM Tris-Cl pH 8.0, 100 mM NaCl, 0.1 mM MgCl2, 0.5 mM 
TCEP-HCl. All preparations of Rrp6 in this chapter except for in the experiments 
presented in Figures 19 to 21 lack the N-terminal 128 residues, which form an obligate 
heterodimer with the cofactor Rrp47 (Feigenbutz et al., 2013b; Schuch et al., 2014). 
Rrp6 containing the full C-terminus was expressed as an N-terminal His6-Smt3 fusion 
in E. coli BL21 (DE3) RIL cells with 250 µM IPTG induction for 16 hours at 18°C. 
The next steps are exactly the same as for the core subunits up to the nickel elution, at 
which point the Nickel eluate is injected onto a 5 mL Hi-Trap Heparin HP column 
(GE) equilibrated in 20 mM Tris-Cl pH 8.0, 250 mM NaCl, 1 mM BME. The column 
was washed with 4 column volumes of the equilibration buffer and eluted with a linear 
gradient of NaCl to 1 M over 20 column volumes. Rrp6 eluted in a peak centered at 
approximately 430 mM NaCl. Fractions containing the Rrp6 peak were pooled, 
concentrated, and digested with 1:1000 molar ratio of SUMO protease overnight at 
4°C. The next day, the protein was separated from His6Smt3 and SUMO protease 
using a Hiload 26/600 Superdex 200 (GE) gel filtration column (in 20 mM Tris-Cl pH 
8.0, 300 mM NaCl, 2 mM BME). Fractions containing Rrp6 were pooled, 
concentrated to 7-10 mg/mL by centrifugation in an Amicon YM-30 filtration unit 
(Millipore), flash frozen in liquid nitrogen, and stored at -80°C. This protocol 
effectively rids the preparation of nucleic acid contamination and C-terminal truncated 
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products. The same protocol was used to purify E. coli RNAse R (cloned as an N-
terminal His6-Smt3 fusion), except the gradient for the heparin column was run from 
250-600 mM KCl in 20 mM Tris-Cl pH 8.0, 0.1 mM MgCl2, 5% v/v glycerol, 0.5 mM 
TCEP-HCl and the protein eluted in a peak at approximately 450 mM KCl. Expression 
and purification of the Rrp6/Rrp47 heterodimer was nearly the same as for Rrp6DN, 
except for that it was transformed into SoluBL21 (DE3) RIL cells (Genlantis) that 
were grown and induced in a 12 L fermenter rather than flasks. Additionally, the 
protein elutes at higher NaCl concentrations (~600 mM) from the heparin column and 
its Smt3 tag remains uncleaved until reconstitution (see Chapter 2). Heparin 
purification for Rrp44 is detailed in the next chapter. 
 
Synthesis and HPLC purification of 3’-3’ RNAs 
 5’ alkynyl RNA oligonucleotides were synthesized and purified by standard 
desalting by Integrated DNA technologies. 17 and 18 sequences were 5’ (hexynyl)UA 
UUA UUU AUU UUA AAA 3’ and 5’ (hexynyl)UUA UUA UUU AUU UUA AAA 
3’, respectively. Copper click chemistry was carried out via modification of published 
protocols (El-Sagheer and Brown, 2012; Paredes and Das, 2011). Click reactions (10-
200 µL) contained 200 µM 5’ hexynyl oligonucleotide, 5 mM sodium ascorbate, 80 
mM potassium phosphate pH 7.0 and 100 µM 1,5 diazido-3-oxapentane (Santa Cruz 
Biotechnology, 10 mM stock made in DMSO). Reactions were initiated with the 
addition 1/10 volume of 5 mM CuCl2, 5 mM Tris(3-hydroxypropltriazolemethyl) 
amine (Sigma-Aldrich) and incubated at 25°C for 30 minutes. Reactions were 
quenched by addition of EDTA to 10 mM, diluted to 500 µL with TE buffer and 
fractionated by DEAE chromatography as described below. The concentration series 
for the 1,5 diazido-3-oxapentane titration shown in Figure 9B is 10, 25, 50, 100, 200, 
400, and 1000 µM. Click reactions were fractionated by DEAE chromatography 
	 92 
(Waters Protein-Pak DEAE 8HR 1000 Å 8 µm 5x50 mm column) using an Alliance 
2695 HPLC separation module (Waters). The column was run at a flow-rate of 0.5 
mL/min at 50°C and equilibrated in buffer A (10 mM Tris-Cl pH 8.0, 400 mM NaCl, 
0.1 mM EDTA). A linear gradient to 80% buffer B (10 mM Tris-Cl pH 8.0, 600 mM 
NaCl, 0.1 mM EDTA) was run from 2.5 min to 30 min after injection and fractions 
were collected every 1 minute (Figures 10A and 10B). Fractions were analyzed by 
UREA-PAGE using SYBR Gold staining (Life Technologies), and those containing 
the desired product were adjusted to 300 mM sodium acetate pH 5.2 and 70% ethanol 
to precipitate the RNA. The precipitate was then pelleted by centrifugation at 20,000 x 
g (4°C), the solvent decanted, the pellet washed with cold 70% ethanol, centrifuged 
again, the solvent decanted, and the pellet air-dried for 1 hr and resuspended in 
approximately 1/10th the original reaction volume of RNAse free water (Ambion). 
RNA concentration was calculated by measuring A260 using a Nanodrop 2000 and 
dividing that value by a theoretical extinction coefficient based on its sequence. This 
procedure regularly yielded 40-55% of the expected 3’-3’ RNA product at 
concentrations of 400-550 µM. 
 
Crystallization of Exo11 in complex with 3’-3’ RNA 
 Exo11Rrp44 D171N/D551N, Rrp6(residues129-684)D238N at a concentration of 13-15 mg/mL 
(by Bradford assay) in 20 mM Tris-Cl pH 8.0, 100 mM NaCl, 0.1 mM MgCl2, 1 mM 
TCEP-HCl was mixed in a 1.0:0.9 protein:RNA molar ratio with 3’-3’ RNA and 
incubated for 2 hours on ice prior to mixing with well solution. Then, 0.8 µL of 
protein/RNA solution was mixed with 0.4 µL of well solution (100 mM sodium citrate 
pH 5.25, 7 mM NaMES pH 6.5, 6.5-7% PEG 3350, 175 mM (NH4)2SO4, 0.25-1 mM 
MgCl2; final pH 5.6) in 24-well hanging drop format, sealed and incubated at 4°C. 
Crystals appeared after 1.5 days and grew to their full size (~350 µm in the largest 
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dimension) after 1-2 weeks. Prior to freezing in liquid nitrogen, crystals were 
transferred to well solution containing 5% v/v glycerol, incubated for 1-5 min, then 
transferred in four steps with increasing glycerol to final well solution containing 30% 
v/v glycerol. 
 
Structure determination.  
 X-ray diffraction data were collected at the Advanced Photon Source 24-ID-C 
beam line equipped with a Pilatus-6MF detector. Data was obtained from a single 
crystal diffracted at a wavelength of 0.9795 Å at 100 K and processed using HKL2000 
(Otwinowski and Minor, 1997). Statistics reported in Table 1 were obtained using 
Phenix (Adams et al., 2010). The structure was solved by molecular replacement using 
Phaser (McCoy et al., 2007) and coordinates of the yeast Exo106 (PDB: 4OO1) and 
yeast Rrp44 (PDB: 2WP8) as search models. The structure is refined to R/Rfree values 
of 0.249/0.201. The final model includes 24 of the 34 possible nucleotides, and 3731 
of the 4158 amino acids present in the crystal. Analysis of the contents of dissolved 
crystals is consistent with 1:1 RNA:exosome complex (Figures 10E and 10F). The 
asymmetric unit contains one complex. Iterative rounds of refinement were 
accomplished using Phenix (Adams et al., 2010). RNA and side chains were manually 
built using Coot (Emsley et al., 2010). Simulated annealing omit maps and maps used 
during building were also generated using CNS (Brunger, 2007). The model was 
refined using positional refinement, real-space refinement and individual B-factor 
refinement. Figures depicting the structure, including the surface representations in 
Figure 2A and the graphical abstract, were prepared with Pymol (Schrödinger). 
Structure quality was assessed using MolProbity (Chen et al., 2010) indicating the 
model has excellent geometry with 94.6% in favored, 5.2% in allowed, and 0.2% in 
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outlier regions of Ramachandran space. The structure scored in the 100th percentile for 
the Clash and MolProbity scores. 
 
RNA binding and decay assays 
 AU-rich RNA sequences (Integrated DNA Technologies) were A AUU AUU 
UAU UAU UUA UUU AUU AUU UAU UUA UUU AUU AUU UAU UUA UUA, 
AUU AUU UAU UUA UUA AUU AUU UAU AUU UUA UUU AUU, and AU 
UUA UUU AUU AUU for the 49, 36 and 14 nt RNA and were HPLC purified by 
Integrated DNA technologies. The sequence of the 5’-3’ RNA used in Figure S1C is 
AAA AUU UUA UUU AUU UAU UUA UUA UUU AUU UUA AAA to mimic that 
of the corresponding 3’-3’ RNA. PolyA RNAs (Dharmacon) were of the sequence Ax, 
where x = length in nucleotides of the indicated species, and were HPLC purified by 
Dharmacon. Unless otherwise noted (for example in the experiments in Figures 19 and 
20), decay assays contained 1 nM enzyme and 10 nM RNA substrate in RNA decay 
buffer (20 mM Tris-Cl pH 8.0, 50 mM KCl, 0.5 mM MgCl2, 0.5 mM TCEP-HCl, 0.1 
% IGEPAL co-630). For gel analysis of decay products, an aliquot of decay reactions 
containing 5’ fluorescein or 5’ 6-carboxyfluorescein (FAM) RNAs was quenched at 
the indicated times with an equal volume of 89 mM Tris-borate pH 8.3, 7 M Urea, 2 
mM EDTA, 12% w/v Ficoll, 0.005 % w/v xylene cyanol and 10 µL was loaded onto 
15% acrylamide TBE urea gels (Life Technologies). Gels were imaged for fluorescein 
fluorescence using a Typhoon FLA9500 instrument (GE). For measuring initial rates 
of decay of Exo1044 or Rrp44 in Exo1144/6 (Figures 14D and 15D), the Rrp44 product 
was quantified at the first two to three non-zero time points in triplicate using ImageJ 
(NIH) and converted to nM via a standard curve of fully decayed RNA. Initial rate is 
calculated as the slope of the linear regime of decay under these conditions. For 
quantification of Rrp44 activity in Exo1044 and Exo1144/6 complexes (Figures 14B, 
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14C, 15B, 15C, 15E and 15F), nM of Rrp44 product was calculated in the same 
fashion. For decay assays using 3’ phosphate RNAs (Figures 22D and 24G), reactions 
were incubated at 30°C for 5 minutes in the presence or absence of 0.01 U/µL calf 
intestinal phosphatase (CIP, from New England Biolabs) prior to addition of the 
exonucleases as indicated. For KD measurements, binding reactions (20 µL) contained 
30 nM 5’ FAM RNA and variable protein concentrations in RNA decay buffer. 
Proteins were buffer exchanged into RNA decay buffer prior to the binding 
experiment using Micro Biospin 6 columns (Bio-Rad). To render them catalytically 
inactive, Rrp44 contained D171N and D551N mutations and Rrp6129-733 contained a 
D238N mutation. Reactions were incubated for 20 minutes at room temperature in 
black low-volume, non-binding, round-bottom 384 well plates (Corning) prior to 
anisotropy measurement (λex = 495 nm, λem = 525 nm) using a Spectramax M5 plate 
reader (Molecular Devices). KDs were calculated from a triplicate measurement using 
eleven 1:2 serial dilutions of a given protein plus a -protein control using a receptor 
depletion model to fit (Wasmuth and Lima, 2012a). 
 
Ion-pair reverse phase HPLC analysis of decay products 
 20 µL RNA decay reactions containing 1 µM enzyme and 10 µM 49 nt 5’ 
FAM AU-rich RNA (or mock substrates) were incubated for 25 minutes at 30°C in 
RNA decay buffer lacking IGEPAL CO-630. After incubation, reactions were 
quenched with the addition of EDTA to 10 mM, adjusted to 10 mM N(C4H9)4HSO4 
(Sigma), and the products separated by HPLC using a Nova-Pak C18 60 Å 4 µM 3.9 x 
150 mm reverse-phase column (Waters). The column was equilibrated with RP buffer 
A (50 mM potassium phosphate pH 7.0, 10 mM N(C4H9)4HSO4) and run at a flow rate 
of 1 mL/min at 40°C. Products were eluted with a linear gradient to 100% RP buffer B 
(RP buffer A containing 50% v/v acetonitrile) from t=5 to t=20 minutes (Figures 22E 
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and 24A through 24D). UV absorbance was monitored at 260 nm for detection of 
nucleotides and small RNA decay products (Figures 22E, 24A, and 24C) and 490 nm 
for detection of the 5’ FAM label (Figures 24B and 24D). 
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CHAPTER 2: Crystal Structure of the Mpp6-Exosome and Reconstitution of Helicase-
Dependent RNA Decay  
 
Introduction 
 
 Biochemical and structural characterization of the RNA exosome complex has, 
with few exceptions (Kowalinski et al., 2016; Makino et al., 2015; Wasmuth et al., 
2017; Falk et al., 2017), been performed in the absence of its protein cofactors. The 
cofactor-less studies revealed that Exo9 modulates the activities of Dis3 and Rrp6; that 
the Rrp6 protein can stimulate Dis3; that RNAs greater than 30 nucleotides utilize the 
Exo9 central channel to guide RNA to Rrp6 for distributive trimming or through the 
entire channel to Dis3 for processive decay; and the existence of a minor channel-
independent “direct-access” route to Dis3 for shorter RNAs (Liu et al., 2006; Makino 
et al., 2013b; Wasmuth and Lima, 2012a; Wasmuth et al., 2014; Zinder et al., 2016). 
However, genetic studies in diverse model systems suggest that most of the important 
functions of the RNA exosome are facilitated by its protein cofactors (Kilchert et al., 
2016; Lee et al., 2013; Milligan et al., 2008; Mitchell et al., 2003; Schilders, 2005), 
prompting a need for rigorous biochemical and structural characterization of these 
complexes. 
The nuclear exosome is associated with the cofactors Mpp6 and Rrp47, whose 
individual deletion in vivo results in misprocessing of nuclear exosome substrates, 
while concomitant loss leads to synthetic lethality (Butler and Mitchell, 2011; 
Callahan and Butler, 2008; Feigenbutz et al., 2013a; Milligan et al., 2008). These 
genetic observations resemble deletions of the TRAMP complex, a three protein 
complex that catalyzes polyadenylation and subsequent degradation of an array of 
nuclear RNAs (LaCava et al., 2005; Vanacova et al., 2005; Wyers et al., 2005) 
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through one of two non-templated poly(A) polymerases Trf4/5, one of two zinc 
knuckle proteins Air1/2, and the essential RNA helicase Mtr4. This complex is 
thought to bridge the nuclear exosome to other RNPs, including ribosome biogenesis 
factors (Thoms et al., 2015). Indeed, Rrp47 binds directly to Rrp6 via the Rrp6 N-
terminal domain, an interaction that stabilizes Rrp6 and Rrp47 (Dedic et al., 2014; 
Feigenbutz et al., 2013a; 2013b; Stead et al., 2007). This interaction also generates a 
composite interface that recruits Mtr4 (Schuch et al., 2014) in vitro and in vivo, 
though other factors are speculated to exist (Stuparevic et al., 2013). In contrast, Mpp6 
function is less clear, due in part to its poor sequence conservation. Its synthetic 
lethality with Rrp6 in yeast suggested Mpp6 may be a Dis3 cofactor (Milligan et al., 
2008), while in human it was posited as a Rrp6 cofactor (Schilders, 2005) and has 
been reported to recruit Mtr4 (Chen et al., 2001; Lim et al., 2017; Lubas et al., 2011; 
Schilders et al., 2007). 
To better understand how Mpp6 influences nuclear exosome activities and 
Mtr4 recruitment, we present the functional characterization of nuclear exosome 
complexes with Mpp6, Rrp47 and Mtr4 from the budding yeast S. cerevisiae and the 
crystal structure of a 12-subunit nuclear exosome complex bound to Mpp6 and RNA 
to a resolution of 3.3 Å. Biochemical and genetic experiments suggest that Mpp6 can 
bind RNA and stimulate the activities of the nuclear exosome, and that both Mpp6 and 
Rrp47 contribute to recruitment of the Mtr4 helicase to facilitate activation of the 
nuclear exosome and degradation of structured RNA. 
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Results 
 
Mpp6 is anchored to Exo9 via contacts to the S1/KH ring subunit Rrp40 
To facilitate crystallization of the nuclear exosome bound to a minimal fragment of 
Mpp6 (residues 81-120; Mpp6minimal) and RNA, copper ‘click chemistry’ was used to 
generate a synthetic 3’-3’ RNA that was designed to simultaneously engage both 
exonuclease sites of the complex as previously (Zinder et al., 2016) (Chapter 1). This 
RNA was incubated with the complex, and well solutions similar to those used to 
crystallize Exo11Dis3exo-endo-/Rrp6exo-ΔNΔC were screened (Zinder et al., 2016). These 
efforts resulted in crystals which closely resembled Exo11 in morphology, final size, 
and growth kinetics. After screening several crystals, diffraction was collected to 3.3 
Å and the structure was solved (Table 3, Figure 27A). Similar to the previous 
structure, one RNA 3’ end is anchored in the Dis3 active site with Dis3 adopting a 
direct-access conformation (Liu et al., 2014; 2016; Makino et al., 2015; Zinder et al., 
2016) while the other 3’ end is anchored in the Rrp6 active site of an adjacent complex 
(Zinder et al., 2016) (Figure 9D). Although only 4-5 residues of RNA can be 
visualized in the Rrp6 active site, noncontiguous densities were observed proximal to 
residues previously identified to contact RNA, including Arg110 of Rrp40, and Rrp6 
residues within the EXO and HRDC domains, in particular Tyr244, Tyr430, and 
Arg461 (Makino et al., 2015; Zinder et al., 2016). Densities corresponding to the loop 
and pair of helices in Rrp43 previously referred to as ‘Rrp43L1’ (Zinder et al., 2016) 
were not observed. 
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Table 3. Crystallographic data and refinement statistics. One crystal was used. Highest 
resolution shell is in parentheses. From Wasmuth et al., 2017. 
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Figure 27. Structure of the 12-subunit Mpp6 nuclear exosome. (A) Global view of 
Exo12Dis3exo-endo-/Rrp6exo-/Mpp6Min bound to a 3’-3’ RNA. Mpp6Minimal interacts with an 
extended surface across the S1/KH subunit, Rrp40. View from side (left) and top 
(right). Exosome subunits shown as surface view, Mpp6 in green, Rrp6 in teal, Rrp40 
in cartoon (orange), RNA in black sticks. (B) Mpp6Minimal (green) makes extensive 
contacts to Rrp40 (orange) and spans all three of its domains. (C) Mpp6Minimal 
(transparent purple surface in middle and right panels) binds to a conserved surface of 
Rrp40. Other conserved surfaces important for RNA binding and scaffolding 
interactions to other exosome subunits are indicated. Surface conservation calculated 
with ConSurf (Ashkenazy et al., 2010). Data acquired by Dr. Elizabeth Wasmuth with 
reagents prepared by John Zinder and Dr. Elizabeth Wasmuth. Figure prepared by Dr. 
Elizabeth Wasmuth with assistance from Dr. Christopher Lima. Figure and caption 
from Figure 2 of Wasmuth et al., 2017. 
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Electron densities for Mpp6 residues 90 to 118 were evident on the surface of 
Rrp40. Mpp6Minimal residues 90-97 adopt a distorted parallel beta-strand configuration 
that complements the second beta-strand of the Rrp40 N-terminal domain (NTD) 
while residues 98-103 adopt a helical conformation that wedges between the Rrp40 
NTD and S1 domain (Figure 27B). Mpp6 residues 110-118 adopt an anti-parallel beta-
strand conformation that complements the second beta-strand of the KH domain 
(Figure 27B). Although modeled, densities for amino acids 104-107 were very weak 
in comparison to other portions of Mpp6. Interactions between Rrp40 and Mpp6 are 
mediated by Rrp40 surfaces with comparable conservation to those involved in 
contacts to Rrp45 and Rrp46 or RNA (Malet et al., 2010; Wasmuth et al., 2014; Zinder 
et al., 2016) (Figure 27C). Contacts observed in our structure are also consistent with 
crosslinking and mass spectrometry data reported previously as well as a recent crystal 
structure of Mpp6Minimal bound to Exo9 (Falk et al., 2017; Shi et al., 2015) (Figure 29). 
The most prominent electron density observed for Mpp6 corresponds to 
Arg112 within the last beta strand. Arg112 projects into a pocket formed between the 
S1 and KH domains of Rrp40 (Figure 28A) and resides in one of two regions of Mpp6 
previously identified as conserved from yeast to man (Milligan et al., 2008). Given its 
location in the structure and evolutionary conservation, we refer to Mpp6 Arg112 as 
the “arginine anchor”. Mutation of this residue results in a loss of interaction of the 
exosome core in human (Falk et al., 2017) and yeast (Wasmuth et al., 2017) models. 
Interestingly, two known mutations within Rrp40 that are associated with neurological 
disorders lie proximal to the arginine anchor of Mpp6. These include Gly148 (Gly191 
in human), which is mutated to cysteine in hereditary spastic paraplegia in humans 
(Halevy et al., 2014), and Trp195 (Trp238 in human), which is mutated to arginine in 
pontocerebeller hypoplasia and spinal motor neuron degeneration (Wan et al., 2012).  
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Figure 28. Mpp6minimal from two different crystal structures. Crystal structures of 
Mpp6 bound to the exosome core from this work (A) and Falk et al., 2017 (B). 
Terminal amino acids of the models and the R112 ‘arginine anchor’ of Mpp6 are 
indicated. The structure in the asymmetric unit with the most residues modeled for 
Mpp6 from PDB 50KZ was aligned to Rrp40 from PDB 5VZJ.  
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Modeling of the W238R mutation in S. cerevisiae as well as mouse neurons revealed 
that the mutant protein was unstable and rapidly degraded by the proteaseome (Fasken 
et al., 2017). Human Exo9 reconstituted with Rrp40 W238R showed a decreased 
affinity for human Mpp6 in vitro (Falk et al., 2017), suggesting a loss of interaction 
between Mpp6 and the exosome may also contribute to the disease. 
 
Mpp6 can recruit Mtr4 to the exosome 
 Results presented thus far do not explain the synthetic lethality observed when 
Mpp6 is deleted along with Rrp6, Rrp47, or Air1, a component of the TRAMP 
complex (Milligan et al., 2008). Mutagenesis experiments designed to disrupt the 
tripartite interaction between Rrp47-Rrp6 NTD-Mtr4Nterm did not alter yeast viability, 
Mtr4-exosome association, or RNA processing (Schuch et al., 2014). However, 
synthetic lethality was observed when mutations in the tripartite interaction with Mtr4 
were combined with a Mtr4 C-terminal GFP tag, consistent with Mtr4 recruitment to 
the exosome being dependent on additional factors or Mtr4 surfaces that interact with 
Rrp6, Mpp6, Rrp47 or other components of the TRAMP complex. Furthermore, 
experiments in human suggest that both Mpp6 and Rrp47 contribute to Mtr4 
recruitment (Chen et al., 2001; Lubas et al., 2011; Schilders et al., 2007).  
Mpp6 and/or Rrp47 were added to full-length Exo11Dis3/Rrp6 to determine if 
these cofactors contribute to interactions with Mtr4 via analytical gel filtration (Figure 
29). Consistent with previous results, Mtr4 did not co-elute with the exosome in the 
absence of Rrp47 and Mpp6 while co-elution was observed in the presence of Rrp47 
(Schuch et al., 2014) (Figure 29). When Mpp6 and Rrp47 were both present, more 
Mtr4 was detected in fractions containing the exosome suggesting greater stability of 
the complex. Importantly, Mpp6 was capable of recruiting Mtr4 to the exosome in the 
absence of Rrp47 and, to lesser extent, in the absence of Rrp6. Removing the C-
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terminal 30 amino acids of Mpp6 (1-156) did not disrupt Mtr4 interaction, but removal 
of the N-terminal 81 amino acids in Mpp6 (82-186) or the conserved N-terminal 22 
amino acid motif in Mpp6 (23-120) resulted in no detectable interactions with Mtr4. 
Mpp6Min (81-120) failed to interact with Mtr4. These data suggest that Mpp6 elements 
required for exosome activation are distinct from those required for Mtr4 recruitment. 
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Figure 29. Mpp6 physically tethers Mtr4 to the nuclear exosome. (A) Mpp6 
contributes to Mtr4 recruitment in Exo11Dis3/Rrp6. Analytical gel filtration experiments 
were performed with Exo10Dis3 and Exo11Dis3/Rrp6, Rrp47, Mtr4, with various 
truncations of Mpp6 and Rrp6 as indicated. Bar graphs represent the ratio of Mtr4 
(122 kDa) to Dis3 (114 kDa) in peak fractions of the complex, as calculated by 
densitometric analysis of the fractions on SDS-PAGE, with error bars representing 
plus or minus one standard deviation. (B) Representative SDS-PAGE of analytical gel 
filtration runs (Superdex 200 Increase) of the indicated Mtr4-exosome combinations 
presented in panel A, with each lane representing an independent fraction. Gels were 
SYPRO Ruby stained and the ratio of Mtr4 to Dis3 was calculated via densitometry 
within lanes indicated by solid lines above each gel. Data acquired by Dr. Elizabeth 
Wasmuth with reagents prepared by John Zinder, Dr. Elizabeth Wasmuth, and Dr. 
Mom Das. Figure prepared by Dr. Elizabeth Wasmuth with assistance from Dr. 
Christopher Lima. Figure and caption adapted from Figure 5 and supplemental Figure 
5 of Wasmuth et al., 2017.  
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Preparative reconstitution of the nuclear exosome using full-length components 
 Previous in vitro studies of exosome using the Rrp6/Rrp47 heterodimer have 
used C-terminally truncated of Rrp6 and Rrp47, which are particularly low-expressing 
and difficult to handle proteins, to facilitate their purification and subsequent 
characterization (Dedic et al., 2014; Makino et al., 2015; Schuch et al., 2014). We 
sought to develop methods for the purification of large quantities of highly pure full-
length Rrp6/47 heterodimer, and while doing so re-optimized the purification of 
Rrp44, Mpp6, and Mtr4 proteins (Figure 30). 
Rrp6 containing its N-terminal PMC2NT domain behaves poorly in the 
absence of its obligate binding partner (Dedic et al., 2014; Feigenbutz et al., 2013a), so 
both genes were cloned into a bacterial dual expression vector (see Chapter 1, 
Materials and Methods). An N-terminal His6Smt3 tag was added to Rrp47 because 
free Rrp47 does not associate with the exosome (Stead et al., 2007), so excess protein 
can be easily separated from the complex in gel filtration after reconstitution (Figure 
31A through 31C). Because the Rrp6 and Rrp47 C-termini bind nucleic acid (Costello 
et al., 2011; Wasmuth and Lima, 2017), we reasoned that using a heparin affinity 
column, the stationary phase of which is polyanionic and roughly resembles nucleic 
acid, after nickel elution would allow us to isolate full length proteins from C-terminal 
truncations. Integrity of the N-terminus would be assured via N-terminal tagging in the 
case of Rrp47 and the necessity of the N-terminus for interaction with Rrp47 in the 
case of Rrp6 (Stead et al., 2007). The His6Smt3 tag was left on Rrp47 throughout its 
purification because we have empirically observed that it improves solubility. Adding 
Ulp during the exosome complex reconstitution allows for quantitative tag removal 
(Figures 31C and 31D). We were also able to successfully employ heparin affinity to 
purify His6Smt3-Rrp44, His6Smt3-Mtr4, and His6Smt3-Mpp6 after nickel elution (see 
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Materials and Methods), though their Smt3 tags were cleaved prior to gel filtration 
(Figure 30). 
Reconstitution of Exo13 was performed essentially as before, except one 
equivalent of Csl4, which is often substoichiometric in reconstituted complexes as 
well as those isolated from TAP-tagged yeast strains (Makino et al., 2013b; Wang et 
al., 2007), was added prior to dialysis to replace any that had been lost during the 
Exo9 reconstitution. Since Rrp6’s C-terminus interacts extensively with Csl4, it 
stabilizes the protein on the complex (Makino et al., 2013b). Additionally, we used a 
24 mL gel filtration column for reconstitution of 0.5-2 mg of complex rather than a 
320 mL column as previously, which allowed for greatly increased time efficiency for 
FPLC use (40 min per run vs. 3 hrs per run) and for concentrating. For reconstitution 
of other complexes used in the next section, individual components were omitted from 
the reconstitution (e.g. for Exo12Dis3/Rrp6/Rrp47 Mpp6 was omitted from the 
reconstitution). In complexes lacking Rrp47, Rrp6 contains a truncation of its N-
terminal 128 amino acids to improve its stability (Feigenbutz et al., 2013a) and 
prevent its dimerization (Dedic et al., 2014). 
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Figure 30. Purification of enzymatic subunits and Mpp6 cofactor of the nuclear 
exosome. Heparin affinity (left) and Superdex (right) purification of His6Smt3 tagged 
(A) Dis3, (B) Mtr4, (C)Mpp6, and (D) Rrp47/Rrp6. The heparin purification was 
performed directly after elution from the nickel column, while the Superdex 
purification was run after overnight incubation of the heparin eluate with Ulp (A 
through C) or buffer (D). Traces show absorbance at 280 nm (A280) (black curves) for 
heparin and Superdex columns and conductivity (red curves) for heparin only. Peaks 
of interested are indicated on the traces with an asterisk. SDS-PAGE analysis of the 
load, flowthrough (lanes labeled FT, for heparin only), and peak fractions are shown. 
Gels were stained with Coomassie (panels A through C) or SYPRO Ruby (panel D).  
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Figure 31. Strategy for reconstitution of Exo13 and of helicase-dependent RNA 
degradation. (A) Schematic depiction of Exo13 reconstitution strategy as well as 
Mtr4 mix-in for helicase dependent RNA decay. Shown are two possible RNA fates 
which are either dependent or independent of ATP and Mtr4 as indicated. The RNA 
substrate is shown as a red line with an arrow pointed towards the 3’ end, and the 5’ 6-
carboxyfluorescein label is represented with a green star. Base pairs are represented as 
crossbars between parallel strands. (B) A280 trace and (C) Coomassie stained SDS-
PAGE analysis of fractions from gel filtration of the Exo13 reconstitution. (D) 
SYRPO Ruby stained gel showing Exo13 with and without added Mtr4. 
  
	 113 
Reconstitution of Mtr4 and ATP dependent RNA decay 
To assess whether Mpp6- or Rrp47-mediated recruitment of Mtr4 results in 
Mtr4-dependent RNA degradation, reconstituted exosomes were assayed for decay 
activity in the presence of exogenously added Mtr4 using a 17 nt double stranded 
RNA with a 10 nt 3’ poly(A) overhang (ds17A10) (Makino et al., 2015; Schuch et al., 
2014) in comparison with assays using the same labeled 27 nt RNA without the 
complementary 17 nt strand (ss17A10) (Figures 31A, 31D and 32). Previous studies 
reported that Dis3 is unable to degrade the ds17A10 substrate in the nuclear exosome 
(Makino et al., 2013b), presumably because the 3’ overhang is too short to span the 
Exo9 central channel. We reasoned that after unwinding by Mtr4, the 3’ end of the 
ds17A10 substrate may be able to reach Dis3 through the central channel. 
Rrp6 trimming of the 3’ overhang was stimulated in the presence of Rrp47, 
Mpp6 or both (Figure 32A), consistent with our biochemical observations using 
poly(A) RNA (Wasmuth et al., 2017). Products of Dis3 activity could be detected with 
the ds17A10 substrate, but only when Rrp47 and/or Mpp6 was present. Importantly, this 
activity was also dependent both Mtr4 and ATP, as AMP-PNP, a non-hydrolyzable 
ATP analog, failed to support activity. By contrast, Dis3 degradation of ss17A10 did not 
appear dependent on Mpp6, Rrp47, Mtr4, ATP or AMP-PNP. Trimming of the ds17A10 
3’ overhang by Rrp6 dominated the assay in WT exosomes in the presence of Rrp47 
or Mpp6, so we analyzed Mtr4-dependent decay using exosomes reconstituted with 
catalytically inactivated Rrp6 (Rrp6exo-). As before, Mtr4-dependent decay was only 
observed in the presence of Rrp47 or Mpp6, while addition of both cofactors resulted 
in the greatest stimulation (Figure 32A). These results show that Mtr4 can promote 
degradation of dsRNA by the nuclear exosome, and that this activity is dependent on 
Mpp6 and Rrp47 cofactors. 
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Figure 32. Mtr4-dependent RNA degradation requires either Mpp6 or Rrp47. 
Urea-PAGE analysis of RNA decay products by indicated exosome complexes and 
cofactors. In reactions labeled ‘Rrp6Exo-’, Rrp6 contains a D238N mutation to render 
its exonuclease site catalytically inactive. 5’ fluorescein-labeled poly(A) RNA of 
indicated lengths are present in the leftmost lane of each gel with the Dis3 product 
labeled ‘4-5 nt’. Samples were not heated prior to gel electrophoresis, so the dsRNA 
substrate runs as a duplex at approximately 37 nt (A) Activity of reconstituted RNA 
exosome complexes in the presence or absence of equimolar exogenous Mtr4. (B) 
Mix-in of 1.5-fold molar excess of full-length Mpp6 or indicated truncations in RNA 
decay reactions containing reconstituted Exo12Dis3/Rrp6/Rrp47 or Exo11Dis3/Rrp6ΔN  and 
equimolar Mtr4 (when present). Results shown for an end point assay after 1 minute 
incubation with exosomes containing Rrp6 or 8 minutes for exosomes containing 
Rrp6exo-. (C) RNA degradation activities of reconstituted RNA exosome complexes 
and indicated mutations in the presence of equimolar exogenous Mtr4 and/or Rrp47. 
Cartoons shown above gels in panels A and C depict the exosome core in grey and 
wheat, Rrp6 in blue, Dis3 in pink, Mpp6 in red and Rrp47 in green.  The central body 
of Mpp6 is shown as an ellipse with N- and C-terminal tails labeled or removed to 
reflect the protein used in the assay. The N-terminal PMC2NT domain of Rrp6 is 
shown as an appendage to the Rrp6 protein. From Figure 6 of Wasmuth et al., 2017. 
  
	 115 
 
 
 
 
  
	 116 
Unwinding of the dsRNA region by Mtr4 appears responsible for Dis3 activity, 
but only when it is recruited to the exosome via Rrp47 or Mpp6. To determine the 
relevance of domains in Mpp6 required for this activity, we compared activities of 
exosomes in the presence of exogenous Mpp6 (FL: 1-186, ΔC: 1-120, ΔN: 81-186, 
and Min: 81-120) to those lacking Mpp6 in the presence of Mtr4 (Figure 32B). Results 
suggest that each Mpp6 construct stimulates Rrp6 trimming activity of the 3’ 
overhang, but only FL and ΔC Mpp6 constructs, both of which recruit Mtr4 in gel 
filtration experiments (Figure 29), support ATP/Mtr4/Dis3-dependent RNA decay in 
the absence of Rrp47 (Figure 32B). In the presence of Rrp47, Mpp6 is largely 
dispensable for this activity, but FL and ΔC Mpp6 further increased Mtr4-dependent 
decay. As before, similar trends were observed in assays conducted with exosomes 
containing Rrp6exo-.  
Perhaps consistent with the observation that yeast strains are viable in the 
absence of Rrp6 and Rrp47 (Feigenbutz et al., 2013a; Stuparevic et al., 2013), some 
Mtr4-dependent decay could be observed in complexes lacking Rrp6 (Figure 32C), 
although this required full-length Mpp6 and its activities were weaker in comparison 
to exosomes containing Rrp6 or Rrp6 plus Rrp47. Furthermore, addition of Mpp6 to 
exosomes lacking Rrp6 or Rrp47 also showed an ability to interact with Mtr4 (Figure 
29). These data suggest that Mpp6 could contribute to Mtr4 recruitment in the absence 
of Rrp6 and Rrp47 proteins (Schuch et al., 2014). Importantly, ATP/Mtr4/Dis3-
dependent activity on the ds17A10 substrate was only observed in complexes that could 
physically interact with Mtr4 (Figures 29 and 32), suggesting that the unwinding 
activities of Mtr4 lead to productive degradation only when Mtr4 is physically 
tethered to the RNA exosome. 
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Optimal cell growth depends on unique domains in Rrp6 and Mpp6 
Genetic interactions between Mpp6, Rrp47 and Rrp6 have been reported 
previously (Feigenbutz et al., 2013b; Milligan et al., 2008). While none of these genes 
is essential, deletion of Mpp6 and Rrp6 results in synthetic lethality. Furthermore, 
viability is maintained in cells lacking both Rrp47 and Rrp6 as long as Mpp6 remains 
present. To relate the relevance of Mpp6 and Rrp6 domains defined in this study as 
important for exosome stimulation and Mtr4 recruitment to function in vivo, strains 
lacking Rrp6 and Mpp6 were complemented with mutant alleles for Rrp6 and/or 
Mpp6 in various combinations (Figure 33). Western blotting of these strains showed 
expression of Rrp6 in all cases, with especially high expression for N-terminal 
truncations as previously observed (Figure 34) (Wasmuth and Lima, 2017). We also 
attempted to raise polyclonal antibodies against Mpp6minimal but failed to achieve 
sufficient signal-to-noise to detect even the WT protein in whole cell lysates, possibly 
because of His6Smt3 tag contamination in the antigen sample. 
As stated previously, strains lacking both Rrp6 and Mpp6 are not viable while 
strains containing either full-length Mpp6 or full-length Rrp6 are viable. Importantly, 
in strains lacking Mpp6 removal of the PMC2NT domain in rrp6 (128-733), a 
combination that should eliminate Rrp6 interactions with Rrp47, and by extension the 
Mtr4 helicase, resulted in slower growth while removal of both the Rrp6 PMC2NT 
and lasso in rrp6 (128-634) resulted in no viable colonies (Figure 33B). In contrast, in 
strains lacking Rrp6, only full-length Mpp6 suppressed lethality as strains 
complemented with Mpp6 truncations mpp6 (1-120), mpp6 (81-186) and mpp6 (81-
120) were not viable (Figure 33). This observation is consistent with our in vitro data, 
namely that in the absence of Rrp6, full-length Mpp6 can still mediate recruitment of 
Mtr4 to the exosome (Figures 29 and 32C). In addition, growth defects associated with 
rrp6 (128-733), an allele that should not interact with Rrp47, are suppressed by WT 
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Mpp6 and mpp6 (1-120), but not other mpp6 variants. This result is perhaps consistent 
with biochemical observations, namely that Mpp6 residues 1-120 contribute to 
recruitment of Mtr4 and Mtr4-dependent decay in the absence of Rrp47 (Figures 29 
and 32B). 
Strains containing mpp6 (81-120) phenocopied ∆mpp6, suggesting that either 
this construct is not expressed or that the exosome association domain is not sufficient 
to support Mpp6 functions in vivo, despite its ability to stimulate nuclear exosome 
activity in vitro (Wasmuth et al., 2017). However, since the Mpp6 (81-120) protein did 
not result in productive interactions with Mtr4 in vitro (Figures 29), the observation 
that mpp6 (81-120) phenocopies ∆mpp6 is also consistent with a model in which Mtr4 
recruitment is defective. Finally, a strain harboring mpp6 (81-186) and rrp6 (128-634) 
was viable despite the fact that both Rrp47- and Mpp6-dependent mechanisms for 
Mtr4 recruitment are presumed missing. Although this strain grows much slower than 
any other characterized in this study, its viability suggests that combining the Mpp6 
exosome associating region with its C-terminal domain is sufficient to suppress 
lethality observed for rrp6 (128-634), perhaps through interactions with the 
transcriptional termination machinery via Nrd1 as noted previously (Kim et al., 2016). 
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Figure 33. Optimal cell growth depends on unique domains in Rrp6 and Mpp6. 
(A) Growth analysis of S. cerevisiae strains carrying viable combinations of Rrp6 and 
Mpp6 alleles. Ten-fold dilutions series of the rrp6Δ mpp6Δ strains transformed with 
the indicated pRS415 mpp6 and pRS413 rrp6 plasmids. Spotting was performed on 
SD-His-Leu or YPAD solid media and cells were incubated at 30°C for 2 days. 
Cartoons depict mpp6 and rrp6 alleles with respect to N- and C-terminal deletions. (B) 
Scoring table of the yeast growth phenotypes established in panel A after 1 day 
growth. Scoring is based on a subjective five-point system where five “+” symbols 
(“+++++”) correspond to the fastest observed growth rate and one “+” symbol to the 
slowest growth rate. Plasmid combinations indicated with the “-“ symbol resulted in 
synthetic lethality. Data generated by Dr. Dimitrios Zattas. Figure prepared by Dr. 
Dimitrios Zattas with assistance from Dr. Christopher Lima. Figure 7 of Wasmuth et 
al., 2017.   
	 120 
 
 
 
 
 
	 121 
 
 
 
 
 
 
Figure 34. Expression of Rrp6 variants. Western blot of soluble S. cerevisiae lysates 
after cryo-milling and extraction using affinity purified rabbit polyclonal antibodies 
against S. cerevisiae Rrp6 residues 128-518 or S. cerevisiae Mtr4 residues 80-1073. 
From selected strains in Figure 33. After primary antibody treatment, membranes were 
incubated with anti-rabbit-horseradish peroxidase, washed, developed, and visualized 
for chemiluminescence. For Mpp6, FL encompasses residues 1-186, min is 81-120, 
DN is 120-186, and DC is 1-120. For Rrp6, FL encompasses residues 1-733, DN is 
128-733, and DNDC is 128-634.
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Discussion 
 
Experiments presented here suggest that the nuclear exosome cofactor, Mpp6, 
can associate with the Exo9 core through interactions with the S1/KH subunit Rrp40 
to recruit the helicase Mtr4 and to stimulate Rrp6 activity in the exosome. A minimal 
region of Mpp6 comprised of amino acids 81-120 appears sufficient for exosome 
association and stimulation in vitro, although it is defective for recruitment of Mtr4. 
As our structure shows, this fragment includes a conserved arginine anchor that is 
important for Mpp6 interactions with the exosome core. 
This work also sheds light on dual functions of Mpp6 and Rrp47 insofar as 
both factors can stimulate RNA exosome activities and both contribute to Mtr4 
recruitment and Mtr4-dependent degradation in vitro, perhaps providing some 
additional insights to in vivo synthetic interactions reported in previous studies 
(Feigenbutz et al., 2013b; Milligan et al., 2008). Interactions between the nuclear 
exosome and Rrp47 or Mpp6 result in stimulation of exosome activities, but they rely 
on distinct surfaces for these activities. Rrp47 interacts with the N-terminal PMC2NT 
domain of Rrp6 (Makino et al., 2015; Schuch et al., 2014; Stead et al., 2007), while 
Mpp6 interaction occurs via the Exo9 core (Falk et al., 2017; Schuch et al., 2014). 
Rrp47 and Mpp6 each contribute to Mtr4 interactions with Exo11Dis3/Rrp6, and 
inclusion of both cofactors appears to maximize these interactions. While we were 
unable to decouple Rrp47-mediated stimulation from its ability to recruit Mtr4, genetic 
and biochemical results suggest that a minimal fragment of Mpp6 (residues 81-120) 
that supports Mpp6-exosome interaction was not sufficient to support growth in vivo 
when paired with an rrp6 allele that does not interact with Rrp47, and that additional 
Mpp6 elements are required for optimal cell growth. 
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Results from our characterization of cofactor-dependent Mtr4 recruitment for 
degradation of a structured substrate show that Rrp6’s activity dominates the reaction 
and creates a trimmed product that is apparently stable towards further degradation, 
even in the presence of Mtr4 and ATP (Figure 32A). In contrast, the substrate is nearly 
completely degraded by Dis3 over the course of the reaction when a catalytically 
inactive Rrp6 is present using the same conditions (Figure 32A), suggesting that 
Rrp6’s activity can serve to protect structured substrates from full degradation by Dis3 
in some cases. In cells, Mtr4 can be incorporated into the TRAMP complex (LaCava 
et al., 2005; Wyers et al., 2005), the polyadenylation activity of which could 
antagonize this protective trimming by Rrp6 and allow Mtr4/Dis3 additional 
opportunities to engage the 3’ end. Furthermore, polyadenylation by TRAMP is 
stimulated on unmodified or mutant substrates (Vanacova et al., 2005), providing the 
model for selective degradation of these substrates over their healthy counterparts by 
the TRAMP-exosome presented in Figure 35. One caveat of this simplified model is 
that it does not hold for all RNAs or in all organisms, especially in light of findings 
that human Rrp6’s activity has been implicated in the total degradation of some 
substrates in human and that Dis3’s activity can be used for processing and not 
degradation in both yeast and human (Fromm et al., 2017; Tomecki et al., 2014) 
(Figure 8D). Additionally, the poly(A) polymerase and zinc-knuckle components of 
TRAMP are found primarily in the nucleolus of human, where Dis3 is depleted (Lubas 
et al., 2011; Staals et al., 2010; Tomecki et al., 2010) (Table 1 and Figure 1B), 
suggesting different means for RNA quality in higher eukaryotes. 
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Figure 35. Model for RNA quality control by the S. cerevisiae nuclear RNA 
exosome. A prototypical structured RNA is represented as a black line and base pairs 
between strands shown as crossbars. Arrow thickness indicates the predicted 
favorability of a given transition. ‘Direct capture’ refers to the possible scenario in 
which polyadenylation alone can generate a poly(A) tail long enough to engage Dis3 
without need for unwinding by Mtr4. (A) Healthy RNAs are deadenylated and 
unwound at lower rates than aberrant RNAs, so flux through those pathways is 
limited. (B) Aberrant RNAs will be polyadenylated and unwound at faster rates, 
stimulating their degradation. A generic aberration (e.g. lesion, mutation, lack of post-
transcriptional modification) is indicated by a dashed line and highlighted with a red 
arrow.  
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Our genetic experiments uncovered the curious finding that some strains that 
include deletions and truncations that cannot recruit Mtr4 in vitro, for example 
rrp6(128-733)∆mpp6, showed only a modest growth defect and not lethality as in 
∆mpp6∆rrp47. One possible explanation is that recruitment of Mtr4 to the exosome is 
not essential for viability. If this is the case, Rrp47 may be playing roles outside of the 
context of the exosome that are essential in the context of Mpp6 knockout. This seems 
unlikely, however, as Rrp47 is rapidly degraded in yeast strains that lack Rrp6’s N-
terminus (Feigenbutz et al., 2013b). Another possibility is that increased expression of 
Rrp6 when its N-terminus has been removed can compensate for poor Mtr4 
recruitment in vivo (Wasmuth and Lima, 2017) (Figure 34). If this is the case, Rrp47’s 
essential functions in mpp6 null strains could be to stabilize Rrp6 from degradation 
(Feigenbutz et al., 2013a), to recruit Mtr4 (Schuch et al., 2014), and/or to stimulate 
Rrp6’s activity. A third and related explanation is that there could be other yet 
unknown factors that can facilitate helicase-dependent RNA decay by the exosome in 
the absence of Rrp47 and Mpp6 that require stable Rrp6 bound to the core, which 
would not be the case if Rrp6 contained its N-terminus in the absence of Rrp47 
(Feigenbutz et al., 2013a). Additional details have been resolved by our work with 
respect to the contributions of Mpp6 and Rrp47 to nuclear exosome function, however 
critical work remains to resolve the structural and mechanistic bases for activities 
associated with the Mtr4 helicase. 
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Materials and Methods 
 
Exosome subunit purification, complex reconstitution, and analyses.  
Cloning, expression, purification of exosome subunits and reconstitution of 
various complexes have been described previously (see Chapter 1, Materials and 
Methods). S. cerevisiae Mpp6 (full-length and various truncations), Rrp47, and Mtr4 
were cloned into pRSF-Duet1 with a N-terminal Smt3-fusion tag, and were 
transformed into E. coli BL21 (DE3) RIL (Novagen). Recombinant protein expression 
was induced by addition of 0.4 mM isopropyl-β-D-thiogalactoside and overnight 
shaking at 18°C. Cells were lysed by sonication, and supernatants were purified by Ni-
NTA. For Mpp6 variants and Rrp47, further purification was performed on a Superdex 
75 (GE), followed by overnight cleavage of the Smt3 tag using Ulp1 protease, and a 
final purification on a heparin Hi-Trap column to remove Smt3 and nucleic acid 
impurities. Mtr4 was purified on a Superdex 200 (GE), subject to Ulp1 cleavage 
overnight, and purified by MonoQ (GE) to remove Smt3. Alternative purification 
protocols for Dis3, Mpp6, and Mtr4 are described in Figure 30 were employed for the 
reconstitution of complexes used for RNA decay (Figure 32). Briefly, these proteins 
were eluted from the nickel resin using a low-salt buffer (20 mM Tris-Cl, 150 mM 
NaCl, 250 mM imidazole-HCl pH 8.0, 1 mM BME) and injected over heparin column. 
The column was washed and the proteins eluted in using a linear gradiant from 150 
mM to 1 M NaCl in 20 mM Tris-Cl pH 8.0 1 mM BME. Proteins were then Ulp 
digested overnight at 4°C and purified over Superdex200 (for Rrp44 and Mtr4) or 
Superdex75 (for Mpp6) to remove the cleaved tag. 
For interactions with Mtr4 (Figure 29), 1.0 µM Exo11Dis3/Rrp6 was incubated 
with 5-fold molar excess Mpp6 or Rrp47, and 2-fold molar excess Mtr4 on ice for 30 
minutes in a total volume of 400 microliters of 100 mM NaCl, 40 mM MES pH6.5, 1 
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mM TCEP and run on a Superdex 200 Increase (GE), and fractions analyzed by SDS-
PAGE and stained with Sypro Ruby. Densitometry was used to calculate the ratios of 
Mtr4 to Dis3 in fractions corresponding to nuclear exosome peaks using Fujifilm 
Multi Gauge. 
 
3’-3’ RNA synthesis and purification.  
Alkynyl (5’ hexynyl UUU AUU AUU UAU UUU AAA A 3’) and azido (5’ 
azide/NHS UUA UUU UAA AA 3’) RNAs were synthesized and purified by 
Integrated DNA Technologies. RNAs were ligated by incubating 200 µM alkynyl 
RNA with 100 µM azido RNA in 80 mM potassium phosphate (pH 7.0), 5 mM 
sodium ascorbate, 0.5 mM CuSO4/THPTA at 25°C for 1 hour. Quenching and 
purification of the reaction by DEAE chromatography were performed as previously 
described (see Chapter 1, Materials and Methods). 
 
Crystallization and structure determination. 
Exo12Dis3exo-endo-/Rrp6exo-/Mpp6 was mixed in a 1:1 molar ratio with a single-
stranded 30 nucleotide RNA bearing two 3’ ends synthesized by click chemistry (See 
Chapter 1) incubated on ice for 30 minutes. After one week, the protein-RNA complex 
formed single crystals at 4°C in 11-13% PEG3350, 100 mM NaCitrate pH 5.6, 7 mM 
MES pH 6.5, and 175-200 mM ammonium sulfate that continued to grow for up to 
one month. Crystals were cryoprotected in mother liquor augmented with 21% 
glycerol, introduced in three steps of 7% increments. Native x-ray diffraction data 
were collected at the Advanced Photon Source 24-ID-E and 24-ID-C beam lines 
(NECAT), and 23-ID-D (GM/CA) at the selenium edge. Data were processed using 
HKL2000 (Otwinowski and Minor, 1997) and the structure solved by molecular 
replacement using Phaser (McCoy et al., 2007) in the Phenix suite (Adams et al., 
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2010) with the coordinates of yeast Exo10Rrp6exo- (PDB: 4OO1) and Exo11Dis3exo-endo-
/Rrp6exo- (PDB: 5K36) as search models (Table 2). Iterative rounds of refinement were 
accomplished using Phenix (Adams et al., 2010). RNA and protein were manually 
built using Coot (Emsley et al., 2010). The model was refined using positional 
refinement, real-space refinement and individual B-factor refinement. Figures 
depicting structures were prepared with PyMol (Schrödinger). Surface conservation 
was calculated using ConSurf (Ashkenazy et al., 2010). Structure quality was assessed 
using MolProbity (Chen et al., 2010). 
 
RNA degradation assays. 
 RNA oligonucleotides were synthesized with a 5' fluorescein as described 
previously (Liu et al., 2006; Wasmuth et al., 2014) and purchased from Integrated 
DNA Technologies (IDT) or Dharmacon. For the substrates used in Figure 32, the 5’ 
6-carboxyfluorescein bottom strand (5’ FAM CCC CAC CAC CAU CAC UUA AAA 
AAA AAA 3’) and duplex top strand (5’ AAG UGA UGG UGG UGG GG 3’) were 
synthesized and HPLC purified by IDT. To prepare the ds17A10 substrate used in 
Figure 32, top and bottom strands were mixed at 100 and 150 µM, respectively, in 20 
µL of 10 mM Tris-Cl pH 8.0, 100 mM KCl, 0.5 mM EDTA, heated to 95°C for 5 min, 
cooled to 60°C for 2 minutes, then to 4°C in a thermocycler. The ss17A10 was prepared 
in a similar manner, except the top strand was excluded from the reaction. Annealing 
reactions were fractionated by DEAE chromatography (Waters Protein-Pak DEAE 
8HR 1000 Å 8 µm 5x50 mm column) using a linear gradient from 300 mM NaCl to 
700 mM NaCl in 10 mM Tris-Cl pH 8.0, 0.1 mM EDTA pH 8.0 at 40°C. Fractions 
were collected and analyzed by TBE-PAGE using SYBR Gold staining (Life 
Technologies). RNA in fractions containing the desired product was ethanol 
precipitated and the pellet resuspended in ultrapure H2O. 
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For the RNA degradation assays in Figure 32, the final concentrations were 10 
nM exosome, 10 nM Mtr4 if present, 1 mM ATP or AMPPNP, 0.5 U/µL RNAse 
inhibitor (New England Biolabs), and 10 nM RNA substrate in 20 mM HEPES-KOH 
pH 7.5, 50 mM KCl, 1.1 mM MgCl2, 0.5 mM TCEP-KOH pH 7.0, 0.02 % IGEPAL 
co-630. 50 mM ATP and AMPPNP stock solutions were adjusted to pH 7.0 with 
KOH. Exosome complexes were incubated on ice with Mtr4 at 1 µM each in the 
above buffer for 1 hour prior to initiating the reaction. A mix containing RNA, ATP or 
AMPPNP, and RNAse inhibitor (all at 1.1x final concentration) was incubated at 20°C 
for 5 min prior to initiation with 1/10 volume of 100 nM enzyme. Reactions were 
quenched after the indicated incubation times by adding 10 µL of reaction to 5 µL of 
stop mix (0.3 % w/v SDS, 30 mM EDTA pH 8.0, 3 U/mL proteinase K [New England 
Biolabs]) followed by proteinase K digestion at 37°C for 1 hour and flash freezing in 
liquid nitrogen for storage at -80°C. Prior to gel loading, 15 µL of 89 mM Tris-borate 
pH 8.3, 7 M Urea, 2 mM EDTA, 12% w/v Ficoll, 0.005 % w/v xylene cyanol was 
added. The Mpp6 mix-in experiments were carried out in a similar fashion, except the 
indicated Mpp6 construct was included in the initial enzyme mix at 1.5 µM (1.5-fold 
molar excess). These reactions were incubated at 20°C for 1 or 8 min for Rrp6 and 
Rrp6exo-, respectively. 7.5 µL was loaded onto 15% acrylamide TBE urea gels (Life 
Technologies) to detect decay products. Gels were imaged for fluorescein fluorescence 
using a Typhoon FLA9500 instrument (GE). 
 
Yeast growth assays.  
Detailed protocols for generation of the strains can be found in (Wasmuth et 
al., 2017). Briefly, to obtain viable rrp6 mpp6Δ strains in the presence of various 
combinations of pRS413 rrp6 and pRS415 mpp6 vectors, the rrp6 mpp6Δ + pRS426 
RRP6 strain was transformed with these plasmids and plated on selective SD -Ura-
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His-Leu solid medium. Individual clones were then streaked onto SD-His-Leu+5-FOA 
medium to select for viable strains lacking the pRS426 RRP6 cover plasmid but 
maintaining the pRS415 and pRS413 vectors. Growth was monitored at 25°C and 
30°C for 8 days. Yeast growth via serial dilution was performed based on a recently 
published protocol (Watts et al., 2015). All yeast strains were grown in selective SD -
His-Leu medium overnight at 30°C. The next day, cells were diluted to an OD600 of 1 
before being spotted on SD -His-Leu or YPAD media in a ten-fold dilution series 
using a multichannel pipette (4 µl per spot). Cells were incubated at 30°C for 2 days 
and then imaged. 
 
Antibodies and Western Blotting 
 Polyclonal antibodies were generated by inoculating rabbits with either 
purified S. cerevisiae Rrp6 residues 129-518 (Wasmuth and Lima, 2017) or Mtr4 
residues 80-1073 (Pocono Rabbit Farm). Affinity purifying the resulting sera 
generated primary antibody stocks that were used at 1:2500 dilutions. Western blots 
were developed by incubation with a 1:5000 dilution of anti-rabbit IgG-HRP (GE) 
followed by washing and treatment with ECL solutions (Pierce). Membranes were 
imaged using a GelDoc (Bio-Rad). 
Cell powders of the indicated strains were prepared from 2L of culture grown 
in SD -His-Leu at 30°C with shaking to an OD600 of 1.0 by grinding in a Cryomill 
(Retsch) at liquid nitrogen temperatures. Powder was stored at -80°C until needed. For 
protein extraction, cell powder was resuspended in 3 volumes of buffer (50 mM 
HEPES-NaOH pH 7.5, 100 mM NaCl, 0.5 mM MgCl2, 0.1% v/v IGEPAL ca-630, 5 
mM TCEP-NaOH pH 7.0, 1x EDTA free protease inhibitor from Pierce, 1 mM PMSF) 
by briefly vortexing followed by incubation on ice for 10 minutes. The suspension was 
then centrifuged at 20,000 x g for 10 minutes and 10 µL of clarified lysate was added 
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to 65 µL of ddH2O and 25 µL of 4x LDS loading buffer containing 100 mM BME. 
These samples were boiled for 5 minutes, then 5 µL was fractionated by SDS-PAGE, 
transferred to a PVDF membrane, and treated with antibodies using standard 
protocols. 
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CHAPTER 3: Structural Studies of Helicase-Dependent RNA decay by the Mtr4- 
Exosome Complex 
 
Introduction 
 
 RNA helicases play central roles in many areas of RNA biology including 
RNA processing, RNA decay, and RNP biogenesis (Pyle, 2008). The related helicases 
Ski2 and Mtr4 both contribute to RNA exosome function as members of the Ski and 
TRAMP complexes, respectively (Figures 1, 6, and 7). In S. cerevisiae, essentiality of 
Mtr4’s ATPase activity and synthetic lethality of Dski2Dxrn1 emphasize the 
importance of these helicases in the RNA exosome’s functions (Johnson and 
Kolodner, 1995; Taylor et al., 2014). Estimates of protein copy number using 
complementary methods place S cerevisiae Mtr4 at higher protein expression levels 
than the other components of the TRAMP polyadenylation complex (Ghaemmaghami 
et al., 2003; Kulak et al., 2014). This combined with the observation that disrupting 
Mtr4/Trf interactions is non-lethal (Losh et al., 2015) suggests that Mtr4 can act either 
inside or outside of the context of TRAMP. 
 Mtr4 is recruited to the S. cerevisiae exosome through the Mpp6 cofactor and 
the Rrp6/Rrp47 heterodimer (Schuch et al., 2014; Wasmuth et al., 2017) (Figure 29), 
and this recruitment enables degradation of structured substrates (Figure 32). Crystal 
structures of Mtr4 and exosome complexes have lead to a speculative structural model 
for channeling by the TRAMP-exosome complex presented in Figures 6B and 6C, 
however the connections that tether Mtr4 to the exosome as well as how the 
orientation of the helicase relative to the exosome remain largely unknown. To address 
this, we sought to structurally characterize a 14-component exosome complex (Exo14) 
from S. cerevisiae containing the Exo9 core, Rrp6, Rrp47, Dis3, Mtr4 and an 
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engineered substrate. While the work is ongoing, we observe a 3D class at an overall 
resolution of 4.0 Å into which exosome components and archless Mtr4 can be readily 
docked. In the model, Mtr4 sits atop the S1/KH cap using the same surface as Rrp6 
does in other structures (Makino et al., 2015; Wasmuth et al., 2014; Zinder et al., 
2016), and is channeling RNA through Exo9 to Dis3. Some density corresponding to 
the Rrp6 EAR (Figure 4A) is observed, but the majority of Rrp6/Rrp47 as well as 
Mpp6 cannot be docked into the volume. We also observe a less populated class at 
approximately 6.0 Å which contains Mtr4’s arch and additional densities that may 
correspond to Rrp6’s N-terminal domains and possibly Rrp47. Finally, we provide 
evidence that exosome complexes capable of recruitment of Mtr4 can stimulate its 
helicase activities for degradation of structured substrates. 
 
Results 
 
Design and testing a substrate for capturing the Mtr4-exosome 
 Our ultimate goal was to trap the Mtr4-exosome in a state after unwinding of 
the substrate and channeling to Dis3 to degradation. One of the challenges we faced 
was that an RNA 3’ end has multiple components to engage in this complex, namely 
Mtr4, Dis3 (if the ssRNA portion is sufficiently long) and Rrp6. To overcome this, we 
include in our substrate a double stranded region with a short (8 nt) poly(A) overhang 
that we predicted would predominantly bind Mtr4 when incubated with the complex in 
the absence of ATP (Figure 36). 
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Figure 36. Substrate for capturing loaded Exo14. (A) Example nucleotide sequence 
for a tripartite substrate with length of the variable region (v) equal to 38 nucleotides. 
(B) Schematic representation of tripartite substrates. Black represents RNA regions, 
blue represents DNA, and arrows point towards the 3’ end. 
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 Another challenge we faced was that we wished to stall the helicase after ATP 
had been added to prevent dissociation. Mtr4 is a DExH family helicase that can use 
ATP to translocate along the ‘bottom strand,’ as it arbitrarily schematized, in the 3’ to 
5’ direction on RNA but not DNA (Jia et al., 2012; Pyle, 2008). However, this 
translocation can displace an annealed DNA or RNA ‘top strand’ oligo with 
approximately equal efficiency (Lim et al., 2017 and Puno MR, unpublished). We 
sought to take advantage of this by employing a bottom strand (g strand) in our 
substrate that is an RNA/DNA chimera (Figure 36). We reasoned that Mtr4 would be 
able to translocate along the RNA portion until it hit the RNA/DNA junction, at which 
point it would hopefully remain stalled. We included a short RNA oligo annealed to 
the DNA portion of the chimera (a strand) to ensure that it would form an A-form 
helix and to aid in stalling the helicase, and a strand of DNA annealed to the RNA 
portion (b strand) to limit the 3’ overhang to the 8 nt poly(A) tract. Heat-cooling these 
three strands and gel purifying the product forms the tri-partite substrates (abg) in 
Figure 36. 
To estimate the length of RNA required to reach Dis3 through Mtr4 and the 
central channel, we used RNA lengths from known structures of Exo10Dis3 bound to a 
stem-loop RNA (Makino et al., 2013b) (30 nt), Exo12Dis3/Rrp6/Rrp47 (Makino et al., 
2015) (~10-12 nt), and Mtr4 bound to RNA (Weir et al., 2010) (+5 nt). This gave us 
an approximate length of the 3’ overhang after unwinding of 46 nt, which is in good 
agreement with data from RNase protection assays using S. cerevisiae Exo14 (Falk et 
al., 2017). 
To see if this substrate was behaving as intended, ultraviolet (UV)-crosslinking 
was performed by using substrates of varying lengths with a 4-thio uracil (4SU) 
nucleobase two nucleotides from the 3’ end of the g strand (Figure 37A). Irradiating a 
sample of protein mixed with a 4SU containing oligonucleotide with long-wavelength 
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UV light allows the nucleobase to crosslink to proteins, so long as they are bound near 
the 4SU modification. Protein-nucleic acid adducts can be visualized after separation 
by SDS-PAGE via the fluorescein label in the 4SU containing bottom strand (Figure 
37A). 
We irradiated Exo13 and Exo14 complexes (nuclease-inactive) after prolonged 
incubation with substrates and either ATP or AMP-PNP. In the presence of either 
nucleotide Exo13 shows inefficient crosslinking to all the substrates tested, with weak 
signals that correspond to Dis3 and Rrp6 proteins. In contrast, Exo14 shows a strong 
signal corresponding to a crosslink to Mtr4 in all cases, leading to the speculative 
model depicted in Figure 37B. For Exo14 with ATP, use of the two shorter substrates 
generates signal corresponding to crosslinks to Exo9 subunits as well as Rrp6. 
Curiously, for the substrate with a variable region of 20 nt (28 nt overhang after 
unwinding when the poly(A) tract is accounted for), a crosslink to Dis3 appears. Three 
possible explanations that could account for this observation are 1. Mtr4 is displacing 
Rrp6 from the Exo9, as previously observed with a stem loop plus poly(U) RNA 
bound to Dis3 (Makino et al., 2015) and the RNA is highly extended 2. after the long 
incubation, unwound substrate is released from Mtr4 and engages Dis3 through the 
central channel as in previous structures (Kowalinski et al., 2016; Liu et al., 2016; 
Makino et al., 2013b) or 3. Dis3 is engaging the unwound RNA independent of the 
central channel. When using Exo14, ATP and the longer substrates, crosslinks to Dis3 
dominate the reaction. These data lead to the (once again speculative) model presented 
in Figure 37C, and show that the longer substrates can thread through the core and 
engage Dis3 when ATP and Mtr4 are present. 
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Figure 37. RNA crosslinking reveals ATP-induced substrate translocation by the 
Mtr4-exosome. (A) Top: Schematic representation of crosslinking substrates. Black 
represents RNA regions, blue represents DNA, green indicates the 5’ fluorescein label 
on the g strand, the marker indicates a 4SU modification 2 nt before the 3’ end of the g 
strand, and arrows point towards the 3’ end. Bottom: SDS-PAGE analysis of RNA 
crosslinking to exosome complexes in the presence of ATP or AMP-PNP. Gels were 
imaged for fluorescein signal and crosslinked adducts are indicated. Data generated by 
Dr. M. Rhyan Puno with Exo13 and Exo14 supplied by John Zinder. (B and C) 
speculative models from the Exo14/AMP-PNP (B) or Exo14/ATP (C) cases in panel 
A. Inactive exonuclease subunits are indicated with red X’s and helicase direction is 
shown with a gear.   
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The nuclear RNA exosome stimulates unwinding by Mtr4 
Assured that the 3’ end of our substrate was being fed to Dis3, we sought to 
directly observe unwinding. To this end, we performed helicase assays using abg with 
variable region v = 38 nt containing a 3’ label on the b strand (Figure 38A). Given the 
high melting temperature of our substrate, reannealing of the displaced strand during 
workup precluded any activity measurement except when an unlabeled DNA oligo 
complementary to the b strand was included in the reaction (DNA Trap, see next 
section). Mtr4 alone was unable to unwind the substrate under the conditions 
employed in the assay, consistent with the low level of activity previously observed 
(Jia et al., 2012). Exo13Dis3/Rrp6/Rrp47/Mpp6, having no intrinsic helicase activity, was also 
unable to unwind the substrate. Combining Mtr4 with Exo13 or Exo11Dis3/Mpp6, both of 
which contain elements that recruit Mtr4 (Figure 29), produced a robust, ATP-
dependent release of the b strand. 
When using complexes with catalytically active Dis3 and/or Rrp6 on an RNA 
variant of this substrate, we observe similar trends to those seen in Figure 32 with 
respect to Mtr4- and ATP-dependent Dis3 activity (Figure 38B). These experiments 
showed that the nuclear exosome complex can stimulate Mtr4’s RNA helicase activity 
for degradation of structured substrates and gave us confidence that we would be able 
to load Exo14 and engage Dis3 with this tripartite substrate. 
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Figure 38. The exosome stimulates Mtr4’s helicase activity for degradation of 
structured substrates. Gels are 4-20% acrylamide-TBE and were imaged for 
fluorescein signal. The substrate contains a variable region (v) of 38 nt as described in 
Figure 36. (A) RNA helicase assay. Top: schematic of the substrate used in the 
helicase assay. Black indicates RNA regions, blue is DNA, and the 5’ fluorescein label 
is represented by a green star. Bottom: RNA unwinding time courses by Mtr4 in the 
presence or absence of catalytically inactive exosome complexes. Reactions were 
conducted using ATP or AMP-PNP as indicated. Markers in the first lane are (from 
top) 49, 37, 24, 18, 14, and 8 nt 5’ fluorescein poly(A) RNA. A marker indicating the 
trap annealed to the released strand is included in the second lane of the gels. (B) RNA 
decay assay. Top: schematic of the substrate used in the decay assay. Schematics are 
as in panel A. Bottom: RNA decay time courses using the indicated complexes. 
Catalytically inactive Rrp6 is indicated with a red X. Reactions were conducted using 
ATP or AMP-PNP as indicated.  
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Loading Exo14 with a substrate stabilizes Mtr4 on the exosome and requires a trap 
for the displaced strand 
 As our final goal was to characterize the loaded Exo14 complex by cryo-EM, 
we first set out to optimize the solubility of the complex. Specifically, we were 
concerned that the C-termini of Rrp6 and Rrp47, both of which are predicted to be 
disordered and decrease the expression levels and solubility of the heterodimer 
(Costello et al., 2011; Wasmuth and Lima, 2017), would cause aggregation during 
concentration or upon vitrification. To solve this, we reconstituted 13-component 
complexes lacking the C-terminal 100 amino acids of Rrp6 and 80 amino acids of 
Rrp47, which will henceforth be referred to as Exo13tr. Amino acids 700-721 from 
Rrp6’s sequence were appended onto the truncated Rrp6, as that stretch had previously 
been shown to increase activity of the enzyme without compromising solubility (see 
Materials and Methods) (Wasmuth and Lima, 2017). 
The Exo13tr complex’s activity was compared to WT (both with catalytically 
inert Rrp6) in a helicase-dependent RNA decay assay as previously (see Chapter 2), 
and showed nearly identical activity (Figure 39). Furthermore, when channel 
occlusion mutant of Rrp41 (see Chapter 1) was included in the complex, Exo13tr lost 
helicase-dependent Dis3 activity altogether, indicating that the substrate was entering 
the central channel of un-occluded Exo13tr with the help of Mtr4 and ATP. This result 
is inconsistent with a model in the literature wherein Mtr4 can feed RNA to Dis3’s 
direct-access conformation (Delan-Forino et al., 2017), however that model relied on 
the unconfirmed hypothesis that a mutation in the S1 domain of Dis3 selectively 
disrupted direct-access RNA degradation by Dis3 (see Chapter 1, Discussion). Both 
Exo13 and Exo13tr were able to degrade poly(A) RNA in the presence of AMP-PNP 
but, interestingly, this activity was enhanced when using ATP.  
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Figure 39. Exo13 containing truncations in Rrp6 and Rrp47 retains near-WT 
activity. RNA decay assays using the indicated complexes on 37 nt poly(A) and 
ds17A10 RNA (see Chapter 2, Materials and Methods), both of which contain 5’ 
fluorescein labels. Exo13tr refers to a complex containing Rrp6 and Rrp47 C-terminal 
truncations described in the text. Rrp6 contains a D238N mutation to render it 
catalytically inactive in all cases. The red asterisk marks an artifact from workup of 
that particular reaction. Gels are 15% acrylamide TBE-urea and imaged for 
fluorescein signal. Markers are (from top) 37, 24, 18, 14, and 8 nt 5’ fluorescein 
poly(A) RNA. The Dis3 product runs at the bottom of the gel.  
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A necessary but absent control would be to test decay on 37 nt poly(A) RNA in the 
absence of Mtr4, but nevertheless these data suggest that Mtr4 is competing with Dis3 
for the 3’ end of this particular substrate when it cannot translocate. 
 Next, we sought to optimize conditions for preparative loading of the substrate 
into an exonuclease dead complex. Given that the previous Exo14 reconstitution 
protocol (Figure 29) required a buffer that was optimized for Mtr4:exosome 
stoichiometry and not yield (see Chapter 2 Materials and Methods), we opted to mix 
1.1-fold excess Mtr4 with Exo13tr prior to addition of RNA rather than use 
reconstituted Exo14. After mixing the two protein components and incubating on ice, 
the proteins were added to RNA substrates and incubated at room temperature. Then, 
either AMP-PNP (Reaction 3), ATP (Reaction 4), ATP plus a DNA Trap 
complementary to the b strand (Reaction 5), or ATP plus RPA, a trimeric protein 
complex from S. cerevisiae that binds ssDNA (courtesy of Dr. Laurent Cappadocia, 
Reaction 6) was added (Figure 40). After incubation at room temperature, the 
reactions were fractionated by gel filtration (Figure 40B) and peak fractions were 
analyzed the for protein and nucleic acid content by PAGE with SYPRO Ruby and 
SYBR Gold staining, respectively (Figures 40C, 40D, and 40E). As controls, substrate 
only (Reaction 1) or Exo14 + ATP with no added nucleic acid (Reaction 2) were 
injected. 
 For the substrate alone (Reaction 1, solid black curve), a single peak centered 
at 16.4 mL containing nucleic acid and no protein (Peak 2) was observed as expected 
(Figure 40). The UV traces for the Exo14 complex alone (Reaction 2, dashed black 
curve) showed a broad peak centered at 12.1 mL (Peak 1), with a second minor peak 
centered at 14.5 mL, corresponding to the exosome and Mtr4, respectively (Figure 
40B). Gels of the first peak showed that it contained Exo13tr components but sub-
stoichiometric amounts of Mtr4 and no RNA (Figures 40C and 40D).  
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Figure 40. Gel filtration analysis of Mtr4-exosome loading reactions. (A) Table 
describing the shorthand for the reaction conditions used. ‘RNA’ refers to an abg 
tripartite substrate with v = 20 nt. (B) A280 traces from gel filtration (Superdex200, 24 
mL column volume) from the six reactions. (C) SYPRO Ruby stained SDS-PAGE of 
the load and first peak from each reaction. Three 0.5 mL fractions that approximately 
encompassed the peak’s centroid were pooled for each ‘Peak’ sample throughout this 
figure. For the Reaction 6 load, RPA subunits (Rfa1, Rfa2, and Rfa3) are highlighted. 
Asterisks in the Reaction 3 Peak lane indicate unknown protein contamination. (D) 
Nucleic acid gels of the load and two main peaks. Samples were treated with 
Proteinase K prior to separation. Gels are 4-20% acrylamide-TBE and were visualized 
with SYBR Gold for detection of nucleic acid. (E) High-resolution gel of Peak 1 from 
Reaction 5. The sample from panel D was run in both lanes 1 and 4 alongside standard 
curves of the indicated markers. Gel is 4-20% acrylamide-TBE, but was run for 50% 
longer than the gels in panel D. Visualization was as in panel D. (F) Nucleic acid gels 
of miscellaneous peaks from Reactions 5 and 6. Sample preparation and gel are as in 
panel D.   
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While this result contrasts the result from gel filtration in Chapter 2 (Figure 29), which 
showed stoichiometric association of Mtr4 with Exo13, the reactions presented here 
were conducted at much lower concentrations and using different reaction and gel-
filtration buffers. For the remaining reactions, Peak 1 had a higher UV absorbance, 
was narrower, and eluted earlier (centered at ~11.5 mL) than with protein alone. 
Reactions 3 and 4 (red curves in Figure 40B) behaved nearly identically, with greater 
amounts of Mtr4 present in the protein gel of Peak 1 (Figure 40C) than for without 
substrate (Reaction 2), and mostly abg, or the full substrate, in Peak 1 (Figures 40D). 
For Reaction 4, the lack of a significant proportion of ag (the expected product of 
unwinding) in Peak 1 suggests that the b-strand is either not being displaced or is co-
migrating with the complex throughout gel filtration and re-annealing during the 
workup to make the sample for the gel. Reactions 5 and 6 (blue curves in Figure 40B), 
by contrast, both contain traps to sequester the displaced strand and show ag and no 
abg in their Peak 1 (Figures 40D and 40E). For Reaction 5, two additional peaks 
appear: Peak 2’ contains the trapped b-strand and Peak 2’’ contains the excess DNA 
trap oligo, though it is difficult to visualize, potentially because it is C-rich and SYBR 
gold has poor fluorescence when bound to poly(dC) (Tuma et al., 1999) (Figure 40F). 
Reaction 6 has an additional peak (Peak 1’) that contains the b strand (presumably 
bound to the RPA trimer), though it is also is contaminated with abg from Peak 2 
(Figure 40F). These experiments demonstrate that nucleic acid strengthens the Mtr4-
exosome interaction independent of substrate loading (compare Reaction 3 to 
Reactions 4 through 6), and that the observation of efficient loading is aided by use of 
a DNA or protein trap. 
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Crosslinking of Exo14 to stabilize the complex 
 3D reconstructions from preliminary cryo-EM analysis of substrate loaded 
Exo14tr showed that some of the subunits were substoichiometric or entirely missing. 
Among these, Csl4 and the Rrp6 EAR were the most noticeably weak. To address this, 
we optimized protocols to crosslink the complex using homo-bifunctional amine-to-
amine (glutaraldehyde, ~5 Ångstrom spacer) and sulfhydryl-to-sulfhydryl (BM(PEG)3, 
~18 Ångstrom spacer) crosslinking molecules (Figure 41). 
Treating the substrate-loaded Exo14tr complex with increasing amounts of 
glutaraldehyde resulted in mobility shifts in many of the subunits, most noticeably 
Rrp6 and Mtr4, and generated a smear of high molecular weight species (Figure 41A, 
left half). By contrast, treatment with BM(PEG)3 resulted in discrete high molecular 
weight bands, with few noticeable shifts among the majority of subunits (Figure 41A, 
right half), presumably because surface cysteines are scarce relative to surface lysines. 
The most obvious effect was the disappearance of the Rrp6 and Csl4 proteins, and the 
strengthening of signal around the Mtr4 band. We suspected that the signal that co-
migrated with Mtr4 was derived from an Rrp6/Csl4 crosslinked species, and 
performed Western blotting analysis on the crosslinked and un-crosslinked complex to 
investigate (Figure 41B). When the Rrp6 and Mtr4 blots were aligned to the direct 
blue protein stain, a shift in molecular weight of the Rrp6 signal to approximately the 
same mobility as the un-crosslinked Mtr4 band was observed, supporting our 
suspicion. Additionally, ~50% of the Mtr4 signal shifted upwards, indicating that its 
cysteines form crosslinks to other cysteines in the complex, though this cannot be 
rationalized using current structural models.  
	 147 
 
 
 
 
 
 
 
Figure 41. Protein-protein crosslinking using glutaraldehyde or BM(PEG)3. (A) 
SYPRO Ruby stained SDS-PAGE showing Exo14tr complexes treated with different 
concentrations of an amine-to-amine (glutaraldehyde) or sulfhydryl-to-sulfhydryl 
(BM(PEG)3) crosslinking molecule. Molecular structures are shown above the gel. (B) 
Western blot analysis of crosslinked (50 µM BM(PEG)3) and un-crosslinked Exo14tr. 
The same PVDF membrane was visualized using protein stain (left, direct blue) or a 
Western blot and manually aligned. Rabbit polyclonal antibodies were raised against 
Rrp6 residues 129-518 or Mtr4 residues 80-1073 and affinity purified (see Chapter 2, 
Materials and Methods). Western blots were treated with a secondary antibody 
conjugated to HRP and visualized for chemiluminescence. Membrane was stripped 
and re-probed after Rrp6 detection using standard protocols.  
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S. cerevisiae Rrp6 contains three cysteines in its entire sequence, one of which, 
C553, is 12 or 16 Ångstroms away from C18 and C66 of Csl4, respectively (Figure 
42A). The other two are either buried (C252) or out of the way of the majority of 
proteins (C101) in the N-terminal ‘lid’ (Figure 42A). An Exo13tr complex containing 
Rrp6C553S was reconstituted and treated with BM(PEG)3 in parallel with WT. 
Crosslinks were observed by Western blotting and SYPRO Ruby staining (Figures 
42B and 42C). Rrp6C553S showed weaker crosslinking by Western blot, and fewer 
high-molecular weight species were observed in the corresponding SYRPO stained 
gel, indicating this residue is participating in cysteine-to-cysteine crosslinking in the 
complex. In both the Western and the SYPRO it is clear that un-crosslinked Rrp6 
intensity of the mutant diminishes in the presence of the BM(PEG)3 (though not as 
dramatically as in the WT case), which suggests that the two other cysteines may 
participate in yet unknown protein-protein interactions. 
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Figure 42. Structural modeling of Rrp6 crosslinking. (A) Location on the nuclear 
exosome of Rrp6’s three cysteines. Model is from PDB 5K36, with Rrp6/Rrp47 N-
terminal bundle from PDB 5C0W. Distances in zoom panel are shown in Ångstroms. 
Panel generated using Pymol (Schrödinger). (B) Western blot of Exo13tr containing 
WT and C553S mutant Rrp6 treated with different amounts of BM(PEG)3. Antibody 
and visualization is as in previous figure. Reaction contained 500 nM Exo13tr. (C) 
SYPRO Ruby stained SDS-PAGE showing WT and mutant Exo13 complexes treated 
with different concentrations BM(PEG)3. Reaction contained 500 nM Exo13tr.  
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Preparation of loaded ScExo14tr for cryo-EM data collection 
Having optimized the loading reaction and protein crosslinking, we set out to 
collect cryo-EM data for high resolution structure determination of the loaded Exo14tr 
complex. The substrate in Figure 36A with v = 38 nt was chosen for these studies, as it 
showed strong 3’ UV-crosslinks to Dis3 after ATP addition (Figure 37A) and could 
reach Dis3 for degradation with ATP and Mtr4 present (Figure 38B). Rather than 
purifying the loaded complex via gel filtration, which would risk dissociating the 
loaded complex both through dilution on the column and because it is time 
consuming, the loading reaction was simply concentrated and desalted into reaction 
buffer containing ADP after incubation. Furthermore, the components that gel 
filtration removes, namely excess Mtr4, substrate, and unreacted ATP, are small 
enough that they will either not be seen or can be easily removed by 2D or 3D 
classification during data processing. ADP was added to the final buffer because Mtr4 
has previously been crystallized bound to RNA and ADP (Weir et al., 2010) and 
because addition of ADP enhanced Mtr4’s ability to shield RNA when bound to the 
exosome in RNase protection assays (Falk et al., 2017). After desalting, the complex 
was diluted to a pre-determined concentration, treated with BM(PEG)3, quenched with 
DTT, adjusted to the final detergent concentration, and grids were prepared. 
 
Data collection, processing, and 3D classification 
We collected movies using a target defocus range of -1.5 to -2.5 µm on a Titan 
Krios equipped with K2 Summit direct detector over a span of approximately 40 
hours. The complex appears to have a desirable behavior (in terms of particle size and 
distribution) in relatively thick ice (Figure 43A), but not when then ice is excessively 
thick. Because of this, holes for collection were picked based on an ideal value for 
pixel density (which relates to ice thickness) that was determined during screening 
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using a python script (Laurent Cappadocia, unpublished). This resulted in 1483 
movies, which after motion correction (Zheng et al., 2017) and CTF estimation 
(Zhang, 2016) was reduced to 1144 using a 4.4 Ångstrom max resolution cutoff plus 
manual pruning. Auto-picking in Relion 2 (Kimanius et al., 2016) resulted in an initial 
batch of 245,000 particles, 222,625 of which remained after conservative selecting of 
2D-class averages in CryoSPARC (Punjani et al., 2017) to remove debris and other 
aberrant particles (Figure 44). From this batch, an initial 3D classification in Relion 
resulted in 6 classes (Figure 43B), all of which resemble various subcomplexes of the 
exosome in size and shape but differ in their resolution, population, and apparent 
stoichiometry of the complex. The two most populated classes (Classes 4 and 6) from 
this were pooled and subjected to further 3D classification (Figure 44). 
A common feature of the six 3D classes at this point was that they all 
contained the non-catalytic core (the most clear element being the C-terminal helix of 
Rrp45, highlighted in Figure 43B with a red circle) and Dis3 in the through-channel 
conformation (Liu et al., 2014; 2016; Makino et al., 2013b). The pooled classes 
resulted in a volume that encompassed these elements as well as additional densities 
above the S1/KH subunit Rrp4, which we will refer to as ‘top densities’. These 
densities were poorly defined relative to the core region, so focused classification was 
performed to separate particles that contained these densities (42%) from particles that 
did not (58%) (see Materials and Methods) (Figure 44). The resulting classes were 
subjected to a second round of focused classification for Csl4, which was relatively 
weak in both classes and throughout. After this point, the class that contained top 
densities was separated into two 3D classes, Class I and Class II (Figures 44, 45A and 
45B). Attempts at further classification did not result in significantly different 
structures. Class II additionally contains densities on the side of the exosome proximal 
to the Rrp4 S1/KH protein and Rrp42 PH-like protein as well as extra densities above 
	 152 
the S1/KH ring (Figures 44 and 45B). Finally, focused classification for Csl4 from the 
particles that did not contain top densities resulted in Class III (Figures 44 and 45C). 
Analysis of particle orientation from 3D refinement in CryoSPARC revealed 
orientation bias in all three classes, though this was more severe for Classes I and II 
than for Class III (Figure 44). 
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Figure 43. Initial characterization of a cryo-EM dataset. (A) Representative 
micrograph used in analysis. Image was low-pass filtered at 20 Å. Green circles are 
250 Å in diameter and show the un-pruned output from auto-picking in Relion. (B) 
Initial 3D classification from 222,625 particles in Relion. The classes that were used 
for subsequent analysis (Classes 4 and 6) are highlighted in bold. Exo10Dis3 from PDB 
4IFD (with RNA and Rrp6 EAR removed) is shown for comparison, with the C-
terminal helix of Rrp45 highlighted by a red oval. Figure generated using Chimera 
(Pettersen et al,. 2004).  
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Figure 44. Summary of 3D classification. Particle count and resolution are shown at 
different steps of 3D classification in Relion. The three classes used in subsequent 
analyses (Class I, Class II, Class III) are highlighted in bold font. For post-processed 
3D volumes, masked densities are shown. Next to each of these classes the orientation 
distribution generated by a homogenous 3D refinement of those particles in 
CryoSPARC is shown. Each point represents a discrete orientation using a horizontal 
coordinate system, and the color of a point represents how many particles are in that 
particular orientation for the 3D reconstruction. White regions indicate that there are 
no particles in those orientations.  
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Structural modeling into 3D-classes 
Because of the relatively low resolution of the data, rudimentary docking of 
pre-existing crystal structures in Chimera was performed (Pettersen et al., 2004) 
without significant building or refinement (Figure 45). Elements that were clearly not 
encompassed by the volumes after docking were removed, resulting in the models 
presented in Figures 45 through 48. The crystal structure of the yeast exosome with 
Dis3 bound to RNA in the through-channel conformation (Makino et al., 2013b) (PDB 
4IFD) could be readily docked into all three classes, though density for the Rrp6 EAR 
from that structure was weak or absent (Figures 45, 46C, and 46E). Mtr4 fit well into 
the top density for Classes I and II, including the bound RNA and ADP from PDB 
2XGJ (Weir et al., 2010) (Figures 45, 46A, 46B, and 46E), though density for the arch 
was comparatively weak in Class I (Figures 45A and 45B). In these classes, RNA 
appears to continue from the 3’ end of the RNA in Mtr4 through the central channel, 
and there is weak but contiguous density connecting it to the Dis3 RNA (Figures 46B, 
46D, and 46E). Densities extending from the 5’ end of the RNA was weak or absent in 
both Mtr4-containing classes, and the duplex region of the substrate was not apparent. 
Class III also appears to contain RNA throughout its central channel engaging Dis3 
(Figure 46F). The catalytic module of Rrp6 and the N-terminal helical bundle with 
Rrp47 could not be modeled into any of the three classes. Mpp6 bound to Rrp40 was 
also not observable in any of the three models, though some additional densities in that 
region were present at high contour levels. While it is likely absent, it remains possible 
that Mpp6 is either present in multiple conformations or in a subset of the particles 
included in the classes. 
Interestingly, Mtr4 sits on the same conserved surface of Rrp4 in these models 
as Rrp6 does in previous structures (Wasmuth et al., 2014; Zinder et al., 2016) (Figure 
47). Another notable aspect of the models is that the Trf4 and Air2 peptide motifs that 
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bind the Mtr4 catalytic core could accommodated (Falk et al., 2014; Losh et al., 2015) 
(Figure 48), raising the possibility that TRAMP may engage the exosome in a similar 
manner as we observe for Mtr4 alone. 
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Figure 45. Docking of crystal structures into 3D classes. Grey surface is the post-
processed, masked density contoured to 7.5 (arb. units) throughout. Through-channel 
Dis3 bound to RNA, Exo9 and Rrp6 EAR (if present) are from PDB 4IFD. Mtr4 
bound to RNA and ADP is from PDB 2XGJ. Figure was generated using Pymol 
(Schrödinger). (A) Docking into Class I. RNA is indicated as well as a fragment of the 
Rrp6 EAR. Mtr4’s arch domain, which spans residues 607 to 878, was removed from 
the model as well as most of the Rrp6 EAR. (B) Docking into Class II. RNA is 
indicated as well as a fragment of the Rrp6 EAR. Additional densities that could not 
be modeled into are highlighted. (C) Docking into Class III. RNA is indicated. The 
Rrp6 EAR from PDB 4IFD was not encompassed in the density and removed from the 
model.  
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Figure 46. RNA and other features in 3D classes. Grey mesh is the masked, post-
processed density contoured to 7.5 s and red surface is contoured to 12.5 s 
throughout. Models are as in the previous figure, though an additional fragment of the 
Rrp6 EAR is shown for Class I for illustrative purposes. Figure generated using Pymol 
(Schrödinger). (A through F) Features in Class I. (A) ADP is the ATPase site of Mtr4. 
Sidechains of Phe148 and Arg574 that sandwich the adenosine moiety of ADP are 
highlighted. Both the mesh and surface were carved to within 3 Å of the ADP 
molecule. (B) RNA in and around Mtr4. 5’ and 3’ ends of the RNA from PDB 2XGJ 
are indicated. Both the mesh and surface were carved to within 3 Å of a place-holder 
RNA model. (C) Density for the Rrp6 EAR. Note that the lack of red surfaces in this 
panel is because no signal was observed at 12.5 s. The amino acid boundaries of the 
model are indicated. Mesh was carved to within 3 Å of the Rrp6 EAR model. (D) 
RNA in and around Dis3. 5’ and 3’ ends of the RNA from PDB 4IFD are indicated. 
Both the mesh and surface were carved to within 3 Å of a dummy RNA model. (E) 
Density through the central channel, Dis3, and Mtr4 of Class II. Both the mesh and 
surface were carved to within 5 Å of a place-holder RNA model. Also shown are 
densities caved to within 5 Å of the ADP molecule in Mtr4 and the Rrp6 EAR. (F) 
Density through the central channel and Dis3 of Class III. Both the mesh and surface 
were carved to within 3 Å of a place-holder RNA model.  
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Figure 47. Rrp6 can be displaced from the S1/KH ring. Structures were aligned 
based in the Rrp4 chain. Panels A through C were generated using Pymol 
(Schrödinger). (A) Mtr4 sits on top of Rrp4 (shown as a red surface) in the model from 
Class I (and Class II, though that is not shown). (B) Rrp6’s catalytic module sits on the 
same surface in a structure of Exo11Dis3/Rrp6 bound to a 3’-3’ RNA and other structures 
(not shown). (C) Rrp6’s catalytic module is displaced from Rrp4 in a crystal structure 
where Dis3 is engaging a structured RNA with long overhang through the central 
channel. (D through F) Schematic representations of the above panels. RNA 5’ and 3’ 
ends are indicated, and dashed lines surrounding subunits or in nucleic acid indicates 
that they are disordered or missing in the corresponding structure. Dashed lines in the 
core represent the central channel.  
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Figure 48. TRAMP subunits can be accommodated in the model from Class I. 
Structural model from the density in Class I. PDB 4U4C was aligned to the model, 
and the Trf4 and Air2 peptides contained within it are highlighted. Amino acid 
boundaries of Trf4 and Air2 peptides are indicated. Figure generated using Pymol 
(Schrödinger).  
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Discussion 
 
 These studies represent a proof of principle for employing a specialized mixed 
RNA/DNA substrate to structurally characterize helicase-dependent RNA decay by 
the S. cerevisiae exosome. Using this substrate, we observe a state of the complex in 
which Rrp6/Rrp47 has been displaced from the S1/KH cap by Mtr4 for channeling to 
Dis3. We envision this state as it relates to the competition for the 3’ end of the RNA 
between Rrp6 trimming and Mtr4 channeling in helicase-dependent RNA decay 
(Figures 32, 38B and 39): when Mtr4 ‘wins’ the competition, it can temporarily 
displace Rrp6/Rrp47 from the core and ensure it feeds the RNA along a path through 
the central channel to Dis3 (Figure 47D). This displacement of Rrp6 from the cap 
reminiscent of that observed in a crystal structure of Exo12Dis3/Rrp6/Rrp47 bound to a 
stem-loop poly(U)30 RNA (Makino et al., 2015) (Figures 47C and 47F), and may be an 
important facet of RNA decay by the nuclear exosome. Affinities between the 
conserved top surface of Rrp4 and Mtr4 or Rrp6’s catalytic module are likely 
negligible, as neither binds the exosome without special elements to tether it (Schuch 
et al., 2014; Wasmuth and Lima, 2017; Wasmuth et al., 2014; 2017), so stable binding 
to this site by these enzymes is likely facilitated by RNA. Consistent with this, all 
high-resolution crystal structures of Rrp6 bound to the exosome to date include 
nucleic acid in its active site (Wasmuth et al., 2014; 2017; Zinder et al., 2016). After 
the RNA is degraded by Dis3, Mtr4 is no longer tethered to Rrp4 and can dissociate, 
potentially allowing Rrp6/Rrp47 to replace it. The interplay between competition for 
the RNA 3’ end and competition for binding to Rrp4 between Mtr4 and Rrp6/Rrp47 
may prove to be a fruitful area for future studies. 
 As previously mentioned, the catalytic module of Rrp6 and its N-terminal 
helical bundle could not be modeled into any of the final classes, while Rrp6’s EAR 
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was weak or absent. A previous model from cryo-EM of the cytoplasmic exosome 
bound Ski7 observed a similar effect: Ski7’s globular domain was entirely absent from 
3D reconstructions while its EAR domain, which binds the same surface as Rrp6’s, 
was weak relative to other regions (Liu et al., 2016). However, the investigators 
observed a signal with roughly the size and shape of Ski7’s globular domains in 
aligned 2D class averages from negative stain EM (but not cryo-EM), though it was 
clear that it was not adopting a single conformation relative to the rest of the complex. 
This could also be the case for the Rrp6/47, and future studies may need to use 
negative stain EM or label Rrp6/Rrp47 with gold (or another electron-rich tag) in 
order to observe it. That being said, the density on the side of the exosome in Class II, 
while weak, vaguely resembles Rrp6’s catalytic module. This class represents a small 
proportion (<10%) of the total particles, however, and may have only be stabilized by 
crosslinking. 
 Using the current strategy, classes containing Mtr4 represent approximately 
40% of the total particles, though 20% of those lack Csl4. The Mtr4-containing class 
is further split 70% and 30% (into Classes I and II), leaving a small proportion of the 
desired complexes from the original population in spite of efforts to ensure stable 
association of Mtr4 through crosslinking and other protocols. Absence of Mpp6 as 
well as poor occupancy for Csl4 and thus Rrp6/Rrp47 (Rrp6 cannot associate with the 
exosome without Csl4) is at odds with their apparent stoichiometry as measured by 
SDS-PAGE and densitometry. This suggests that the complex is denaturing during 
grid preparation, or that populations of sub-stoichiometric complexes (which may 
represent a small fraction of the total population) are preferentially entering the holes 
in the grid over intact complexes. Conditions such as the crosslinking, reaction buffer, 
grid choice (graphene coating has been previously employed to resolve some of these 
issues), and detergent may need to be further optimized to mitigate these issues. 
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Furthermore, use of particle polishing and focused refinement (which may require 
larger datasets) may greatly enhance the resolution of the reconstructions and allow 
for more elegant structural modeling than simple docking. 
These studies also provide a framework for the addition of more cofactors to 
the 14-component complex. With the determinants for and effects of Mtr4 recruitment 
more or less resolved, future studies can include the Trf/Air heterodimer to degrade 
substrates for which Mtr4’s unwinding activity would not be sufficient. Additionally, 
reconstitution of co-transcriptional recruitment of the TRAMP-exosome by the Nrd1-
Nab3-Sen1 (NNS) termination complex (Vasiljeva et al., 2008) provides a tantalizing 
target for use of biochemical and cryo-EM analysis in future work. 
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Materials and Methods 
 
Oligonucleotides  
 All oligonucleotides were purchased and HPLC purified by Dharmacon. The 
sequence of the RNA top strand (a) used throughout this chapter is 5’ 
AGCACCGUAAAGACGC 3’ . Chimeric bottom strands (g) for the tripartite 
substrates with v=12, 20, 38, and 43 are (from 5’ to 3’ end) 
dGdCdGdTdCdTdTdTdAdCdGdGdTdGdCdTCACCACACCACACAAAAAAAA, 
dGdCdGdTdCdTdTdTdAdCdGdGdTdGdCdTCACACCACACCACACCACACAAA
AAAAA, 
dGdCdGdTdCdTdTdTdAdCdGdGdTdGdCdTCACACCACACCACACCACACCCA
CACCACCAAAAAAAA, and 
dGdCdGdTdCdTdTdTdAdCdGdGdTdGdCdTCACCACACCACACCACACCACAC
CACACCACACCACACCACACAAAAAAAA, where a ‘d’ preceding a letter 
indicates a deoxyribonucleoside. DNA blocking oligos (b) for  v=12, 20, 38, and 43 
are (from 5’ to 3’) dGdTdGdTdGdGdTdGdTdGdGdTdG, 
dGdTdGdTdGdGdTdGdTdGdGdTdGdTdGdGdTdGdT, 
dGdTdGdTdGdGdTdGdTdGdGdTdGdTdGdGdTdGdTdGdGdTdGdTdGdGdTdGdTd
GdGdTdGdTdGdGdT, and 
dGdTdGdTdGdGdTdGdTdGdGdTdGdTdGdGdTdGdTdGdGdTdGdTdGdGdTdGdTd
GdGdTdGdTdGdGdTdGdTdGdGdT. The sequence of the ‘DNA Trap’ used in 
Figures 38B, 40, and for the preparative loading reaction was 5’ 
dAdCdAdCdCdAdCdAdCdCdAdCdAdCdCdAdCdAdC 3’. Substrates for UV 
crosslinking experiments in Figure 37A were ordered with a 5’ fluorescein and a 4 
thio-uridine 2 nt from the 3’ end and were otherwise the same sequences as above. 
The substrate for the helicase assays in Figure 38A contained a 3’ fluorescein label b-
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strand and had a variable region length v = 38 nt. The substrate for the decay assay in 
Figure 38B contained a g-strand that was of length v = 38 nt, was composed entirely of 
RNA and contained a 5’ fluorescein label. Tripartite substrates were annealed by heat-
cooling using excess a and b and purified by gel filtration on a Superdex200 increase 
10/3000 GL column. 
 
Cloning and expression of Rrp6tr/Rrp47tr 
 Rrp6 was amplified from a plasmid containing the full-length gene using 3’ 
GTATGAGGATCCACTTCTGAAAATCCGGATGTACTTTTATC 3’ and 5’ 
CACCGTCGACTTACCTCCTCTTTTTAGCTGCCCTTGGTCCATTACTATCGCT
AGATGATGGGTCGAATCTCCTTTTCTTCTTAATCTCCTCTAGCTTGACAGGA 
3’ as the forward and reverse primers respectively. The amplicon was cloned into the 
BamHI and SalI sites of pRSFduet-Smt3 (see Chapter 1, Materials and Methods). 
Then, Rrp47 was amplified from a vector containing the full-length protein using 5’ 
GTATGACATATGGAAGATATCGAAAAGATAAAACCATA 3’ and 5’ 
AGACTCCTCGAGCTACTTCTTCCCTCCTTTCTTTTTTCC 3’ and inserted into 
the NdeI and XhoI sites of that vector. Note that Rrp6 had to be cured of internal NdeI 
and BamHI sites prior to employing this strategy. The heterodimer was expressed in 
BL21 (DE3) RIL cells and purified by nickel, heparin, and gel filtration 
chromatographies similar to other exosome components (See Chapters 1 and 2, 
Materials and Methods). 
 
Protein-nucleic acid UV crosslinking 
Protein samples (200 nM) were incubated with 100 nM 5’ fluorescein- and 
internal 4SU-labeled RNA in a buffer containing 20 mM Tris-HCl pH 7.0, 100 mM 
NaCl, 2.5 mM MgCl2, 5 mM BME, and 2 mM AMPPNP or ATP. To induce 
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crosslinking, samples were exposed to long-range UV (365 nm) for 20 minutes at 4°C 
using a 4W handheld UV lamp (UVP). RNA-protein adducts were separated using 
NuPage 4-12% Bis-Tris protein gels (Thermo Fisher Scientific) and visualized using 
Typhoon FLA 9500 laser scanner (GE Healthcare). 
 
Helicase and RNA degradation assays 
 For the decay timecourses in Figure 38B final concentrations were 20 nM 
exosome, 22 nM or 0 nM Mtr4, 1 mM ATP or AMP-PNP, 0.5 U/µL RNAse inhibitor 
(New England Biolabs), and 10 nM RNA substrate in RNA decay buffer (20 mM 
HEPES-KOH pH 7.5, 50 mM potassium acetate, 1.1 mM magnesium acetate, 2.5 mM 
DTT, 0.01 % IGEPAL). 50 mM ATP and AMP-PNP stock solutions were adjusted to 
pH 7.0 with KOH. Exosome complexes were incubated on ice with Mtr4 (or buffer) at 
2 µM and 2.2 µM, respectively, in RNA decay buffer for 1 hour prior to diluting 1:10 
in RNA decay buffer and initiating the reaction. A mix containing RNA, ATP or 
AMP-PNP, and RNAse inhibitor (all at 1.1x final concentration) was incubated at 
20°C for 5 min prior to initiation with 1/10 volume of 200 nM enzyme mix. Reactions 
were quenched after the indicated incubation times by adding 10 µL of reaction to 5 
µL of stop mix (0.3 % w/v SDS, 30 mM EDTA pH 8.0, 3 U/mL proteinase K [New 
England Biolabs]) followed by proteinase K digestion at 37°C for 1 hour and flash 
freezing in liquid nitrogen for storage at -80°C. 3.5 µL sample was loaded per lane and 
run for 45 minutes on 4-20% acrylamide-TBE gels using 0.5x TBE as running buffer. 
Helicase assays used the exact same protocol except a different substrate was used 
(see above) and the exosome subunits were inactive in all reactions. For the reactions 
in Figure 39, reaction conditions and substrate are described in Chapter 2 Materials 
and Methods. 
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RNA loading pilot experiments 
 Catalytically inert Exo13tr complexes were mixed with a 1.1-fold molar excess 
of Mtr4, diluted to 10 µM in Superdex buffer (20 mM HEPES-KOH pH 7.5, 100 mM 
KOAc, 0.5 mM Mg(OAc)2, 2.5 mM DTT) and incubated on ice for an hour. During 
this incubation, four 10x initiation mix containing either 20 mM ATP-KOH pH 7.0, 20 
mM AMP-PNP-KOH pH 7.0, ATP plus 4 µM DNA Trap (described above), or ATP 
plus 2 µM RPA were prepared in reaction buffer plus 20 mM Mg(OAc)2. Then, 11 µL 
of the Mtr4/exosome mix or buffer (for the substrate only reaction) was mixed with 
480 µL of reaction buffer and 2.75 µL of a 40 µM stock of the tripartite substrate with 
v = 20 nt or buffer (for the –RNA reaction) and incubated at room temperature for 5 
minutes. Then, 55 µL of one of the initiation mixes described above was added and 
the reaction was incubated at room temperature for 40 min. Final concentrations were 
0 or 200 nM Exo13tr, 0 or 220 nM Mtr4, 0 or 2 mM ATP-Mg, 0 or 2 mM AMP-PNP-
Mg, 0 or 200 nM substrate, 0 or 400 nM DNA trap, and 0 or 200 nM RPA. The 
reaction was then centrifuged and the supernatant loaded onto a Superdex200 increase 
10/300 GL column. 500 µL fractions were collected and the three fractions 
surrounding the centroid of each peak were analyzed for protein and nucleic acid 
content. For the nucleic acid gels, samples were treated with proteinase K as above 
prior to PAGE analysis. SYBR Gold staining was performed per manufacturer’s 
recommendations, and gels were imaged using a Typhoon FLA 9500 instrument. 
 
Protein crosslinking 
 Prior to crosslinking, proteins were desalted using Bio-Spin 6 columns (Bio-
Rad) that had been equilibrated in 20 mM HEPES-KOH pH 7.5, 100 mM KOAc, 1 
mM Mg(OAc)2, 0.5 mM ADP and 0.05 mM TCEP-HCl. Complexes were then diluted 
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to 550 nM and treated with 1/10th volume of a 10x solution of BM(PEG)3 (Thermo 
Scientific. Prepared fresh in buffer from powder directly before the experiment) or 
glutaraldehyde and incubated at 4°C for 1 hr for BM(PEG)3 or 25°C for 15 min for 
glutaraldehyde. The BM(PEG)3 reaction was quenched by the addition of DTT to 2.5 
mM and the glutaraldehyde reaction was quenched with the addition of Tris-Cl pH 8.0 
to 50 mM. The reactions were analyzed by SDS-PAGE using either SYPRO Ruby 
staining or Western blotting as previously (see Chapter 2, Materials and Methods). 
 
Sample preparation for cryo-EM 
 Catalytically inert Exo13tr complexes were mixed with a 1.1-fold molar excess 
of Mtr4, diluted to 5 µM in loading buffer (20 mM HEPES-KOH pH 7.5, 100 mM 
KOAc, 0.5 mM Mg(OAc)2, 25 µM TCEP-HCl) and incubated on ice for an hour. 
During that time, a 10x initiation mix containing 20 mM ATP, 4 µM DNA trap, and 
20 mM Mg(OAc)2 in loading buffer was prepared. Then, 40 µL of the Mtr4-exosome 
mixture was mixed with 1140 µL of loading buffer and 18.6 µL of a 7 µM tripartite 
substrate with v = 38 nt and incubated at room temperature for 10 min. After this 
incubation, 130 µL of initiation mix was added and the reaction incubated at room 
temperature for 50 minutes. Final concentrations were 150 nM Exo14tr, 100 nM 
substrate, 400 nM DNA trap oligo, and 2 mM ATP-Mg. During this incubation, a 
Biospin 6 column was equilibrated in loading buffer containing an additional 1 mM 
Mg(OAc)2 and 1 mM ADP (ADP buffer). Once the reaction was finished, the sample 
was concentrated to 50 µL in a Microcon YM-30 (Millipore) and buffer exchanged 
into ADP buffer using the Biospin column. At this point the concentration of the 
complex was determined by a Bradford assay and the protein diluted to 600 nM with 
ADP buffer. 16 µL of this solution was aliquoted into a microcentrifuge tube and 2 µL 
of a 1 mM BM(PEG)3 solution in ADP buffer was added. The sample was incubated 
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at 4°C for 1 hr to crosslink and was then quenched by the addition of 2 µL of a 25 mM 
DTT, 0.1% w/v CHAPSO solution in ADP buffer. This resulted in the following final 
concentrations for the sample: 500 nM complex, 100 µM quenched BM(PEG)3, 0.01% 
w/v CHAPSO, 2.5 mM DTT, 1.0 mM ADP-Mg in loading buffer. 
 4 µL of this solution was applied to a UltrAufoil 300 mesh R1.2/1.3 grid 
(EMS) that had been glow discharged at 15 mA for 1 minute. After a 30 second wait 
time, the grid was blotted with Whatman paper for 2.5 seconds at 95% humidity and 
plunged into liquid nitrogen-cooled liquid ethane using a Vitrobot Mark IV (FEI). 
 
Data Collection and processing 
 Screening and data collection were performed at Memorial Sloan Kettering on 
the Titan Krios 300 kV microscope equipped with a Gatan K2 Summit direct detector. 
Data collection was performed in super-resolution mode using a target defocus range 
of -1.5 to -2.5 µm. 10 second exposures were fractionated to into 50 frames, and the 
collection resulted in a total of 1483 micrographs with a pixel size of 1.089 Å. After 
motion correction, pruning via max resolution cutoff from CTF estimations, and 
manual pruning 1145 micrographs were included for subsequent analysis (see Results 
section of this chapter for details). 
 1000 particles from 50 of these movies (chosen at random) were manually 
selected, extracted (384 pixel box, 350 pixel background circle), and used to generate 
2D class averages as references for auto-picking on these micrographs. The result of 
this was extracted again and subjected to 2D classification, and selected classes from 
that were used for auto-picking using all 1145 micrographs (360 Å mask, picking 
threshold 0.25, 150 Å minimum inter-particle distance). 
 Ab initio 3D models were generated and refined in CryoSPARC and used as 
starting models for 3D classification in Relion. Additionally, a round of pruning via 
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selecting from 2D class averages in CryoSPARC enabled the removal of ~20,000 
particles in the early phases (Figure 44). After that and an initial round of 3D 
classification (Figure 43B), focused 3D classification was performed via modification 
of established protocols (Bai et al., 2015). PDB 4IFD (which contains Exo9 plus 
RNA, Dis3 in the through-channel conformation, and the Rrp6 EAR) was docked into 
3D volumes from refinements in Relion, and its chains corresponding to the RNA and 
the Rrp6 EAR were removed. The map was then segmented using Segger in Chimera 
(Pettersen et al., 2004) and the segments were grouped based on chains in the docked 
model. For the top density focused classification, all of the segments encompassing 
4IFD were merged into a single group, and this was used to generate a synthetic map 
based on those regions. Then, the segments on the top were grouped and used to make 
another synthetic map. The first synthetic map, which includes essentially every part 
of the original volume except for the top, was then used to generate a mask that was 
subtracted from all of the particles (whose orientations are known) in Relion. Using 
these subtracted particles, a 3D classification was performed without an image 
alignment and using a mask generate from the second synthetic map (which only 
encompasses the top densities). Finally, the desired class is selected from these two, 
the particles re-extracted, and refined again to proceed on to the next step. Focused 
classification for Csl4 was performed in essentially the same manner, except all of the 
segments except those encompassing Csl4 were subtracted from the map and the Csl4 
region was used as a mask for alignment-free 3D classification. 
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CONCLUSIONS 
 
 The work presented in this dissertation represents a small but significant step 
forward in our study of RNA exosome function. Specifically, the findings related to 
conformation control of Dis3 exonuclease activity, channeling of RNA through Exo9 
to Rrp6, and the determinants for helicase-assisted degradation of structured substrates 
all expand on our already rich understanding of the intrinsically regulated nature of 
RNA decay by the S. cerevisiae RNA exosome. 
 The speculative analogy made nearly two decades ago between RNA 
degradation by the exosome and protein degradation by the proteasome has turned out 
to be apt in more ways than the authors could have anticipated. Certainly, both 
complexes contain active sites that are shielded from their exteriors, but in addition the 
exosome-associated RNA helicases mirror proteasome-associated unfoldase activities: 
both consume ATP to unfold structured substrates and thread them through a narrow 
channel in the complex for their degradation. Stimulation of the nuclear exosome by 
the TRAMP-dependent addition of 3’ poly(A) tails calls to mind the role of K48-
linked poly-ubiquitin chains, added to proteins by the vast network of E2 enzymes and 
E3 ligases, in protein degradation. Furthermore, misfolded or otherwise aberrant 
proteins and RNAs can both be targeted for poly-ubiquitination or polyadenylation, 
respectively, over their healthy counterparts. Finally, these stimulatory activities can 
be antagonized by de-ubiquitinases for proteins and Rrp6 for nuclear transcripts to 
protect substrates that may have been mistakenly tagged for degradation. In hindsight, 
it is not terribly surprising that evolution ‘decided’ to use the same general strategies 
for restricting spurious protein or RNA degradation by these complexes, both of which 
are essential for maintaining normal cellular activities. 
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 While S. cerevisiae remains a powerful model system with a vast literature, 
advances in gene editing and mammalian protein expression systems have already 
begun to rapidly expand the study of exosome function in metazoans. Leveraging 
these new tools, investigators will have unprecedented control over these systems, and 
their work will undoubtedly illuminate how the exosome’s activities contribute to 
normal cellular function as well as disease states in humans. We anticipate that 
structural and biochemical characterization of exosome complexes using metazoan 
proteins will be essential to our interpretation of these studies, as it has been for S. 
cerevisiae. Hopefully our work, including use of 3’-3’ RNAs to trap nuclear 
complexes and the methods we’ve developed for observing helicase-dependent RNA 
decay, can be applied to these systems and be as useful to other investigators as they 
have been for us in our study of this remarkable complex.  
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APPENDIX A1: SYNTHESIS OF ASYMMETRIC 3’-3’ RNAS 
 
Prior to use of the diazido crosslinking molecule (Figure 9B), our initial 
strategy for synthesizing 3’-3’ RNAs used two differentially 5’ modified synthetic 
RNAs, both of which were purchased from IDT. The first RNA contains a 5’ azido 
modification and is an 11 nt in length, and the second contains a 5’ hexynyl group and 
is of variable length. Copper click chemistry was used to covalently attach these two 
5’ modifications, resulting in asymmetric RNAs containing two 3’ ends (Figure A1.1, 
panels A and B). 
These substrates were tested for complex formation with Exo12Dis3exo-endo-
/Rrp6exo-/Rrp47 (Figure A1.2) and were used RNase protection assays to determine the 
ideal length for crystallization (Figure A1.3). The RNase protection assays showed 
that a catalytically inert Exo10Dis3 can protect both 3’-3’ and 5’-3’ RNAs from 
degradation by exogenously added catalytically active Rrp6, and that 3’-3’ RNAs are 
trimmed down to the approximately the same size apparently independent of the initial 
size used. The 3’ end of the 5’-3’ RNA is presumably engaged by Dis3 and thus is 
inaccessible towards Rrp6’s trimming activity. Furthermore, Rrp6 that lacks the region 
necessary for interaction with Exo9 (Rrp6DNDC) cannot degrade Exo10Dis3 protected 
3’-3’ RNAs to the same extent as Rrp6 that can associate with Exo9 (Rrp6DN), 
suggesting that these RNAs are indeed being threaded through the central channel to 
Dis3. Interestingly, these data contrast the channel-independent engagement of 3’-3’ 
RNA by Dis3 observed in the crystal structures (Figures 9D and 27A). 
These RNAs were used to determine the preliminary structures of the nuclear 
exosome in Chapter 1 and the final structure of the Mpp6 exosome presented in 
Chapter 2 (Figure 27A). Synthesis and purification of these RNAs are described in the 
Materials and Methods section of Chapter 2.   
 b 
 
 
 
 
 
 
 
 
 
 
Figure A1.1. Synthesis scheme for asymmetric 3’-3’ RNAs. (A) Synthesis scheme 
for generating 3’-3’ RNAs from 5’ alkynyl and 5’ azido RNAs. RNA is represented as 
an arrow pointing from 5’ to 3’. R represents a proprietary aliphatic linker. Gel is 15% 
acrylamide TBE-urea and RNA is visualized using SYBR gold stain. Equal ng of total 
RNA was loaded in each lane. (B) Synthesis of asymmetric 3’-3’ RNAs of different 
lengths. ‘HPLC’ label indicates reactions that were purified by weak anion exchange 
as detailed in Chapter 1. 
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Figure A1.2. Exo1244exo-endo-/6exo-/47 forms a complex with an asymmetric 3’-3’ 30 
nt RNA. A Superdex200 increase 10/300 GL column was run in 20 mM Tris-Cl pH 
8.0, 100 mM NaCl, 0.1 mM MgCl2, 0.5 mM TCEP-HCl and 400 µL fractions were 
collected. Absorbance at 280 nm (A280) is shown as a blue curve roughly aligned to 
the fractions. Native PAGE is a 4-20% acrylamide TBE gel and Urea PAGE is a 15% 
acrylamide TBE urea gel. Both are visualized using SYBR Gold staining. 
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Figure A1.3. Exo10Dis3exo-endo- can protect RNA from exogenously added Rrp6. (A) 
reaction scheme for a Exo10Dis3 protection of 3’-3’ RNAs from exogenous Rrp6. Side 
views are shown with exosome components indicated, and the central channel is 
depicted with dashed lines. RNA is represented as a black line with arrows pointing 
towards the 3’ end. (B) SYBR gold stained 15% acrylamide-urea PAGE of reaction 
timecourses. Reactions contained 100 nM RNA, 120 nM Exo10Dis3exo-endo-, 120 nM 
Rrp6129-533 (Rrp6DNDC) or Rrp6129-733 (Rrp6DN) added directly after time = 0 min. 
RNA and Exo10Dis3 were incubated together at 30°C for 5 min at 1.1x final 
concentration prior to initiation with 1/10th volume of 10x Rrp6. Reactions were 
conducted in 20 mM Tris-Cl pH 8.0, 50 mM KCl, 0.5 mM MgCl2, 10 mM DTT at 
30°C.  
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APPENDIX A2: 3’ PHOSPHATE RNA DECAY BY DIS3 MUTANTS 
 
 In addition to the mutants tested in Figures 24F and 24G, we assayed other 
mutant Dis3 enzymes for degradation of 3’ phosphate RNA (Figure A2.1). These 
mutants purified essentially as WT with the exception of the Y595W/R600D double 
mutant (Figure A2.1 panel B). None of the mutants tested showed differential activity 
on 3’ phosphate RNA compared to 3’ OH RNA. 
  
 f 
 
 
 
 
 
 
 
 
 
 
Figure A2.1. Mutants in Arg600 and Tyr595 do not alter Dis3 activity on 3’ 
phosphate RNA relative to 3’ OH RNA. (A) RNA decay of 3’ phosphate 5’ FAM 49 
nt AU-rich RNA in the presence or absence of a phosphatase (CIP) by the indicated 
enzymes. Gels are 15% acrylamide TBE-urea and were imaged for fluorescein signal. 
(B) SYPRO Ruby stained gels showing the indicated purified mutants. (C) Structure 
of RNA in Dis3’s active site in the nuclear exosome (PDB 5K36) with sidechains of 
mutated residues shown. 
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APPENDIX A3: DIS3 PULLDOWN FROM MUTANT YEAST STRAINS 
 
 In order to further develop models for Mtr4 recruitment to the exosome in 
vivo, we transformed a C-terminal TAP-tagged Rrp44 (selected for with a URA 
marker, from Wasmuth et al., 2012) into selected viable strains from the experiments 
in Figure 33 and performed IgG pulldowns using lysates from each of the resulting 
strains in the presence or absence of RNase A (see Chapter 2 Materials and Methods 
for cell growth and cryo-milling protocols) (Figures A3.1 and A3.2). 
One gram of cell powder was resuspended in 3 mL of extraction buffer (50 
mM HEPES-NaOH pH 7.5, 100 mM NaCl, 0.5 mM MgCl2, 0.1% v/v IGEPAL ca-
630, 5 mM Na-TCEP pH 7.0, 1 mM PMSF, 1x protease inhibitor cocktail [Pierce]), 
incubated on ice for 10 min, then centrifuged at 20,000 x g for 10 min at 4°C. The 
supernatant was transferred to fresh tubes, then centrifuged again to further clarify the 
extract. For the ‘input’ sample, 40 µL of this supernatant was added to 110 µL of 
water and 50 µL 4x LDS + BME sample buffer and boiled for 5 min. Then, 1 mL of 
supernatant was added to 30 µL equilibrated IgG beads (GE Healthcare) and in a 
separate tube, 1 mL was added to beads + 10 µg RNase A (Qiagen). The tubes were 
rotated at 4°C for 1 hr, the beads were centrifuged at 500 x g for 30 seconds and the 
supernatant discarded. The beads were then washed with 900 µL wash buffer (25 mM 
HEPES-NaOH pH 7.5, 100 mM NaCl, 0.01% v/v IGEPAL ca-630, 1 mM Na-TCEP 
pH 7.0), centrifuged, then the supernatant discarded. The beads were washed again in 
a similar fashion, then resuspended in 100 µL TEV solution (50 mM Tris-Cl pH 8.0, 
250 mM NaCl, 2 mM Na-TCEP pH 7.0, 0.01 % v/v IGEPAL ca-630, 1 µM TEV 
protease) and incubated at 4°C overnight. The next morning the beads were agitated, 
centrifuged, and 90 µl of supernatant was added to 30 µL of 4x LDS + BME sample 
buffer for the pulldown samples. Lysates and TEV eluates were analyzed for the 
 h 
presence of exosome components and the TAP tag via Western blotting (Figure A3.1). 
TEV cleaves between the protein A and CBP portions of the TAG, thus releasing the 
complex from the beads (Figure A3.1, CBP blot). 
 This protocol suffered from several technical challenges that made the results 
essentially uninterpretable. The cryo-milling and/or extraction of from the powder 
were highly variable, making it very difficult to normalize the pulldown for total 
protein input (Figure A3.1, Direct Blue stain). Additionally, Mtr4 bound 
nonspecifically to the beads under the conditions used (Strain N and Lane 1, Figures 
A3.1 and A3.2 respectively), and at higher salt concentrations (e.g. 150 mM) Mtr4 
doesn’t bind the exosome in reconstitutions (not shown). Treatment of the lysate with 
RNase A appeared to mitigate this non-specific binding but not eliminate it (compare 
lane 1 from Figure 3.2 panels B and C). A positive result from these experiments was 
that the Rrp47 antibody appears to be functioning well, insofar as only complexes 
containing the TAP tagged Dis3 and the N-terminus of Rrp6 could pull down Rrp47 
(Figure A3.2). 
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Figure A3.1. Optimization of the pulldown protocol. Strain N and W both contain 
full length Rrp6 and Mpp6 but strain N lacks the TAP-tagged Dis3. Anti-CBP detects 
the calmodulin binding protein region of the TAP tag and was purchased from 
Millipore. Anti-Mtr4 is as described previously (see Materials and Methods, Chapter 
2). 
  
 j 
 
 
 
 
 
 
 
 
 
Figure A3.2. Pulldown of TAP-tagged Dis3 in different mutant S. cerevisiae 
strains. Western blotting was performed as previously (Chapter 2, Materials and 
Methods). Rabbit polyclonal antibodies were raised against calmodulin binding 
protein (CBP, Millipore), Mtr4 residues 80-1073, Rrp6 residues 129-516, and Rrp47 
residues 1-100 and affinity purified. Rrp6 and Mpp6 boundaries are as indicated at the 
bottom of panel A. (A) Input samples. (B and C) TEV eluates in the absence (B) or 
presence (C) of RNase A. 
